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SUMMARY 
This thesis investigated the effects of dietary supplementation with the guanidino 
compounds creatine (Cr) and arginine on metabolism in humans. Experiments 
studied the influence of exercise and Cr + carbohydrate (CHO) ingestion upon 
muscle glycogen and Cr accumulation, the effects of arginine ingestion upon the 
fate of ingested CHO, the influence of Cr + CHO supplementation upon muscle 
glycogen accumulation and endurance exercise performance, and the effects of Cr 
supplementation upon various indices of health. Biochemical analysis was 
performed on venous blood samples and on muscle biopsy samples from vastus 
lateralis obtained from subjects during the experiments. Blood samples were 
analysed for glucose, insulin and lactate concentrations and muscle samples for 
adenosine triphosphate, Cr, phosphocreatine and glycogen concentrations. 
Exhaustive exercise, performed prior to Cr + CHO supplementation, augmented 
muscle Cr accumulation, but Cr accumulation was diminished in non-exercised 
muscle. This was possibly due to a blunted CHO-stimulated insulin response 
after exercise, which would diminish insulin-mediated Cr transport. Creatine + 
CHO supplementation augmented glycogen resynthesis in exercised muscle to a 
greater extent than CHO supplementation alone. A tendency for greater glycogen 
synthesis was observed following Cr + CHO supplementation without prior 
exercise, and was paralleled by a tendency for subsequent submaximal exercise to 
be prolonged. Ingestion of 10 g arginine with a CHO drink was found not to have 
any influence upon the fate of the ingested glucose. This was probably due to the 
resulting plasma arginine concentration being insufficient to influence CHO 
disposal. Finally, acute (5 day) and prolonged (8 week) Cr supplementation 
produced no adverse effect upon health, as indicated by markers of 
haematological, hepatological, muscle and renal function. 
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Chapter 1 
REVIEW OF LITERATURE 
1.1 Introduction 
In the last decade a substantial amount of research has been conducted upon the 
effects of the guanidino compound, creatine (Cr), on various aspects of cellular 
function. The majority of this research has addressed the various roles that Cr and 
its phosphorylated form, phosphocreatine (PCr) play in muscular function, either 
in conditions of muscle disease, or in healthy muscle of individuals performing 
exercise. Much of the recent work has addressed this latter role, and has 
demonstrated that supplementation of the diet with Cr can increase muscle Cr 
concentration and lead to subsequent improvements in exercise performance. 
This research has led to the practice of `Cr supplementation' becoming very 
popular worldwide with professional and amateur sportspersons. This review 
aims to summarise the research that has contributed to our current understanding 
of muscle Cr metabolism and also to highlight areas for further investigation of 
the aspects of Cr supplementation and muscle function. 
1.2 Historical perspective of creatine research 
Creatine was first isolated and identified as a `new organic constituent of meat' in 
1835 by the French scientist, Chevreul (cited by Needham, 1971). In 1847, 
Liebig observed that Cr was a regular constituent of mammalian muscle, but only 
present in small amounts in other organs that he investigated (cited by Needham, 
1971; Balsom et al, 1994). Liebig also noticed that this compound was present in 
much higher amounts in muscle of wild foxes than in that of captive specimens. 
From this he was the first to propose that Cr was associated with muscular work. 
An important discovery relating to the function of Cr in muscle was achieved in 
1927 by Fiske and Subbarow (cited in Needham, 1971), who reported a labile 
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phosphorous in resting muscle of the cat, which they termed `phosphoryl' Cr. 
They demonstrated that levels of muscle PCr diminished when the muscle was 
electrically stimulated, but returned to resting levels in the following recovery 
period. Eggleton and Eggleton (1928) supported the finding that the labile 
phosphorous was a compound of Cr. They also reported that the `combined 
creatine' (i. e. PCr) was present in a much higher proportion in resting muscle than 
was present in fatigued or rigor muscle (i. e. myofibril cross bridge detachment is 
not possible due to a lack of ATP, found following death or poisoning of muscle 
by metabolic inhibitors). These studies supported earlier findings (Schlossmann, 
1924; Tiegs, 1926; both cited in Needham, 1971), which stated that concentration 
of "diffusible creatine" (i. e. Cr not combined with phosphorous) increased during 
muscle contraction. These findings suggested that PCr was used in some way 
during muscular contraction, possibly as an energy source, and the resulting 
product, Cr was used to resynthesise PCr during recovery from contraction. Work 
by Lohmann (1928) and Fiske & Subbarow (1929) had identified another 
compound involved in muscular energy provision (cited in Needham, 1971). This 
compound, identified as adenosine triphosphate (ATP), was suggested to play a 
role, in combination with PCr, in muscle energy provision which did not involve 
production of lactic acid. Subsequent work by Lundsgaard (c. 1930, cited in 
Needham, 1971) confirmed this relationship, and helped fuel research leading to 
Cr and PCr being recognised as key intermediates of skeletal muscle metabolism 
(Bessman & Carpenter, 1985). 
Around this time a substance which had been discovered in urine of man by 
Heintz and Pettenkofer (c. 1860, cited in Needham, 1971), was identified by 
Liebig as creatinine. The excretion of this substance was found to be related to 
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the amount of active muscle tissue in the body, leading Chanutin (1926, cited in 
Needham, 1971) to conclude that creatinine was directly derived from the Cr 
stored in muscle. 
These early findings led investigators to determine whether or not Cr could be 
taken into the body from the diet. The first Cr feeding experiments were 
conducted in the early part of the 20th century, using Cr extracted from either 
meat or urine. These experiments showed that levels of Cr and creatinine 
recovered from urine amounted to less than the amount of Cr given in the feeding. 
This led to the conclusion that some of the Cr fed to animals or man was retained 
in the body. This hypothesis was given further support by the findings of Folin 
and Denis in 1912 and 1914 (cited in Needham, 1971) that cats fed Cr showed 
increases in muscle Cr content of up to 70%. 
In 1939 Ray et al (cited in Chaikelis, 1940) discovered that feeding subjects 60 g 
gelatin (containing 25% glycine) per day, resulted in a delay in fatigue 
development. At about the same time, Bloch & Schoenheimer (1939) 
demonstrated that Cr was synthesised from glycine and 2 other amino acids; 
arginine and methionine. It was subsequently demonstrated that ingestion of 6g 
of glycine every day for 10 weeks produced improvements in some measurements 
of muscle performance (Chaikelis, 1940). It was postulated that glycine ingestion 
stimulated Cr biosynthesis, thereby increasing muscle Cr concentration 
sufficiently to improve exercise performance. This suggestion was supported by 
work of Borsook et al (1941), which demonstrated that consuming gelatin or 
arginine and glycine increased Cr biosynthesis. This and subsequent research led 
to the elucidation of the Cr biosynthetic pathway involving the 3 amino acids and 
2 enzymes (Walker, 1979; Figure 1.1; section 1.3). 
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Little further research was published concerning Cr supplementation until Sipilä 
et al (1981) released the findings of a year-long Cr treatment of patients with 
gyrate atrophy of the choroid and retina. This disease is caused by a metabolic 
disorder resulting in an inability to synthesise Cr. Subjects ingested 1.5 g Cr per 
day for a year, which reversed the type II muscle fibre atrophy associated with the 
disease. Over the period of the treatment there was a subjective increase in 
strength, and anecdotal evidence led the investigators to hypothesise that Cr 
ingestion may influence exercise performance. Despite this finding, Cr 
supplementation did not attract further attention until 1992, when Harris et al 
published the results of a number of supplementation trials which had been 
conducted in their laboratory. The findings of this investigation and the 
subsequent research which it prompted are discussed in more detail in section 1.7. 
1.3 Biosynthesis of Creatine 
Creatine is synthesised by the body from three amino acids, glycine, arginine and 
methionine (Fig. 1.1). In the first reaction, an amidine group is transferred from 
arginine to glycine, producing ornithine and guaiiidinoacetate. This reaction is 
catalysed by L-arginine: glycine amidinotransferase (commonly called 
transamidinase) and is reversible (Walker, 1960,1979). The second reaction, 
catalysed by S-adenosylmethionine: guanidinoacetate N-methyltransferase, 
involves the irreversible transfer of a methyl group from S-adenosylmethionine to 
guanidinoacetate, and results in the formation of Cr and S-adenosylhomocysteine 
(Walker, 1960,1979). In man, this biosynthesis occurs mainly in the liver and, to 
a lesser extent, in the pancreas and the initial reaction can also occur in the 
kidneys (Walker, 1979). In addition to endogenous synthesis, Cr can also be 
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Figure 1.1 Biosynthesis of creatine. (Walker, 1979) 
DIET FOOD 
CREATINE 
tCYCLOCREATW 
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(98%) (2x) 
ADP ATP 
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(70x) ,,, e , (ans) 
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I NH,. CO=. . {---------%-----N --------------- 
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CAP 1 
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tig. 1. Reactions involved in the biosynthcsis and mctabolism of creatine. De nova 
biosynthesis of ercatine can occur in liver and pancreas of man and in liver of chicks. In 
contrast to human liver, human pancreas and chick liver have low arginase levels and can- 
not synthesize citrulline from ornithine. Controls modulate excessive biosynthesis of 
creatine during ingestion of creative-containing diets and periods of inadequate food intake 
and thus spare amino acid precursors of creatine and the important one-carbon pools. 
Tissues containing crcatinc kinasc take up and release creatinc and its synthetic analog 
cyclocreatine by unknown mechanisms; percentages phosphorylated in resting muscle are 
given in parentheses. The crcatinc-creatine-P pool is continuously depleted throughout life 
by the formation and excretion of creatininc, about 2 g/day in man; this loss must be 
replaced from the diet or by biosynthesis. AT-SH, glycine amidinotransferasc; MT, gua- 
nidinoacetate N-methyltransfcrasc; CK, crcatinc kinase; SAM, S adenosylmethionine; 
SAH, S-adenosylhomocysteine; CAP, carbamoyl phosphate; 1-C, one-carbon derivative. 
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obtained in the diet from meat and fish, although biosynthesis alone supplies 
sufficient Cr to maintain normal muscle function in healthy individuals. This is 
demonstrated in the case of vegetarians, who receive no Cr from dietary sources, 
and have serum Cr levels within the normal range, albeit possibly at the lower end 
of the scale (Delanghe et al, 1989). The rate of Cr biosynthesis is controlled by 
the content of the transamidinase enzyme, which is regulated by feedback 
inhibition from Cr (Walker, 1979). Creatine feeding has been demonstrated to 
decrease transamidinase protein content and activity at a pre-translational level, as 
evidenced by a decrease in transamidinase mRNA (McGuire et al, 1984). The 
major sites of Cr synthesis, the liver, pancreas and kidneys, have relatively low 
concentrations of Cr, and these sites do not phosphorylate Cr to any significant 
extent (Walker, 1979), indicating that Cr is transported away from sites of 
synthesis to sites of storage. This separation of biosynthesis and utilisation 
provides the opportunity for regulation of uptake and retention of Cr by muscle, 
and excretion of excess Cr by the kidneys (Walker, 1979). 
1.4 Creatine transport 
Creatine is transported in blood, with normal resting plasma concentrations in 
man being 50-100 gmol. l"1 (Harris et al, 1992). The total concentration of Cr and 
PCr (TCr) in muscle is far greater than in plasma, in the region of 110 - 130 
mmol. kg 1 (Harris et al, 1974), suggesting that Cr enters muscle against a strong 
concentration gradient. Two mechanisms have been proposed to explain the high 
Cr concentration in skeletal muscle, a specific transport process for Cr entry into 
the cell and the ability of the cell to `trap' Cr within the cell, thereby preventing 
its loss. 
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A specific Cr transporter has been identified in brain, heart, kidney and skeletal 
muscle of rabbit (Guimbal & Kilimann, 1993) and rat (Schloss et al, 1994). 
Investigation of human tissues has shown that mRNA for this Cr transporter are 
expressed in brain, heart, intestine, kidney, ovaries, skeletal muscle and testes, and 
that the transporter belongs to a group of transporter proteins involved in 
neurotransmitter uptake (Nash et al, 1994). 
The presence of a transport system that mediates Cr entry into cells had, however, 
been proposed many years prior to the discovery of the transport protein itself. 
An energy-dependent, saturable entry process was shown to exist for transport of 
Cr into muscle (Fitch & Shields, 1966; Fitch et al, 1968; Daly & Seifter, 1980). 
Creatine transport into rat extensor digitorum longus (EDL) muscle in vitro was 
inhibited under anaerobic conditions and by the presence of an oxidative 
phosphorylation uncoupling compound, 2,4-dinitrophenol (Fitch & Shields, 
1966). These findings demonstrated that Cr transport was an energy-requiring 
process. Analysis of the kinetic properties of Cr transport into muscle revealed a 
saturable process with a Michaelis constant (K, Y, ) for Cr entry of 500 gmol. L"1 and 
a maximal reaction velocity (V ) of 600 µmo1. L'l. h"'. Relatively little Cr was 
lost from the muscle, suggesting that Cr entry and loss were dissociated from one 
another. It was later demonstrated that the entry process was specific for Cr, or 
compounds with very similar structure, separating the proposed Cr transporter 
from other transporters, such as those for transport of amino acids or other small 
molecules (Fitch et al, 1968). The compounds with similar structure to Cr that 
were transported into the cell were found to inhibit Cr uptake. It was proposed 
that these compounds might be of use to further investigate the effects of low 
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cellular Cr concentration upon muscle function, particularly in disease states such 
as Duchenne muscular dystrophy. 
A study of Cr uptake by a variety of cultured cells known to accumulate Cr 
supported the previous findings that the process was saturable, and inhibited by 
structural analogues and metabolic inhibitors (Daly & Seifter, 1980). These 
investigators demonstrated that Cr uptake was a heterogeneous process, with at 
least two components. One component of Cr transport had a low K,,, for Cr (0.02 
- 0.04 mM) and contributed to less than 10% of the total Cr transport activity. 
The other component exhibited a higher K,,, (3.1 - 6.4 mM), was dependent upon 
the presence of Na and Cl" in the incubation medium and could occur against a 
strong concentration gradient. It was also shown that Cr uptake by the cultured 
cells was inhibited in the presence of compounds that inhibited the activity of 
Na+/K+ATPase (Daly & Seifter, 1980). The observation of non-linear 
Lineweaver-Burke plots of Na+-dependent Cr uptake prompted the authors to 
suggest that phosphorylation of Cr taken into the cell stimulated Cr transport to 
some extent. Subsequent work, however, demonstrated that intracellular 
phosphorylation of Cr was not necessary for net Cr accumulation by human 
monocytes and macrophages exhibiting similar uptake (Loike et al, 1986). 
Cr transport by cultured rat and human skeletal muscle cells was examined by 
Loike and colleagues (1988). In a series of experiments the authors demonstrated 
that the concentration of Cr in the culture medium specifically affected the rate of 
Cr transport. At high extracellular Cr concentrations it appeared that the Na+- 
dependent, but not the Na+-independent, component of transport was down- 
regulated. This high extracellular Cr concentration did not alter Cr efflux from 
the cell, nor did it affect the affinity of the transport mechanism for Cr, which 
8 
suggested that either the amount of the transport component or its rate of turnover 
were under regulation. It was shown that Cr had to enter the cell to exert this 
regulatory effect, but that its phosphorylation was not required. Maximal 
downregulation of transport activity was between 70 - 80 % and was achieved 
after 24 h incubation in medium containing a high Cr concentration. The authors 
demonstrated that the turnover rate of transporter was relatively slow and that 
protein synthesis was involved in the down-regulation process (Loike et al, 1988). 
The recent identification and cloning of the Cr transporter and its mRNA has 
enabled investigation of the effects of in vivo Cr supplementation on its content in 
skeletal muscle (Guerro-Ontiveros & Wallimann, 1998). Prolonged (3 -6 month) 
Cr feeding in rats was shown to significantly decrease the muscle Cr transporter 
content. However, the amount of Cr administered to rats in this study was 
exceptionally high (equivalent to humans ingesting 150 g. d"'). The effect of Cr 
supplementation on Cr transporter content of human muscle is currently unknown. 
It has been proposed that the high Cr concentration of skeletal muscle is achieved 
by `trapping' Cr once it has been transported inside muscle (Fitch & Shields, 
1966; Fitch, 1977). Phosphocreatine is a polar molecule, and therefore cannot 
pass through membranes (Fitch, 1977). As 60% of muscle Cr is in the form of 
PCr it is thought that this may account for a certain amount of muscular Cr 
retention, but is not wholly responsible (Fitch, 1977). Other methods of muscle 
cell Cr entrapment proposed include binding to intracellular components and the 
existence of membranes which restrict passage of selected compounds (Fitch & 
Shields, 1966; Fitch, 1977). This latter theory would depend on muscle having a 
separate method of transporting Cr out of the muscle. This method would act 
with a lower affinity for Cr than the process allowing Cr to enter the muscle, and 
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would account for the difference between entry and loss of Cr demonstrated in 
vitro by rat skeletal muscle (Fitch & Shields, 1966). Recently it has been 
proposed that a fraction of Cr is compartmentalised within the muscle cell and 
does not contribute to the TCr pool involved in muscle energy metabolism 
(Hochachka & Mossey, 1998). This was suggested by the finding that, in fish 
fast-twitch muscle in vivo, the enzyme creative kinase (CK) did not have access 
to, nor did it interact with, the total intracellular pool of Cr + PCr. The authors 
proposed that a significant amount of Cr was bound within the cell, making it 
unavailable for interaction with CK. Some Cr binding sites have been identified 
(Saks & Ventura-Clapier, 1994), although it has been suggested that further, as 
yet unidentified, Cr binding sites also exist within muscle (Hochachka & Mossey, 
1998). 
1.5 Total creatine pool 
In a normal 70 kg male the total body Cr pool (TCr) is approximately 120 g 
(Walker, 1979), the majority of which (>95%) is located in skeletal muscle at a 
concentration of - 125 mmol. kg"1 d. m. , where it exists in either 
its free (40%) or 
phosphorylated (60%) form, PCr (Harris et al, 1974). The remaining body Cr 
(-5%) is found in small quantities in brain, liver, kidneys and testes (Walker, 
1979). 
Daily Cr turnover is about 2 g. d"1 for a 70 kg male, with Cr being replaced 
through endogenous synthesis, or dietary Cr intake, or both (Walker, 1979). Since 
its first discovery in the urine of man, it has been established that creatinine is the 
sole product of Cr degradation (Needham, 1971). This process is irreversible and 
occurs non-enzymatically with no further degradation of creatinine. Creatinine 
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excretion by the kidneys remains relatively constant in an individual, although it 
does vary between individuals (serum creatinine concentration, 60 - 130 µmol. L"1; 
Fitch, 1977; Medicine Publishing Foundation, 1983), and is primarily dependent 
upon an individual's muscle mass, the major site of creatinine production 
(Heymsfield et al, 1983). For this reason serum creatinine concentration is 
commonly used as a marker of skeletal muscle health and kidney function. 
Excretion of creatinine in the urine increases following a period of Cr 
supplementation and, upon cessation of supplementation, progressively decreases 
as muscle Cr concentrations return to pre-supplemented levels (Hultman et al, 
1996). 
1.6 Role of creatine in muscle metabolism 
Phosphocreatine is involved in energy transfer reactions for resynthesis of ATP. 
Catalysed by CK, PCr is broken down to Cr and a phosphoryl group, along with 
its bond energy, is transferred to adenosine diphosphate (ADP), thereby 
generating ATP. 
CK 
PCr+ADP+H+ Cr+ATP 
As indicated by the above expression this is an equilibrium reaction, however, as 
the free energy of PCr breakdown is greater than that of ATP hydrolysis, ATP 
resynthesis is the more energetically favourable outcome under normal conditions. 
Creatine kinase is present in the body as a number of different isoenzymes, 
dependent upon the tissue in which they are found (Burger et al, 1964). These 
isoenzymes have been found in brain, smooth, and striated muscle. Furthermore, 
it appears that slightly differing CK isoenzymes are compartmentalised within 
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cells, one type in the cytosol and another within mitochondria (Wallimann et al, 
1992). 
With regard to exercise, the most important CK isoenzymes are those present in 
skeletal muscle. One type, cytosolic creatine kinase (CKc), is located in the 
cytosol mainly in subcellular "compartments", such as sites of energy 
consumption (e. g. near myosin ATPase in myofibrils, or near ATPases for ion 
transport), or energy production (e. g. near glycolytic enzymes). The other form of 
CK, mitochondrial creatine kinase (CKM), is located between the inner and outer 
mitochondrial membrane. Much research has been conducted to determine the 
distribution and function of the CK isoenzymes within the cell, and have been 
summarised in a number of extensive reviews (Bessman & Carpenter, 1985; 
Wallimann et al, 1992; Wyss et al, 1992; Saks et al, 1994). These summaries 
have proposed a number of mechanisms by which CK and its associated 
substrates contribute to cellular energy homeostasis. 
The first main role of PCr is as a `temporal energy buffer' during the initial onset 
of muscular activity (Fig. 1.2a). A small proportion (5 - 10 %) of cellular CKc 
exists bound to the central portion of myosin filaments (i. e. the `H-zone' of a 
sarcomere), in close proximity to sites of ATPase activity (Turner et al, 1973; 
Wallimann et al, 1992). Upon contractile activity, the products of ATP hydrolysis 
are `pushed' toward the H-zone from either end of the A-band. The close 
association between CKc and myosin facilitates the rapid transfer of Pi from PCr 
to ADP for ATP resynthesis, maintaining a high ATP: ADP ratio, thus enabling 
contraction to continue. This role of PCr is considered to "buffer" the delay in the 
initiation of glycolysis that occurs at the onset of muscular contraction. Most of 
the remaining CKc of the cell, termed soluble CKc, is compartmentalised near 
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cytoplasmic sites of ATP production, i. e. glycolytic enzymes. The enzymes of 
glycolysis are mainly grouped in a glycolytic complex around the I-band of the 
sarcomere, where they are loosely associated with the major pool of CKc. An 
increase in Pi concentration resulting from PCr hydrolysis at the onset of 
contraction stimulates glycolysis (Connett & Sahlin, 1996), which ultimately 
produces ATP. In glycolytic muscle (e. g. predominantly Type Ilb fibres), it has 
been proposed that the ATP generated by glycolysis is mainly used for generation 
of PCr by CKM, to replenish the muscle pool of PCr and maintain a high PCr/Cr 
ratio in the cell (Wallimann et al, 1992). In oxidative muscle (e. g. predominantly 
Type I fibres) the major source of ATP is derived from oxidative phosphorylation, 
which occurs within the mitochondria. 
It was first proposed in 1981 that a "phosphorylcreatine shuttle" system operated 
within the cell to transfer oxidatively-derived energy from within the 
mitochondria to cellular sites of ATP consumption (Bessman & Geiger, 1981). 
Since then research has expanded upon this work and developed a model of a 
"phosphocreatine circuit" (Fig. 1.2), which is responsible for maintaining energy 
balance throughout the cell (Wallimann et al, 1992; Wyss et al, 1992). 
Mitochondrial CK acts in association with proteins of both the inner and outer 
mitochondrial membranes to transfer energy from ATP in the mitochondrial 
matrix to cytoplasmic Cr. At "contact sites" of inner and outer mitochondrial 
membranes, CKM is functionally associated with adenine nucleotide translocase 
(ANT) of the inner membrane (Wyss et al, 1992), and porin of the outer 
membrane (Brdiczka et al, 1994). This close association is believed to produce a 
highly organised multi-enzyme complex in which Cr from the cytosol enters the 
outer mitochondrial membrane through porin (which in this complex is cation- 
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selective) and passes into a channel within CKM. Adenine nucleotide translocase 
transfers ATP from the mitochondrial matrix to the CKM channel, where it is 
hydrolysed in the presence of Cr, thereby producing ADP and PCr. These 
products then leave the CKM channel, ADP returns to the mitochondrial matrix via 
ANT whilst PCr leaves the complex through porin by electrostatic repulsion due 
to its negative charge (Fig 1.2b(; ); Wyss et al, 1992). A slightly different model 
has also been proposed, in which the PCr formed within CKM enters the 
intermembrane space of the mitochondrion and leaves through porin in its anion- 
selective state (Fig 1.2b(11); Wyss et al, 1992). 
Addition of physiological concentrations (10 - 20 mM) of Cr to a medium 
containing cardiac muscle cells or fibres (Dzheia et al, 1983; Saks et al, 1991; 
Boehm et al, 1996) stimulates mitochondrial respiration. Furthermore, the 
presence of creatine, in a medium containing skinned skeletal muscle fibres, 
increases the sensitivity of mitochondria to small increases in ADP concentration, 
thereby promoting mitochondrial respiration (Tonkonogi et al, 1998). This Cr- 
stimulated respiration is achieved through displacement of the CK reaction 
occurring at the mitochondrial membrane in favour of PCr synthesis, thereby 
stimulating oxidative phosphorylation. Although it is not possible to demonstrate 
this effect in whole muscle, it is feasible that changes in muscle Cr concentration 
will result in a greater capacity of the muscle for mitochondrial respiration. 
The term `shuttle' may be misleading when referring to the transfer of energy 
from production sites to utilisation sites within the cytosol. It has been proposed 
that a series of `microcompartments' exist within the cytoplasmic compartment, in 
which all components of the CK reaction exist in equilibrium (Saks et al, 1994). 
An increase in cytoplasmic ADP concentration (e. g. near a contracting myofibril) 
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acts as a `signal' for ATP resynthesis by the closely associated CKc, the resultant 
Cr is then rephosphorylated by CKc situated slightly further away from the 
myofibril, producing ADP that, in turn, is itself rephosphorylated. This chain of 
dephosphorylation/phosphorylation reactions ultimately results in the propagation 
of a `metabolic wave' that travels from the site of ATP utilisation, through a series 
of CK reactions in the cytosol, to the mitochondrial membrane (Fig 1.2c), where 
Cr is rephosphorylated by mitochondrial ATP, as described above. These 
`signals' may arise from any ATP-utilising activity within the cell and if the 
`frequency' of the signals arriving at the mitochondrial membrane exceeds a 
certain threshold, local ADP concentration will rise. Elevated concentrations of 
both ADP and Cr will stimulate an enhanced rate of oxidative ATP synthesis 
within the mitochondrion (Saks et al, 1994; Wyss et al, 1992), thereby increasing 
the rate of PCr resynthesis by CKM (i. e. the response to the signal becomes 
`amplified'). 
A high intracellular PCr concentration can also prevent ADP accumulation within 
the cell (Wallimann et al, 1992). Under normal resting conditions PCr, via the 
CK reaction, maintains ADP at a relatively low concentration at sites throughout 
the cell. During conditions of metabolic stress, however, such as during maximal 
exercise or at low glycogen concentration at the end of prolonged exercise, ATP 
resynthesis will be insufficient to maintain contraction and ADP will accumulate 
within the cell. Accumulation of ADP can inhibit the activity of ATPases within 
the cell and result in a net loss of adenine nucleotides from the cell. This latter 
effect occurs through the activation of adenylate kinase, which catalyses the 
transphosphorylation of a pair of ADP molecules to ATP, which is utilised by the 
cell to maintain contraction, and adenosine monophosphate (AMP), which is 
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converted to inosine monophosphate (IMP) and ammonia. Both IMP and AMP 
can undergo further degradation to products that, along with ammonia, pass freely 
through the sarcolemma and out of the muscle cell. It can be seen that 
accumulation of ADP would be disadvantageous to muscle as it would result in a 
net loss of adenine nucleotides, ultimately decreasing its ability to sustain 
contraction. Therefore a high intracellular PCr concentration acts to maintain a 
high ATP/ADP ratio, thus preventing adenine nucleotide loss. 
Type I muscle fibre cells typically have relatively high levels of CKM and low 
levels of CKc (Wallimann et al, 1992), whereas in type II muscle fibre cells, the 
opposite is apparent (Yamashita & Yoshioka, 1991; Wallimann et al, 1992). 
There is also a differential distribution of PCr (and thus Cr) between muscle fibre 
types, with type II fibres containing more PCr than type I fibres (Söderlund & 
Hultman, 1991; SSderlund et al, 1992, Greenhaff et al, 1994; Sahlin et al, 1997). 
These differences reflect the functional characteristics of type I and type II fibres. 
Type I fibres are slow-contracting, have a low power output, favour aerobic 
metabolism for resynthesis of ATP during contraction and are relatively resistant 
to fatigue. These characteristics, coupled with the relatively lower levels of PCr 
in these cells, suggest that the `phosphocreatine circuit' is favoured in these 
muscle types. Type II fibres, however, are fast-contracting, have a high power 
output, favour ATP resynthesis via anaerobic processes and fatigue rapidly during 
sustained contraction. Together with the greater proportion of PCr in these fibres, 
the temporal energy buffering role of PCr is most likely to occur in these muscle 
types. 
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1.7 Creatine supplementation in humans 
Because of the equilibrium nature of the CK reaction, it has been hypothesised 
that increasing the concentration of Cr in muscle might increase the availability of 
PCr for rephosphorylation of ADP, thereby delaying muscle fatigue. 
Additionally, increasing the availability of Cr in the cytoplasm might have the 
potential to increase the rate of mitochondrial respiration, and thus oxidative PCr 
regeneration for supply to sites of energy consumption. As mentioned previously, 
early Cr feeding studies demonstrated that a fraction of ingested Cr is retained in 
the body of animals, increasing the body pool of Cr. However, it was not until 
1992, when Harris and colleagues reported that high oral doses of Cr produced 
significant elevation of muscle Cr and PCr concentration in humans, that interest 
was generated concerning the effects of Cr supplementation upon exercise 
performance. 
Creatine monohydrate (Cr. H20) is available as a white crystalline powder which 
is easily soluble in warm water. Orally ingested Cr is transported in the 
bloodstream following absorption and is thought to enter skeletal muscle against a 
concentration gradient in the same way as endogenously synthesised Cr (Harris et 
al, 1992). The Cr. H20 dosage administered by Harris et al (1992) was intended 
to raise plasma Cr to concentrations above the estimated K,,, for Cr entry into 
muscle (500 . tM; Fitch et al, 1968). Harris showed that following ingestion of a5 
g dose of Cr. H20, plasma Cr concentration rose from a baseline of 50-100 
µmol. L"1 to more than 700 µmol. L"t one h later. A smaller dose of 1g was shown 
to produce only a modest rise (-100 pmol. L"1) in plasma Cr concentration. 
Supplementation for a number of days (5 g Cr 4 times per day for 2 or more d) 
resulted in increases of 20-50% in TCr content of muscle, with concentrations 
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achieved after supplementation of between 140 - 160 mmol. kg"1 d. m. This rise 
resulted from increases in both PCr (8% increase) and Cr (36% increase) content. 
The increases in TCr concentration appeared to be less dependent upon the 
duration of the supplementation and dosage rate than upon the initial TCr content 
of the individual's skeletal muscle, with subjects with the lowest initial TCr 
content showing the greatest uptake following supplementation. Creatine 
supplementation was found to have little effect upon those individuals with initial 
muscle Cr content at the higher end of the normal range (- 145 mmol. kg'1 d. m. ), 
suggesting an upper limit to muscle Cr concentration. 
The retention of Cr by the body was found to be greatest during the first days of 
supplementation, with a mean of 32% of the administered dose being retained. 
This was indicated by a comparison of muscle TCr concentration of samples taken 
on day 2 with those taken on day 4 of supplementation, and estimated by renal Cr 
excretion of 3 subjects being 40%, 61% and 68% of the ingested dose on days 1,2 
and 3 respectively. 
The authors also demonstrated that muscle Cr uptake was augmented when 
submaximal exercise was conducted during the supplementation period. Five 
subjects performed 1h of one-legged exercise on the morning of each day of Cr 
supplementation, at a moderate intensity that could be maintained for the whole 
hour. During the supplementation period, three of the five subjects ingested 30 g 
Cr each day for 4 d, another ingested the same amount for 7d and a further 
subject ingested 20 g. dT' for 3.5 d. At the end of the supplementation period the 
authors reported that muscle TCr concentration was significantly greater (-. 9%) in 
the exercised leg than in the non-exercised leg. Creatine accumulation by the 
non-exercised leg was similar to that observed in Cr supplemented subjects not 
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performing exercise. The authors proposed that the enhanced Cr accumulation 
was either as a result of increased total blood flow to the exercised muscle, or by a 
change in the transport kinetics of Cr across the muscle fibre membrane. 
This report by Harris and colleagues (1992) suggested an important role of oral Cr 
supplementation for increasing muscle Cr concentration, and thereby for 
favourably altering muscle metabolism. The results reported were, however, a 
collection of preliminary studies using single subjects, or sample populations of 
relatively small size. Additionally, a wide variation between subjects was seen in 
muscle TCr accumulation and renal Cr excretion. Furthermore, a variety of 
supplementation regimens were used, making it uncertain whether muscle Cr 
accumulation was related to the dosage administered or duration of 
supplementation. A more recent report described the effects of ingesting different 
amounts of Cr over varying time periods on muscle Cr accumulation and 
subsequent degradation in humans (Hultman et al, 1996). Creatine 
supplementation (20 g. d"1,6 d) significantly increased muscle TCr concentration 
above pre-supplemented levels. Thereafter, muscle TCr concentration gradually 
decreased with time, and was matched by a parallel increase in urinary creatinine 
formation and excretion. This suggested to the authors that the rate of creatinine 
production was directly proportional to the muscle Cr concentration. It was also 
shown that maintenance of Cr ingestion following supplementation, at a level 
intended to match the rate of Cr degradation to creatinine (2 g. d'', 28 d; based on 
Walker, 1979), prevented the decrease in muscle TCr concentration with time 
(Hultman et al, 1996). Creatine supplementation with smaller amounts of Cr over 
a longer time period (3 g. d"1,28 d) resulted in a slower rate of muscle Cr 
accumulation compared with that following higher amounts, however, muscle 
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TCr concentrations were no different at the end of the respective supplementation 
periods. The authors concluded that muscle Cr concentration could be increased 
rapidly or at a slower rate by using differing supplementation regimens, and that 
elevated muscle Cr concentration could be maintained by daily ingestion of 
amounts of Cr equivalent to daily degradation to creatinine, thereafter. 
1.7.1 Effects of creatine supplementation upon exercise performance 
Using one supplementation protocol described by Harris et al (1992), Greenhaff 
and colleagues (1993) investigated the effects of Cr supplementation upon skeletal 
muscle torque production and fatigue. They found that subjects performing 
repeated bouts of maximal voluntary contractions of the quadriceps muscle group 
were able to sustain peak isokinetic torque production at a higher level following 
a regimen of oral Cr supplementation (5 g Cr. H20,4 times per day for 5 d). There 
was also a decreased accumulation of plasma ammonia during exercise following 
Cr supplementation, compared with that following placebo-supplementation, 
which suggested that the rate of ADP rephosphorylation was greater during 
exercise following Cr supplementation. 
A number of theories were proposed to explain the improvement in maintenance 
of force production through an increase in muscle TCr concentration. These 
included increased ATP availability, increased muscle metabolic buffering 
capacity, and an increase in the rate of PCr resynthesis from mitochondrial ATP 
during exercise and/or recovery (Greenhaff et al, 1993). The PCr/ADP energy 
transfer system catalysed by CKc plays an important role in muscle contraction as 
it has the ability to maintain a high ratio of ATP to ADP in the cell 
(Kammermeier, 1987). It was proposed that by increasing muscle Cr 
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concentration there would be a consequent increase in muscle PCr (as 
demonstrated by Harris et al, 1992), and therefore an increase in anaerobic ATP 
production by the CK reaction during exercise (Greenhaff et al, 1993). The 
authors calculated that the increases in muscle PCr predicted from Harris' work, 
using the same supplementation regimen, would be sufficient to increase 
anaerobic ATP production by approximately 7%, and suggested that this 
contributed to the 5% increase in peak torque production seen following Cr 
supplementation in their study. 
Another proposed mechanism by which Cr feeding improved exercise 
performance was that the increases in PCr concentration following Cr ingestion, if 
similar to those of Harris et al (1992), could increase the metabolic buffering 
capacity of muscle by about 7%. This was based on the predicted contribution of 
PCr to the acid-base balance of the muscle cell (Sahlin & Hultman, 1980). This 
effect would be mediated through the increased PCr concentration utilising more 
of the H+, generated from glycolysis, in the production of ATP through the CK 
reaction. 
A third proposal for the effect of Cr feeding upon performance of repeated bouts 
of maximal exercise was that the elevation in muscle TCr content increased the 
rate of PCr resynthesis from mitochondrial ATP during exercise and/or recovery. 
It had previously been proposed that mitochondrial ATP synthesis was linked to 
the phosphorylation of Cr at the mitochondrial membrane (Bessman and Geiger, 
1981; Bessman & Carpenter, 1985; Wallimann et al, 1992; Wyss et al, 1992). 
The rate of PCr resynthesis from mitochondrial ATP during exercise and/or 
recovery was proposed to be greater following Cr supplementation (Greenhaff et 
al, 1993). 
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Similar results were observed by Balsom and colleagues (1993a), in a group of 
individuals performing repeated bouts of high intensity exercise on a cycle 
ergometer. Subjects cycled at 140 rpm during 10 six-s bouts of exercise, with 
each bout separated by 30 s of recovery. A high workload was used so that the 
subjects, in the control condition, were unable to maintain the required pedalling 
rate for the whole 6s beyond bouts 4 to 6. Following Cr supplementation, 
subjects were able to sustain pedalling rate throughout each bout for a greater 
number of bouts. The authors proposed reasons similar to Greenhaff et al (1993) 
for these results, namely that there was a greater PCr availability for exercise as a 
result of elevated pre-exercise PCr and that there was a higher rate of resynthesis 
during recovery. 
Much of the subsequent research into the effects of Cr supplementation upon 
exercise performance attempted to address one or more of these proposed 
mechanisms in their experimental design. Subjects supplementing their diet with 
Cr (30 g. d"1,6 d) showed a significant improvement in final run time over four 
repeated short (300 m) and longer (1000 m) distances (Harris et al, 1993). The 
total run time of the 1000 m distance was significantly improved following Cr 
supplementation. After supplementation, the best 300 m and 1000 m run times 
were also significantly reduced. These data supported the proposal that Cr 
supplementation improved performance, although could not offer any insight into 
the mechanisms by which it exerted its action. 
Greenhaff et al (1994) addressed whether oral Cr ingestion did indeed have an 
effect on muscle PCr resynthesis after maximal, PCr-depleting exercise. Using 
human subjects in separate non- and Cr-supplemented conditions (20 g. d"', 5 d), 
isometric contractions of the vastus lateralis muscle were evoked by electrical 
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stimulation, causing a substantial depletion of muscle PCr. In the majority of the 
subjects there was a substantial (25%) increase in muscle TCr concentration 
following supplementation, however, in three of the subjects there was virtually 
no effect of Cr ingestion upon muscle TCr content (- 5% increase). These 
subjects were termed 'non responders'. It appeared that the subjects who had 
muscle TCr concentrations close to or less than 120 mmol. kg"1 d. m. before 
supplementation exhibited the greatest increases in muscle TCr following 
supplementation. This supported similar findings by Harris et al (1992). Those 
subjects with significant increases in muscle TCr concentration demonstrated an 
accelerated rate of PCr resynthesis after 1 min of recovery from contraction. This 
study confirmed the previously-raised hypothesis that an increased muscle Cr 
concentration would facilitate a greater rate of PCr resynthesis by displacing the 
equilibrium reaction catalysed by CK (Greenhaff et al, 1993). It had been 
estimated, in vitro, that the K,,, of CK for Cr was 19 mmol. L'' muscle water, 
whilst for ATP it was 0.6 mmol. L"1 (Bergmeyer, 1965). The concentration of Cr 
in skeletal muscle at rest and following maximal exercise is approximately 13 
mmol. L"' muscle water (Harris et al, 1992) and 37 mmol. L" muscle water (Spriet 
et al, 1987), respectively. During the initial stages of recovery from maximal 
contraction in both Cr- and non-supplemented states, the rate of ATP resynthesis 
from ADP and PCr would be at its highest, and Cr concentration would be above 
the Km of CKM for Cr. The availability of free Cr would therefore be unlikely to 
affect the rate of PCr formation by this process. As PCr resynthesis progressed 
during recovery, however, so would free Cr concentration decline. Once it had 
decreased to around 19 mmol. L"t, free Cr concentration would become a 
determining factor of the rate of PCr resynthesis. From the study of Greenhaff et 
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al (1994) it would appear that free Cr concentration reached this level in the non- 
supplemented state after about 60 s of recovery from maximal contraction. From 
this point, differences in rate of PCr resynthesis were seen between Cr- and non- 
supplemented states, which produced a 30% higher PCr concentration at the end 
of recovery in the Cr-supplemented state. It was suggested that this effect was 
due to free Cr concentration being maintained during the whole recovery period at 
a level higher than that of the Km of CK for Cr in the Cr-supplemented state. The 
data from this investigation provided evidence to suggest that Cr supplementation 
produced improvements in performance (of repeated bouts of maximal, PCr- 
depleting exercise) by enhancing the drive for PCr resynthesis by 
mitochondrially-derived ATP during recovery periods. 
Most of the research up until 1994 had investigated the effects of Cr 
supplementation on maximal exercise of very short duration and short recovery 
time (Balsom et al, 1993a; Greenhaff et al, 1993,1994). Birch and colleagues 
(1994) examined the effect of Cr supplementation (20 g. d"1,5 d) on performance 
during three 30 s bouts of maximal isokinetic cycling interspersed with 4 min of 
recovery. Following supplementation, peak power output (PPO) was increased in 
bout 1, and mean power output and total work done was increased during bouts 1 
and 2. No difference with Cr feeding was observed during bout 3. Peak plasma 
ammonia 2 min after exercise was lower following Cr supplementation, despite 
more work being performed during the first 2 exercise bouts. This supported 
earlier suggestions that Cr supplementation enhanced ATP turnover, as indicated 
by a decrease in markers of adenine nucleotide degradation (Balsom et al, 1993a; 
Greenhaff et al, 1993). The increase in PPO during bout 1 after Cr 
supplementation was not expected, and could not be explained by the authors. 
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Reference was made to the finding that chronic 1-year Cr supplementation 
significantly increased type II muscle fibre cross-sectional area of patients with 
muscle fibre area (Sipilä et al, 1981), and the potential role of Cr in protein 
synthesis (Ingwall, 1976; Bessman & Savabi, 1988). The authors suggested, 
however, that the short duration of Cr supplementation employed in their study (5 
d) would be unlikely to influence muscle protein synthesis. 
Another investigation proposed that if PCr availability and utilisation during 
exercise was related to force maintenance during maximal exercise (Hultman et 
al, 1991), then elevated PCr concentration following Cr supplementation would 
attenuate fatigue and increase total work production (Cooke et al, 1995). 
However, peak power, time to peak power, total work and time to fatigue during 
15 s of maximal cycling exercise were all unaffected by Cr supplementation (20 
g. d"', 5 d). The lack of any improvement of a single bout of exercise 
complemented previous reports that initial bouts of exercise were unaffected by 
Cr supplementation (Balsom et al, 1993a; Greenhaff et al, 1993), but did not 
concur with improvements in PPO observed by Birch et al (1994). The authors 
suggested that PCr concentration had not altered sufficiently for improvements in 
exercise performance to be observed (Cooke et al, 1995), however, no data was 
provided to support this suggestion. It is known that Cr accumulation varies 
between individuals in relation to their muscle Cr concentration before 
supplementation (Harris et al, 1992; Greenhaff et al, 1994). The lack of data 
relating to the success of the Cr supplementation regimen in Cooke and 
colleagues' study (1995) therefore makes the interpretation of the performance 
results difficult. Based upon their data, the authors suggested that the proposed 
ergogenic effect of Cr supplementation was not related to a pre-exercise elevation 
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of muscle PCr stores, but was due to an increased potential for PCr resynthesis 
during recovery. 
The ability to maintain high power output during maximal exercise following Cr 
supplementation was again demonstrated by Balsom and colleagues in 1995. 
Subjects cycled for 5 six-second bouts against a high workload, interspersed with 
30 s recovery periods, followed 40 s after the last bout by 10 s cycling against a 
5% greater workload. Creatine supplementation (20 g. d"1,6 d) significantly 
increased muscle TCr concentration, and power output during 10 s of high 
intensity cycling was better maintained, compared with pre-supplementation 
results. This improvement was attributed to an increased PCr concentration 
observed following the preceding exercise bouts, despite identical work to the pre- 
supplementation trial being performed. Muscle lactate concentration measured 3 
min after the exercise was significantly lower in the Cr supplemented condition. 
Although not observed in this study, blood lactate concentration measured in a 
previous investigation with a similar exercise protocol (Balsom et al, 1993a), 
reflected this result and suggested lower lactate production following Cr 
supplementation. The authors proposed that, as the same amount of work was 
performed before and after supplementation, the contribution to total energy 
production from PCr hydrolysis was greater as a result of Cr supplementation. In 
other experiments, however, no effect of Cr supplementation on muscle lactate 
(Greenhaff et al, 1994) or blood lactate (Birch et al, 1994; Greenhaff et al, 1994) 
concentration had been observed. It is likely that these contrasting findings were 
related to the exercise protocols employed in the studies - PCr would be expected 
to contribute to total ATP resynthesis to a greater extent during 6-s bouts of 
exercise interspersed with 30-s intervals than it would during 30-s of maximal 
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exercise. An additional aim of the study (Balsom et al, 1995) was to investigate 
the effect of Cr supplementation on PPO, measured by specific jump tests (Bosco 
et al, 1983). It was proposed that improved PPO might have been achieved 
through a change in muscle morphology, such as increased type II fibre 
hypertrophy observed with 1 year Cr supplementation (Sipila et al, 1981), 
resulting from Cr-stimulated protein synthesis (Bessman & Savabi, 1988). Jump 
performance did not change following Cr supplementation, suggesting to the 
authors that no major morphological change had occurred. However, this result 
might also have been due to a lack of specificity of the test used (Young et al, 
1997). The authors concluded that exercise performance was improved following 
Cr supplementation due to a greater utilisation of PCr. This was achieved by a 
greater rate of PCr resynthesis during recovery after Cr supplementation. 
The proposal by Greenhaff et al (1994), that Cr supplementation produced 
improvements in ADP rephosphorylation during exercise, mediated by an 
increased PCr concentration, was given support by a subsequent report (Casey et 
al, 1996). The authors found that there was a 30% reduction in ATP loss from 
mixed muscle during maximal isokinetic cycling exercise. Supplementation with 
Cr also produced improvements in maximal exercise performance, as measured 
by total amount of work done during two 30 s bouts of cycling at maximal 
intensity, each separated by 4 min of recovery. A positive correlation was 
observed between the increase in muscle TCr concentration and the improvement 
in exercise performance (r = 0.71, p<0.05, n= 8). This supported the findings of 
Greenhaff et al (1994) that PCr resynthesis during exercise recovery was only 
improved in subjects that exhibited a marked increase in muscle TCr 
concentration. In the above study, however, no significant correlation was found 
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between the change in mixed muscle PCr concentration and the changes in ATP 
loss or exercise performance (Casey et al, 1996). Investigation of different 
muscle fibre types revealed that a positive correlation existed between the change 
in PCr concentration following supplementation in type II fibres and the 
improvement in exercise performance (r = 0.66, p<0.05). Additionally, a 
correlation existed between the change in PCr concentration and the change in 
PCr degradation (and thus ADP rephosphorylation) in type II fibres during 
exercise (r = 0.78, p<0.01). The finding that no such relationship existed in type 
I fibres led the authors to suggest that Cr supplementation exerted a greater effect 
upon type II than type I muscle fibres. 
A small number of studies have addressed the question of whether Cr 
supplementation could influence the performance of prolonged, submaximal 
exercise (Balsom et at, 1993b; Stroud et al, 1994; Myburgh et al, 1996; Godly & 
Yates, 1997; Engelhardt et al, 1998). Such activity, often termed endurance 
exercise, predominantly generates energy via oxidative means. At certain stages 
of endurance exercise, however, anaerobic energy production is also required, 
such as at the onset of exercise, during short periods when exercise intensity 
exceeds maximal aerobic capacity (VO2; e. g. sprint finishes in long distance 
running or cycling; Godly & Yates, 1997; Engelhardt et al, 1998), or when the 
exercise intensity fluctuates continuously (e. g. terrain running; Balsom et al, 
1993b). It was proposed by some of these studies that Cr supplementation might 
improve performance of prolonged exercise that included such energy 
requirements. The results of these investigations revealed, however, that Cr 
supplementation did not improve endurance exercise performance (Balsom et al, 
1993b; Myburgh et al, 1996; Godly & Yates, 1997). Creatine supplementation 
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resulted in a decrease in performance of terrain runners (Balsom et al, 1993b), 
possibly due to an elevation of body mass. Cr supplementation (6 g. d-1,5 d) did 
improve the performance of short intervals of high intensity cycling during a 
period of endurance exercise (Engelhardt et al, 1998). There was also a tendency 
for improved endurance performance in some subjects, although no significant 
improvement was observed. The authors suggested that Cr supplementation 
might be beneficial to endurance athletes if their exercise activities included short 
periods of sprinting. 
Another mechanism by which Cr supplementation had been proposed to influence 
prolonged submaximal exercise was by increasing the availability of Cr for 
transfer of oxidatively-derived energy from mitochondria to sites of utilisation 
(Stroud et al, 1994). It was hypothesised that intracellular Cr availability could 
influence mitochondrial ATP production to the extent that an increase in Cr 
concentration might increase oxygen consumption during exercise and recovery. 
However, whole body respiratory gas exchange (V02 and respiratory exchange 
ratio, RER) and blood lactate concentration of male subjects performing 
incremental running on a treadmill did not change following Cr supplementation 
(20 g. d-l, 5d). The authors concluded that Cr supplementation did not improve 
performance of submaximal incremental exercise. 
Recent evidence suggests that long-term Cr supplementation may have an 
anabolic effect on muscle (Vandenberghe et al, . 
1997). If so, this would have 
implications for treatment of muscle disease and exercise performance. Potential 
anabolic effects of Cr have previously been proposed, based on in vitro evidence 
that Cr stimulated muscle myofibril protein synthesis in cardiac and skeletal 
muscle (Ingwall, 1976), however, these results were not supported by a 
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subsequent investigation (Fry & Morales, 1980). In human patients with gyrate 
atrophy of the choroid and retina, prolonged supplementation with Cr (1 -5 years, 
1.5 g. d"') was associated with an increase in type II muscle fibre diameter of 
vastus lateralis muscle (Sipilä et al, 1981; Vannas-Sulonen et al, 1985). In a 
recent investigation, Cr supplementation during a 10-week resistance training 
intervention caused significantly greater improvements in maximal muscle 
strength and power output during intermittent arm exercise of sedentary female 
subjects (Vandenberghe et al, 1997). Significant increases in muscle PCr 
concentration (measured by 31P-nuclear magnetic resonance; 31P-NMR) and fat- 
free mass, above those of subjects receiving placebo supplements, were also 
observed in Cr supplemented subjects. The authors discussed that this increase 
might have arisen due to a number of factors, such as increased training intensity 
in subjects receiving Cr or a delay in the onset of overtraining. However, they 
also suggested that it was feasible that Cr supplementation facilitated the 
development of muscle hypertrophy during resistance training. Continuation of 
Cr supplementation in a subgroup of subjects after the resistance training had 
finished did not prevent arm power output from diminishing to pre-trained levels. 
Although no measurements of muscle protein concentration were made in this 
investigation, the results suggest that prolonged Cr supplementation may augment 
muscle protein synthesis and have identified a future area for research. 
Early studies investigating the influence of Cr supplementation on exercise 
performance were mainly concerned with the elucidation of the mechanisms by 
which Cr supplementation exerted its ergogenic effect. A significant proportion 
of subsequent investigations have applied the use of Cr supplementation to `field 
studies' of exercise performance of normal subjects or trained individuals. The 
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19.9 mmol. kg"' d. m. ). This increase is below the suggested `threshold level' 
above which significant increases in PCr concentration and PCr resynthesis during 
recovery are observed (20 mmol. kg-1 d. m.; Greenhaff et al, 1994; Casey et al, 
1996). The authors suggested that the relatively small increase in muscle TCr 
concentration seen in their subjects contributed to the lack of any observed 
improvement in exercise performance (Snow et al, 1998). As had been previously 
suggested (Casey et al, 1996), investigation was required of the mechanisms 
governing muscle Cr accumulation, with the aim that a method of maximising the 
response to Cr supplementation could be achieved. If a method could be found to 
maximise muscle Cr accumulation, it would follow that significant improvements 
in muscle function and performance, and in recovery from maximal exercise, 
could be achieved by many individuals, and may reduce the phenomenon of the 
`non-responder'. 
1.8 Factors affecting muscle creatine accumulation 
Before the Cr transporter had been identified, or its transport properties fully 
described, studies of the effect of various treatments upon muscle Cr uptake had 
been conducted. Creatinurea, the presence of greater than normal amounts of Cr 
in urine, induced in rats by exposure to X-rays or by intraperitoneal (ip) injection 
of Cr could be prevented by administration of insulin to the animals (Koszalka & 
Andrew, 1968,1970). Additionally, the elevated blood Cr concentrations 
observed following ip Cr loading were suppressed when insulin was administered 
(Koszalka & Andrew, 1970). Subsequent investigation of the effects of insulin on 
uptake of Cr by muscle of normal and X-irradiated rats demonstrated that insulin 
enhanced the transfer of Cr from the blood into skeletal muscle (Koszalka & 
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findings of these investigations have not been conclusive, however, with Cr 
supplementation producing improvements in exercise performance 
(Vandenberghe et al, 1996,1997; Volek et al, 1997; Aaserud et al, 1998; Kelly & 
Jenkins, 1998; Magnaris & Maughan, 1998; McNaughton et al, 1998; Smith et al, 
1998a; Smith et al, 1998b), preventing previously-observed decrement of exercise 
performance (06pik et al, 1998), or not producing any measurable improvement 
in exercise performance (Mujika et al, 1996; Redondo et al, 1996; Cooke & 
Barnes, 1997; Javierre et al, 1997; Odland et al, 1997; Bermon et al, 1998; Snow 
et al, 1998). Two recent reviews have also summarised a number of preliminary 
reports presented as meeting abstracts (Kreider, 1998a, b), demonstrating differing 
effects of Cr supplementation on exercise performance. The reasons for these 
differences are most likely multi-factorial, and may depend upon the duration of 
supplementation (range 3d- 75 d), the amount of Cr administered (range 10 g. d'1 
- 30 g. d"'), the training status of the subject group (many levels; sedentary, 
untrained individuals up to elite-trained athletes), the age and gender of the 
subject group, and the interaction of any other `treatment' (e. g. strength training). 
The validity of some of the indicators of performance may also be questioned, as 
some may not necessarily be measuring factors proposed to be influenced by Cr 
supplementation. 
A key point mentioned in discussion by a number of investigators who examined 
muscle Cr content following Cr supplementation was the variation in muscle Cr 
accumulation between subjects (Harris et al, 1992; Greenhaff et al, 1994, Casey et 
al, 1996). It was noted in one investigation (Snow et al, 1998) that Cr 
supplementation (30 g. d"', 5 d) resulted in a significant, yet small, increase in 
muscle TCr concentration (mean increase 11.7 ± 2.4 mmol. kg"i d. m., range 2.9 - 
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Andrew, 1972). It was unknown, however, whether insulin acted directly upon Cr 
transport, or whether its action was through other effects of the hormone in vivo, 
such as on growth hormone or testosterone. Removing the possibility of these 
factors by in vitro investigation of rat EDL muscle, Haughland and Chang (1975) 
demonstrated that insulin directly enhanced both the rate of transport and the 
extent of Cr uptake by rat skeletal muscle. More recent work has shown that net 
Cr uptake by cultured mouse skeletal myoblast cells is influenced by a number of 
hormones (Odoom et al, 1996). In a number of experiments the authors addressed 
factors associated with alterations in the rate of Cr transport. The dependence of 
Cr transport upon the presence of Na+ was confirmed, with >90 % of uptake 
occurring via this process. Variation in extracellular Cr concentration upon Cr 
uptake, such as would occur during Cr supplementation, was studied. An 
approximately hyperbolic relationship was observed between extracellular and 
intracellular Cr concentration, with no discernible increase in uptake at 
extracellular concentrations greater than 500 µM. Of particular interest in this 
investigation was the K. of 110 f 25 µM observed for Cr transport by these 
skeletal muscle cells. This was substantially lower than that observed by Fitch 
and colleagues (500µM; Fitch & Shields, 1966; Fitch et al, 1968). If a similar 
exists for human muscle, it is unlikely that plasma availability of Cr will be a 
limiting factor of transport into muscle, as the majority of Cr supplementation 
studies use doses of Cr that produce plasma Cr concentrations of approximately 
800 gmo1. L"1 (Harris et al, 1992). 
Inhibition of Na+/K+ATPase activity of the cells with ouabain prior to incubation 
with Cr significantly decreased final Cr content to 72% of control concentration. 
This supported earlier suggestions that Na+/K+ATPase activity was involved in 
34 
generating a Na+ gradient for Cr transport (Loike et al, 1986). Selected hormones 
chosen for their important physiological role or their effects upon Na+/K+ATPase 
were used to investigate their role in net Cr accumulation. Insulin was 
demonstrated to stimulate Cr accumulation at a supraphysiological concentration 
(3 nM), but not at physiological concentrations (0.2 - 0.8 nM). Amylin, which is 
structurally similar to a neuropeptide released to muscle following nerve 
excitation (calcitonin gene-related peptide, CGRP), more than doubled cellular Cr 
content at moderate physiological concentrations (60 - 90 nM). At a 
supraphysiological concentration (40 µM) the thyroid hormone 3,3', 5- 
triiodothyronine (T3) stimulated Cr uptake from medium containing a high Cr 
concentration, with a diminishing effect at higher T3 concentrations (70 - 110 
µM). Insulin, amylin (working via the CGRP receptor) and T3 are all known to 
stimulate Na+/K+ATPase activity of skeletal muscle, which the authors proposed 
would increase the driving force for Cr accumulation. The authors also 
demonstrated that the stimulatory effects of insulin and insulin-like growth factor 
(IGF-1) upon Cr accumulation might involve intracellular signals via 
phosphorylation of tyrosine residues within the cell. 
The potential mechanisms by which exercise might influence muscle Cr transport 
in vivo (Harris et al, 1992) were also addressed by in vitro investigation (Odoom 
et al, 1996). IGF-1, released in vivo in response to elevated circulating 
concentrations of growth hormone following exercise, was found to stimulate Cr 
accumulation at physiological concentrations. Concentrations of the 
catecholamines, noradrenaline and adrenaline also increase during exercise. The 
authors demonstrated that noradrenaline stimulated Cr uptake in cultured muscle 
cells. Further investigation using adrenergic agonists and antagonists led the 
35 
authors to propose that noradrenaline achieved its effect by activation of 02 
adrenergic receptors. This mechanism was probably mediated through a 
secondary messenger such as cyclic AMP, and acted through stimulation of the 
Na+/K+ATPase of the muscle cells. Similarly, CGRP released at neuromuscular 
junctions in response to motoneuron stimulation, might also mediate an exercise- 
related influence upon muscle Cr transport, as suggested by the effect of amylin. 
Until recently, the majority of the investigations of factors that influenced muscle 
Cr uptake had been conducted in vitro or ex vivo, and in vivo investigations had 
been restricted to studies involving rats. The question of whether any of these 
proposed mechanisms could improve Cr accumulation during a period of Cr 
supplementation in humans has recently been addressed (section 1.8.1). 
1.8.1 Factors affecting muscle creatine accumulation and its ergogenic effects in 
humans 
The potential role of insulin in stimulating muscle Cr retention in humans was 
investigated, by stimulation of endogenous insulin release by ingesting a large 
amount of CHO during a period of Cr supplementation (Green et al, 1996c). 
Subjects consumed a drink containing 93 g CHO when Cr was ingested 
(4 x5g. d"1,5 d), and a high CHO diet was maintained during the supplementation 
period. Creatine excretion was markedly reduced in subjects receiving Cr + CHO 
than in subjects supplemented with Cr only and consuming a normal diet. The 
pattern of plasma Cr and serum insulin appearance and disappearance following 
oral administration of Cr + CHO were similar, and peak plasma Cr concentration 
and the area under plasma Cr/time curve were markedly reduced in the Cr + CHO 
group than in the Cr only group (i. e. Cr disappearance was enhanced). This 
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pattern of response supported the hypothesis that the insulin response to CHO 
ingestion could increase skeletal muscle Cr uptake. However, it was possible that 
a similar series of responses might have been observed if gut absorption of Cr was 
diminished somehow. This investigation estimated the retention of orally 
administered Cr by the body, as estimated by urinary Cr content, however, so did 
not directly measure muscle Cr accumulation. A subsequent investigation 
provided evidence to support this proposal and showed excellent agreement 
between whole body Cr retention and muscle Cr accumulation (Green et al, 
1996a). In this investigation subjects ingested Cr and, in addition to this, one 
group of subjects consumed a drink containing 93 g CHO 30 min after each Cr 
dose. At the end of the supplementation period, subjects ingesting Cr + CHO had 
60% greater muscle Cr accumulation than subjects ingesting Cr only (33.0 ± 3.4 
mmol. kg 1 d. m. vs. 20.7 ± 2.4 mmol. kg"' d. m., respectively). Furthermore, it 
appeared that pre-supplementation TCr concentration did not necessarily 
influence the extent of Cr accumulation when CHO was ingested during 
supplementation. Indeed, one individual receiving Cr + CHO with a high initial 
TCr concentration (152.1 mmol. kg"' d. m. ) increased his muscle TCr concentration 
by more than 40 mmol. kg"l d. m. This would obviously be of benefit to 
individuals wishing to improve their performance of repetitive, high-intensity 
exercise, as TCr increases in excess of 20 mmol. kg-1 d. m. are required for 
improvements in postexercise PCr resynthesis (Greenhaff et al, 1994) and 
exercise performance (Casey et al, 1996). The authors observed that serum 
insulin concentration increased 17-fold 20 min after Cr + CHO ingestion and was 
still significantly greater than basal concentration 60 min after ingestion. This 
response was similar to that previously observed, where plasma appearance and 
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disappearance of insulin and Cr were similar (Green et al, 1996c). The authors 
proposed that the combination of CHO ingestion with Cr supplementation 
augmented muscle Cr accumulation by an insulin-mediated effect. 
The magnitude of Cr retention by human muscle in these investigations was 
greater than previously observed in rat skeletal muscle in vivo, when muscle Cr 
uptake was only slightly increased in the presence of insulin (Koszalka & 
Andrew, 1972), or not affected at all (Greenhaff et al, unpublished data; cited in 
Green et al, 1996a). This prompted questions concerning whether animal models 
of muscle Cr accumulation were a realistic basis for comparison when results 
were to be applied to humans (Green et al, 1996a), and supported the suggestion 
that further research of Cr supplementation in humans was required. 
The amounts of CHO consumed by subjects that augmented muscle Cr 
accumulation (Green et al, 1996a), elicited insulin responses toward the high end 
of the physiological range (Marshall, 1993). Investigations demonstrating an 
effect of insulin upon Cr uptake in cultured mouse skeletal muscle cells have 
shown that supraphysiological insulin concentrations are required to produce an 
effect (Odoom et al, 1996). It had been proposed that insulin exerted its effect of 
increasing Na -dependent Cr transport by stimulating Na+/K+ATPase activity in 
muscle (Odoom et al, 1996). Insulin can also have a number of other effects in 
vivo, however, which would not be apparent in vitro. One such effect, which 
might be expected to influence muscle Cr accumulation, is the stimulation of 
blood flow to the muscle. This would have the effect of increasing the availability 
of Cr for uptake by the muscle, an effect that could not be observed by an in vitro 
study. With the aim of further establishing the role of insulin in mediating Cr 
accumulation by muscle in humans, Steenge et al (1998) used an euglycemic 
38 
insulin clamp technique at different insulin concentrations. Insulin and glucose 
were infused intravenously and maintained at a constant concentration throughout 
a 300 min period on 4 separate occasions. Insulin infusion rate was set to achieve 
one of 4 steady-state circulating insulin concentrations during each visit, which 
represented concentrations within the normal human range and a 
supraphysiological concentration (mean serum insulin concentration; 12,56,109 
or 199 mIU. L-1). The insulin infusion rate eliciting serum insulin concentration of 
- 109 mIU. L"1 was used, as similar concentrations have been achieved following 
ingestion of a drink containing -95 g CHO with Cr (Green et al, 1996a, c). 
Creative was administered as a5g oral dose 60 min after equilibration of insulin 
and glucose concentrations, and was subsequently administered via a nasogastric 
tube to maintain a plasma Cr concentration of - 800 pmol. L"1. Muscle biopsy 
samples were obtained, and forearm and calf blood flow measurements made, 
during each experiment. Insulin stimulated muscle Cr accumulation, but only at 
high or supraphysiological concentrations (100 - 200 mIU. L"t). Total Cr 
concentration increased by 4.6 mmol. kg"1 d. m. and 8.4 mmol. kg"' d. m. during the 
225 min period of Cr infusion with steady-state insulin concentrations of 109 and 
199 mIU. L-1, respectively. Plasma Cr concentration was lower at several time 
points during clamps at those insulin concentrations, indicating that muscle Cr 
transport was increased. Calf and forearm blood flow was increased above basal 
level during all but one treatment condition (forearm blood flow during lowest 
insulin concentration), however, the magnitude of the increase was the same, 
irrespective of the circulating insulin concentration. It was therefore unlikely that 
increased blood flow contributed to the increase in Cr accumulation seen at higher 
insulin concentrations. The findings from these investigations suggested that 
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insulin could augment muscle Cr accumulation in humans, but only at high 
physiological concentrations. Therefore large amounts of CHO must be ingested 
with the Cr supplements for any enhancement of Cr accumulation to occur. 
It was observed by Harris et al (1992) that submaximal exercise performed during 
Cr supplementation resulted in greater Cr accumulation in the exercised muscle. 
No similar effect was observed, however, in subjects performing submaximal 
exercise (cycling at 70% VO2max) during Cr and CHO supplementation (5 g Cr + 
93 g CHO 4 times per day for 5 d; Green et al, 1996c). Exercising subjects 
receiving Cr + CHO showed no different responses of peak plasma Cr 
concentration, plasma Cr bio-availability, urinary Cr excretion or serum insulin 
concentration, when compared with subjects ingesting Cr + CHO without prior 
exercise. It was proposed by the authors that the improvements in muscle Cr 
accumulation with exercise observed by Harris et al (1992) might have resulted 
through improvements in insulin sensitivity of the exercised muscle, and that any 
such improvement was overshadowed by the large response to ingested CHO 
(Green et al, 1996c). 
Additional factors may also have accounted for these contrasting results. Firstly, 
in the study of Harris et al (1992), small population size, various Cr 
supplementation regimens and differing times of muscle sampling make 
interpretation of the results difficult. In addition to this, two subjects were 
vegetarian. Normal reference values for serum Cr are lower in vegetarians than 
for individuals who maintain `normal' diets (Delanghe et al, 1989). It has been 
suggested that vegetarians may have lower than normal muscle Cr concentration 
and it has been demonstrated that upon Cr supplementation vegetarians exhibit 
greater Cr retention than non-vegetarians (Green, 1996; Green et al, 1997). 
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Therefore the inclusion of two vegetarian subjects in the exercising group 
receiving Cr might have skewed accumulation results toward higher values. 
Another report proposed that other nutritional factors might affect muscle Cr 
accumulation in humans (Vandenberghe et al, 1996). It was suggested that 
combining Cr supplementation with ingestion of a compound known to increase 
Na+/K+ pump activity might enhance muscle Cr accumulation and thereby further 
improve muscle performance. Caffeine was ingested with Cr as it has been 
proposed to directly stimulate Na+/K+ pump activity and also increase plasma 
adrenaline concentration, which also stimulates Na /K+ pump activity (Clausen, 
1986). Examination of muscle PCr concentration using 31P-NMR demonstrated 
that ingestion of caffeine during Cr supplementation did not increase muscle PCr 
concentration to any greater extent than supplementation with Cr only. 
Furthermore, the authors showed that caffeine ingestion during supplementation 
abolished the ergogenic effect of Cr supplementation on performance of maximal 
exercise. This result was unexpected and the authors could not provide any 
explanation for its occurrence based upon their data. The effect did not appear to 
be related to an acute action of caffeine upon muscle energetics, as plasma 
caffeine concentration was considered to be minimal at the time of exercise. It 
was therefore suggested that, to obtain the ergogenic effects of Cr 
supplementation, beverages containing caffeine (or any other trimethylxanthine 
compounds) should not be ingested at the same time as Cr. 
1.9 Effects of guanidino compounds on CHO disposal 
Another unexpected, yet interesting, result was observed by Green et a! (1996a) in 
their investigations of the effects of CHO ingestion on Cr accumulation. A 
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greater increase in body mass was observed of subjects ingesting Cr + CHO than 
those ingesting Cr only, although this difference was non-significant (Green et al, 
1996a). This suggested to the investigators that insulin may have contributed to 
the increased body mass by increasing both Cr and glycogen accumulation by 
muscle. Subsequent investigation examined the effects of ingesting Cr only, Cr 
and CHO or CHO only on muscle Cr accumulation and glycogen storage (Green 
et al, 1996b; Green, 1996). Although peak glucose concentration was the same in 
both groups that received CHO, a greater rate of glucose clearance was observed 
with Cr + CHO supplementation. This difference appeared to be mediated by a 
60% greater peak serum insulin concentration following ingestion (Green, 1996). 
Muscle glycogen concentration increased significantly following five days of 
supplementation in the groups that received CHO, but did not change significantly 
in the Cr only group. The increase in muscle glycogen was twice as great in the 
Cr + CHO group than in the CHO only group, although this difference was not 
statistically significant due to a large variation in glycogen concentration in the Cr 
+ CHO group. Furthermore, a positive correlation was observed between 
individual increases in muscle glycogen and TCr of the Cr + CHO group (r = 
0.75, n=8, p<0.05). Whilst caution should be taken when interpreting these 
results (particularly since they have not yet been published in a peer-reviewed 
journal), they are of interest as an apparent relationship between muscle Cr and 
glycogen accumulation would have implications for both maximal and 
submaximal exercise. Submaximal exercise of prolonged duration (i. e. 65% - 
80% VO2max, 60 - 180 min) mainly utilises the body's CHO store for fuel. Pre- 
exercise muscle glycogen concentration is a major determining factor of the 
duration of this type of activity (Bergstrom et al, 1967) and a method of 
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increasing muscle glycogen concentration above normal level might have the 
potential to improve performance of such exercise. 
Of particular interest is the observation that peak insulin concentration was greater 
when Cr was ingested with CHO, compared with CHO ingestion alone (Green, 
1996). A number of investigations have demonstrated that another guanidino 
compound, arginine (itself a precursor of Cr biosynthesis), can also influence 
insulin release to affect whole body CHO disposal. For a given individual, 
plasma insulin concentration increases in response to elevation in blood glucose 
concentration, to a certain extent, in a dose-dependent manner (Mikines, 1992). 
The magnitude of the insulin response will influence the rate of muscle glucose 
transport and glycogen synthase activity. Other factors, including other hormones 
(e. g. glucagon), and some amino acids (e. g. leucine, arginine) also stimulate 
insulin secretion from the pancreas (Ganong, 1979). Arginine is a dibasic amino 
acid that is synthesised by the kidney from citrulline. Physiological roles of 
arginine include regulation of ammonia excretion through the urea cycle and the 
biosynthesis of Cr. It is also the unique substrate for production of nitric oxide 
(NO) used in many tissues as a biological effector molecule (Barbul, 1995). 
Arginine also enhances the secretion of a variety of hormones, including adrenal 
catecholamines, glucagon, growth hormone and insulin (Barbul, 1986). 
Endogenous synthesis of arginine is normally sufficient for daily metabolism, 
although in times of elevated protein turnover such as growth or trauma arginine 
has been considered an indispensible amino acid (Nagakawa et al, 1963; Seifter et 
al, 1978). Exogenous arginine administered intravenously has been demonstrated 
to increase glucose turnover in dogs (i. e. increased glucose production and 
utilisation; Cherrington & Vranic, 1973). This increase is brought about by 
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stimulation of hepatic glucose production and whole-body glucose utilisation by 
elevated concentrations of glucagon and insulin, respectively (Cherrington et al, 
1974). In humans, intravenous administration of arginine, anticipated to elicit 
plasma concentrations of 4 mM, resulted in a2-3 fold increase in circulating 
insulin concentration (Efendic et al, 1974). This pre-treatment with arginine 
caused subsequent potentiation (up to 2-fold) of the initial insulin response to 
infused glucose at a variety of concentrations. 
Three mechanisms by which arginine stimulates insulin release have been 
proposed. Uptake of L-arginine by pancreatic ß-cells exposed to D-glucose 
results in insulin secretion via membrane depolarisation induced by the cationic 
nature of the amino acid (Blachier et al, 1989). Another mechanism proposed is 
that arginine is metabolised by the urea cycle, producing ornithine, which enters 
the TCA cycle as substrate for gluconeogenesis, thereby stimulating insulin 
release through glucose production (Malaisse et al, 1989). Finally, arginine- 
induced plasma elevation of glucose and insulin in rats has been shown to be due, 
in part, to NO formation (Jun & Wennmalm, 1994), however, differential effects 
of NO exist upon glucagon and insulin secretion (Panagiotidis et al, 1992; 
Panagiotidis et al, 1994; Henningsson & Lundquist, 1998). It has also been 
demonstrated that L-arginine administration stimulates insulin-mediated glucose 
uptake through a NO-mediated increase in blood flow (Paolisso et al, 1997). 
Whatever the mechanism by which it acts, it is apparent that arginine influences 
insulin secretion and, of interest in exercise physiology, augments glucose- 
stimulated insulin release and whole-body glucose disposal. This phenomenon is 
of potential value to individuals wishing to improve glycogen repletion following 
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exercise, as the elevated insulin response may have the effect of improving 
muscle glucose transport and/or glycogen synthesis. 
It is possible that the relationship between muscle Cr and glycogen accumulation 
following Cr + CHO ingestion (Green et al, 1996b) might have been influenced 
by factors other than an elevated insulin release. Creatine supplementation has 
been associated with increases in body mass thought to be attributable to body 
water retention (Hultman et al, 1996). It is possible that muscle Cr accumulation 
would cause muscle cells to retain water to maintain their osmotic potential. This 
would result in swelling of muscle fibres that had accumulated Cr. Cell volume 
changes are known to influence a number of cellular functions, including solute 
transport and intracellular metabolism (Lang et al, 1998). A recent investigation 
using human subjects has shown that hypo-osmolal conditions, which are known 
to induce cell swelling, exert protein- and glucose-sparing effects on whole-body 
metabolism (Berneis et al, 1999). Glycogen synthesis in the liver is modulated by 
changes in hepatic cell volume, with an increase observed with cell swelling and a 
decrease with cell shrinkage (Hitussinger, 1996). At present the exact mechanism 
by which cell volume governs this effect is unclear, however, intracellular 
signalling involving mitogen activated protein kinase activity has been proposed 
(Häussinger, 1996). Indirect evidence that swelling of muscle might have a 
similar effect upon muscle glycogen synthesis (Low et al, 1996a; Rennie et al, 
1996) prompted investigation of glycogen synthesis in cultured muscle cells 
exposed to solutions of differing osmotic potential (Low et al, 1996b). It was 
demonstrated that in rat muscle myotubes, which have many characteristics of 
adult muscle (Low et al, 1996b), glycogen synthesis was modulated in association 
with changes in cell volume, and that these changes were not dependent upon 
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changes in cell glucose uptake. These changes may have been co-ordinated via 
intracellular signalling processes that acted through tyrosine kinase activity within 
the cell. Strenuous exercise resulting in muscle lactate accumulation is known to 
increase muscle cell volume (Sahlin, 1983) and it was proposed that this might 
assist muscle glycogen resynthesis in the period following exercise (Low et al, 
1996b). The amino acid glutamine also increases muscle cell volume (Low et al, 
1996a). Post-exercise glycogen resynthesis was enhanced when glutamine was 
provided during recovery (Varnier et al, 1995) by a magnitude similar to the 
changes in muscle cell volume. These findings demonstrate that changes in 
muscle cell volume can influence muscle glycogen synthesis. They also suggest 
that provision of metabolically-active substrates known to increase cell volume 
during a post-exercise period might enhance subsequent glycogen synthesis. 
1.10 Safety aspects of creatine supplementation 
Publication of research findings that Cr supplementation could lead to 
improvements in exercise performance has caused Cr to become an extremely 
popular dietary supplement of athletes. Promotion of Cr as an ergogenic aid by a 
wide range of sport and fitness publications, and anecdotal comments from 
professional sportspersons on its efficacy has contributed to Cr being one of the 
highest selling dietary supplements in the USA. During 1997, USA sales of Cr 
totalled $100 million (£60 million) and forecasts of future sales predicted an 
annual rise of 20 - 25 % (Rowbottom, 1998). A recent questionnaire survey for a 
UK newspaper revealed that almost 57% of over 300 elite sporting competitors in 
the UK had used Cr during their sporting career (Harris & Arthur, 1998). The 
popularity of Cr supplementation amongst athletes has raised concerns from 
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sporting and medical bodies, however, concerning whether any side-effects of Cr 
ingestion exist. Investigations of Cr supplementation to date have only shown one 
recognisable side effect, that of an increase in body mass following Cr feeding for 
5 or more days (e. g. Balsom et al, 1993a, b; Greenhaff et al, 1994). Anecdotal 
suggestions have been made of Cr contributing to liver and kidney damage, 
causing muscle cramping and strains, and producing dehydration and 
gastrointestinal discomfort. Very little evidence has been supplied to support 
these suggestions, yet lay publications and the public media continue to allege that 
Cr supplementation can be harmful. Recently a case study was reported of renal 
dysfunction in a football player who had been taking Cr prior to commencement 
of pre-season training (Pritchard & Kalra, 1998). The patient had pre-existing 
kidney dysfunction, which responded well to medication. Following Cr 
supplementation, however, his serum creatinine concentration was elevated above 
the normal range and creatinine clearance was impaired. One month after 
cessation of Cr supplementation serum creatinine and creatinine clearance were 
within normal range. This study did not investigate the effects of Cr 
supplementation upon kidney function, but merely implied that Cr 
supplementation caused the impaired function. Another letter to a medical journal 
has recently described a case of renal insufficiency in a patient four weeks after he 
had begun ingesting Cr (20 g. d71 Cr. H20, duration of supplementation not 
specified; Koshy et al, 1999). The patient had experienced 4 days of nausea, 
vomiting and bilateral flank pain. Upon hospitalisation, the patient was found to 
have acute focal interstitial nephritis and focal tubular injury and serum creatinine 
concentration was higher than the normal range. Symptoms disappeared 
following treatment with intravenous fluid. To date, these two case studies 
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remain the only scientific evidence to support claims that Cr supplementation may 
not be appropriate for all individuals. By contrast, oral Cr supplementation has 
been used for a number of years in the treatment of gyrate atrophy of the choroid 
and retina (Sipilä et al, 1981; Vannas-Sulonen et al, 1985) and other muscle 
diseases without any adverse effects on health being observed. Intravenous 
administration of PCr has also been demonstrated to improve functional recovery 
of the heart following myocardial infarction and prevent ischaemic damage during 
cardiac surgery (Saks et al, 1992). Recent animal studies have also demonstrated 
that Cr has neuroprotective effects, which may be useful in therapy for 
Huntington's disease and other neurodegenerative diseases (Matthews et al, 1998; 
Klivenyi et al, 1999). 
Despite the lack of evidence from controlled investigations, anecdotal opinions 
continue to be reported that Cr supplementation adversely affects health. This has 
prompted requests for detailed investigation of potential harmful effects of Cr by 
sporting and medical councils. 
1.11 Aims of this thesis 
The principal aim of this thesis is to examine some physiological effects of dietary 
supplementation with the guanidino compounds Cr and arginine in humans. 
Experiments outlined in this review have suggested that Cr accumulation by 
human skeletal muscle might be improved by exercise during supplementation 
(Harris et al, 1992), and by CHO ingestion during supplementation (Green et al, 
1996a). When we consider the possible relationship between muscle glycogen 
and Cr accumulation (Green et al, 1996b) and the influence of exercise upon 
subsequent glycogen synthesis (Bergstrom & Hultman, 1966) and possibly Cr 
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accumulation by muscle (Harris et al, 1992), it is of interest whether these 
responses can be combined. It is hypothesised that the combination of Cr 
supplementation with a glycogen supercompensation protocol might produce 
marked increases in muscle glycogen and Cr concentration, above those that have 
been achieved previously using supercompensation strategies or Cr or Cr + CHO 
supplementation alone. With the aim of addressing this hypothesis, Chapter 3 
describes a study to investigate the effects of a bout of glycogen-depleting 
exercise upon subsequent muscle glycogen and metabolite concentrations, when 
subjects' diets were supplemented with CHO or Cr + CHO. 
As mentioned in this review, another guanidino compound, arginine, has been 
shown to have a potent effect upon insulin release into, and glucose clearance 
from the blood, when administered intravenously. Based upon these findings, and 
following results obtained in Chapter 3, the effects of oral ingestion of arginine 
and CHO upon blood glucose and insulin responses were investigated in Chapter 
4, to establish whether arginine had an effect on the fate of ingested CHO. 
Following from results obtained in Chapter 3, and the previously observed 
relationship between muscle Cr and glycogen accumulation following Cr + CHO 
supplementation (Green et al, 1996b), it is hypothesised that Cr + CHO 
supplementation might be beneficial to individuals who perform prolonged 
exercise. The experiment in Chapter 5 was undertaken to further examine the 
effects of Cr + CHO supplementation upon muscle Cr and glycogen accumulation 
and whether these effects (if any) improved subsequent performance of prolonged 
exercise. 
As the popularity of Cr use as a dietary supplement has increased, so has the 
attention it has received in the media, from both positive and negative viewpoints. 
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With the aim of addressing concerns recently-raised about potential harmful 
effects of Cr supplementation on health, Chapter 6 examines the effects of Cr 
supplementation upon various indices of health, namely haematological, 
hepatological, muscle and renal function. 
In the general discussion, the results of the experiments presented in this thesis are 
discussed. The practical implications that these results may have are considered 
and potential interests for future research are also proposed. 
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Chapter 2 
GENERAL METHODOLOGY 
2.1 Ethical approval and clinical practice 
The University of Nottingham Medical School Research Ethics Committee 
approved all of the experiments described in this thesis. The experiments were 
conducted in laboratories of the School of Biomedical Sciences, University of 
Nottingham Medical School. During all experimental visits a minimum of two 
investigators were present, at least one of whom was qualified to administer first 
aid and had experience in the clinical techniques being used. Additionally, a 
doctor was present within the School to provide medical cover for every 
experiment. A laboratory record of each experiment was recorded and signed by 
the investigator. 
2.2 Recruitment and screening of subjects 
Experimental subjects were recruited by advertisement. Interested volunteers 
were interviewed for suitability for each experiment and the experimental 
protocols were explained to them in detail. In addition to the interview, 
volunteers were provided with an information sheet, which outlined all aspects of 
the investigation and informed them that they could withdraw from the study at 
any time without giving prior notice (see Appendix A). A basic medical 
screening examination was then conducted for all volunteers. Firstly, subjects 
completed a confidential questionnaire relating to aspects of their health, diet and 
activity and measurements of height and weight were taken. A 12-lead ECG 
recording (Cambridge VS-6, Picker International, USA) and measurements of 
blood pressure (Accutor IA, Datascope Corp., Paramus, NJ, USA) in supine and 
standing positions were then performed. With the volunteer's consent, blood 
samples were obtained by venupuncture of an antecubital vein. These samples 
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were analysed for full blood count and for indices of renal and hepatological 
function by the Haematology and Clinical Chemistry departments of the Queen's 
Medical Centre, Nottingham, respectively. A clinician checked the results of the 
medical screening and volunteers considered to be in good health were accepted 
for inclusion in the study. Prior to involvement in each study, subjects signed a 
consent form, which confirmed that they had read and understood the information 
sheet concerning the study, further confirmed that their health was normal and 
stated that their agreement to participate in the study was made of their own free 
will. 
2.3 Measurement of peak oxygen consumption 
Equipment and theoretical basis of measurement 
In the experiments described in Chapters 4 and 5, tests were conducted on 
subjects to determine their peak oxygen consumption (VO2peak). During these 
tests subjects exercised at incrementally increasing workloads and samples of 
expired air were monitored throughout. Expired air samples were analysed and 
recorded at 20-second intervals throughout the exercise period. A headset- 
mounted mouthpiece connected to a computerised analysis system (Vmax 29, 
SensorMedics Corporation, Yorba Linda, CA, USA) set to `mixing chamber' 
mode was used for analysis and recording. Prior to each test, the analysis system 
was calibrated for airflow measurement, and accuracy of oxygen and carbon 
dioxide measurement was determined using certified calibration gases and 
atmospheric air. The analysis system used measured oxygen concentration using 
a paramagnetic oxygen analyser, which generated a signal in response to the 
partial pressure of oxygen in an expired gas sample. Carbon dioxide measurement 
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was made using a non-dispersive infrared technique, which operates by measuring 
the amount of infrared energy that is absorbed in a sample of expired gas. 
Oxygen consumption (V02) was automatically calculated by a computer linked to 
the analysis system, based on the following equation, which is derived as detailed 
in Appendix B: 
02 consumption = Volume of oxygen inspired - Volume of oxygen expired 
Exercise test for VO2peak measurement 
For assessment of VO2peak, each subject performed a continuous incremental 
exercise test on an electrically braked cycle ergometer (Excalibur Sport, Lode 
N. V. Instrumenten, Groningen, The Netherlands), having not eaten during the 
preceding 2 h. Each subject was positioned on the ergometer at a suitable saddle 
height and cycled at a cadence of 70 rpm against increasing workload intensity 
steps of 50 Watts (W), each step lasting 3 min. The initial exercise intensity was 
either 100 W or 150 W, depending upon the subject's experience with cycling 
exercise. As the subject was approaching fatigue, workload increments were 
increased by only 30 W until the subject could no longer maintain the workload 
for 3 min. The exercise test was designed to produce exhaustion within 15 - 20 
min. 
Peak V02 was taken to be the average of the last four V02 measurements recorded 
during the final completed stage of exercise. A similar, shorter test was conducted 
for each subject not less than 3 days later. This involved the subject cycling at a 
warm-up workload for 3 min, followed by cycling at a workload 30 W below that 
of the final completed stage of the previous test. The workload was then 
increased in 30 W increments until the subject could no longer maintain the 
workload for 3 min. The values of V02 measured during both tests were plotted 
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against workload applied for each stage of the exercise test. From the resultant 
plots, workloads could be calculated that would elicit 70 % of VO2peak for use in 
the test protocols in Chapters 4 and 5. 
2.4 Calculation of respiratory exchange ratio and measurement of substrate 
oxidation 
Theoretical basis of measurement 
It is possible to estimate the proportion of substrate that is contributing to energy 
production by assessing the ratio of CO2 produced to 02 consumed, in subjects at 
rest and performing steady-state exercise. This ratio is given the term respiratory 
exchange ratio (RER) and is based upon the fact that fat, carbohydrate and protein 
differ in the amount of 02 used and CO2 produced when they are utilised as fuel. 
Carbon dioxide production (VCO2) can be calculated in a similar manner to 02 
consumption: 
CO2 production = Volume of CO2 expired - Volume of CO2 inspired 
Given VCO2, RER can be calculated by the simple equation, 
RER = VCO') 
V02 % 
In Chapter 4 expired gas samples were collected for estimation of substrate 
oxidation. In order to calculate the oxidation rates of CHO (VO2CHo) and fat 
(V02FAT), the rate of protein oxidation (V02p) is also required as protein 
contributes a small proportion to total energy expenditure. In the experiment 
described, samples were collected at rest and it was assumed that protein 
oxidation contributed to 12.5 % of total energy expenditure during the collection 
period (Weir, 1949). Derivation of the equations for VO2CHO, VO2FAT and V02P 
calculation are shown in Appendix B. 
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Equipment for measuring RER 
Subjects rested on a bed with their head completely covered by a plastic canopy. 
The canopy consisted of a domed hood with an inlet for atmospheric air and an 
outlet from which expired air was collected for analysis by a gas analysis system 
(GEM, Europa Scientific Ltd., UK). Prior to each test, the analysis system was 
calibrated for accuracy of oxygen and carbon dioxide measurement using certified 
calibration gases and atmospheric air. The system generated reports of expired air 
analysis for every 60 seconds of sampling. From these values, the contributions 
of different substrates to oxidative metabolism were estimated. 
2.5 Forearm blood flow measurement 
Theoretical basis of measurement 
In Chapter 4, forearm blood flow was measured using venous occlusion 
plethysmography. This non-invasive technique relies upon the assumption that a 
limb is a cylinder of fixed length and that any change in limb volume will result in 
a change in the circumference at all points of that cylinder (Whitney, 1953). The 
rate of arterial inflow into a limb can be measured by observing changes in limb 
circumference whilst venous flow out of the limb is halted. A high-pressure 
arterial occlusion cuff was wrapped around the wrist and a lower pressure venous 
occlusion cuff was wrapped around the arm above the elbow. To measure 
changes in limb circumference, a mercury-in-rubber strain gauge was attached 
around the forearm between the cuffs. For each blood flow measurement the 
arterial occlusion cuff was inflated to a pressure exceeding arterial systolic 
pressure to prevent any shift of blood away from the hand into the limb. After 
one minute of inflation to avoid introduction of artefact to measurements, the low 
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pressure venous occlusion cuff was inflated above venous pressure, but lower than 
systolic pressure, to allow arterial in-flow. Arterial flow was monitored for 8 
seconds, then the low pressure cuff was deflated to allow venous out-flow of 
blood. Positioning the forearm above the atria of the heart ensured complete 
venous drainage in this period. The cuff was inflated and deflated cyclically for 
approximately 7 measurements. 
Equipment for measurement of blood flow 
Forearm circumference was measured using a tape measure, and a strain gauge of 
appropriate size was attached around the forearm. The strain gauge consisted of a 
compliant silicon rubber tube (bore diameter 0.5 mm, wall thickness 0.25 mm) 
filled with mercury, closed off at each end with platinum wire (0.9 mm diameter). 
The platinum wires were attached to a strain gauge holder to complete a 
Wheatstone Bridge circuit. This circuit enables signals to be generated in 
proportion to changes in length of the mercury-in-rubber tube. The changes in 
length are measured by a galvanometer within the gauge, which in turn is attached 
to a signal amplifier and microcomputer running chart-recording software (Chart 
V 3.4 for Apple Macintosh). Prior to each experiment, the circuit was balanced 
using a 10 g weight to maintain tension. The gauge was then calibrated on a 
wooden forming block. Briefly, the holder was fixed in position whilst the rubber 
tubing was looped over a mount on the end of the calibration block. A screw of 
known pitch was used to adjust the mount for five full turns. The chart-recording 
software recorded the mean size of the resulting signals and subsequent 
calculations of blood flow were based upon the calibration factor obtained. 
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Forearm blood flow was calculated using the following equation: 
Blood flow = slope " pitch calibration screw " chart speed " 200 
Calibration factor limb 
circumference 
where: 
Calibration factor = sum of distance of each step 
number of steps 
Pitch of calibration screw = 0.53 
Slope is measured in mV. s"1, chart speed in mm. s"1 and limb circumference in mm. 
2.6 Supplementation information 
In the experiments in Chapters 3-6 subjects consumed a carbohydrate drink 
containing 18.5 % glucose and simple sugars (LucozadeTM, Smithkline Beecham, 
Coleford, UK). During the 5-day supplementation periods (Chapters 3,5 & 6) 
subjects drank a 500 ml serving of LucozadeTM four times each day, evenly 
distributed throughout the day (e. g. 08: 00,12: 00,16: 00,20: 00 hrs). In Chapter 4 
subjects were given a single 378 ml serving of LucozadeTM during each 
experimental visit, and were required to consume the drink within 5 minutes. 
In Chapter 4, subjects ingested 10 g doses of the amino acids arginine and glycine 
(Ajinomoto Co. inc., Kawasaki City, Japan), on separate occasions. The amino 
acids in powder form were dissolved in 200 ml cold water, to which was added 
50 ml of sugar-free fruit cordial. Subjects were required to consume the amino 
acid drink as quickly as possible. The approximate time for drink consumption 
was 30 s. 
In Chapters 3,5 & 6, subjects' diets were supplemented with Cr in the form of 
creatine monohydrate (Cr. H20; Experimental and Applied Sciences, CO, USA). 
57 
Subjects were provided with vials containing Cr. H20 that they dissolved in a 
warm non-caffeinated drink and consumed on 4 separate occasions each day, 
evenly distributed throughout the day (e. g. 08: 00,12: 00,16: 00,20: 00 hrs), for 5 
days. 
2.7 Dietary manipulation 
In Chapter 3, all subjects were required to maintain a diet of high CHO content. 
To achieve this, subjects were provided with appropriate foodstuffs and dietary 
advice which, if followed, was anticipated to ensure subjects received > 80% of 
their daily energy intake in the form of CHO (see Appendix A). 
In Chapter 4, each subject consumed a standardised meal prior to each 
experimental visit. An identical meal was consumed before every experimental 
visit, which commenced no less than 12 h after the meal. 
In Chapter 5, subjects were asked to follow and keep a record of their normal diet 
over the 3 days prior to the first exhaustive exercise visit. They were asked to 
repeat the recorded diet for the 3 days prior to all subsequent experimental visits, 
in addition to which they also consumed the experimental supplements. 
2.8 Blood sampling procedures and analysis 
In Chapters 3&4 blood samples were obtained from a vein on the dorsal surface 
of the hand. Subjects placed their hand in a heated Perspex chamber in which air 
temperature was maintained at 55 °C in order to arterialise the venous drainage of 
the hand (Gallen and Macdonald, 1990). After allowing the hand to be warmed 
for approximately 10 min, local anaesthesia was applied to the skin (1 % w/v 
lignocaine hydrochloride, Antigen Pharmaceuticals Ltd., Roscrea, Ireland) and a 
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21 gauge venous cannula was inserted retrogradally into a superficial vein on the 
dorsal surface of the hand. Following cannulation, the subject's hand was 
returned to the heated chamber and blood samples obtained from the cannula via a 
3-way tap system. Cannula patency was maintained throughout the experiment by 
an isotonic saline drip (0.9% sodium chloride BP, Baxter Healthcare Ltd. 
Thetford, England, UK). 
In Chapter 5, blood samples were obtained from a cannula inserted into a vein of 
the forearm. Local anaesthesia was applied to the skin (1% w/v lignocaine 
hydrochloride, Antigen Pharmaceuticals Ltd., Roscrea, Ireland) and an 18 gauge 
cannula was inserted retrogradally into an antecubital vein. Blood samples were 
obtained from the cannula via a 3-way tap system and the cannula was kept patent 
using an isotonic saline drip (0.9% sodium chloride BP, Baxter Healthcare Ltd. 
Thetford, England, UK). In Chapters 4&5, the cannula was secured at the site of 
insertion by a waterproof adhesive medical covering to prevent its movement 
whilst the subject exercised. 
Throughout experiments in Chapters 3-5, a 15 min equilibration period was 
allowed between insertion of the cannula and collection of the first blood sample. 
Prior to collection of an experimental blood sample, a2 ml syringe was used to 
remove a mixture of saline and blood contained in the dead-space between the tip 
of the cannula and the 3-way tap. A 10 ml syringe was then used to collect blood 
for analysis, which was divided equally for serum and plasma analysis. 
Additionally, 100 µl of the same sample was immediately introduced into an 
automated analyser (Chapters 3&5, YSI 2300 STAT plus, YSI, Yellow Springs, 
OH, USA; Chapter 4, Hemocue AB, Angelholm, Sweden) for measurement of 
glucose and lactate (Chapter 5 only) concentrations. Previous calibration of the 
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automated equipment by comparison with spectrophotometric glucose and lactate 
analysis of identical samples has determined a very good degree of accuracy of 
this equipment (Fox & Greenhaff, personal communication). 
In Chapters 3&4, blood samples for serum analysis were allowed to clot, 
centrifuged at 3000 rpm for 10 min and the supernatant was stored at -20 T. 
Serum insulin concentration was measured using a commercially available radio- 
immunoassay diagnostic kit (Diagnostic Products Corporation, Los Angeles, CA, 
USA) by the Department of Clinical Chemistry, Queen's Medical Centre, 
Nottingham, UK. 
In Chapter 6, blood samples were obtained by venupuncture of an antecubital 
vein, after subjects had been seated for at least 5 min, and dispensed into separate 
tubes either containing potassium EDTA or plain tubes containing no 
anticoagulant. These samples were analysed for indices of haematological 
function and for indices of hepatological, muscle and renal function by the 
Departments of Haematology and Clinical Chemistry, Queen's Medical Centre, 
Nottingham, respectively. 
2.9 Muscle sampling procedures and analysis 
In Chapters 3&5, muscle samples were obtained by a clinician using the 
percutaneous needle biopsy technique (Bergstrom, 1962). Prior to sampling, a 10 
cm2 (approx. ) area of skin, which covered the area from which the biopsy was to 
be taken, was shaved and cleaned with an alcoholic iodine solution. Local 
anaesthetic (1 % w/v lignocaine hydrochloride, Antigen Pharmaceuticals Ltd., 
Roscrea, Ireland) was injected under the skin and into the muscle and a 10 mm 
incision was made through the skin to allow insertion of the biopsy needle. A 
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biopsy needle was inserted through the incision into the vastus lateralis muscle 
from which a sample was cut (- 50 mg wet weight) and removed from the leg. In 
Chapter 3, the muscle sample was allowed to stand at room temperature for 1 
minute to allow PCr concentration to return to a normal level (Sdderlund & 
Hultman, 1986). Tissue damage due to the muscle biopsy procedure causes Ca2+ 
release in the muscle tissue, which in turn stimulates actomyosin ATPase activity. 
This will result in a transient decrease in PCr concentration as ATP is 
consequently resynthesised. An equilibration period of 1 minute at room 
temperature, prior to muscle tissue freezing, has been demonstrated to more 
accurately reflect the concentrations of ATP and PCr in resting human muscle 
(Söderlund & Hultman, 1986). The muscle sample was then frozen in liquid 
nitrogen and stored at -80 °C for subsequent analysis. In Chapter 5, all muscle 
samples were frozen in liquid nitrogen immediately following removal so that PCr 
and ATP concentrations during exercise and immediately following exhaustion 
could be measured. Once frozen, all muscle samples were freeze-dried and stored 
at -80 °C. 
Prior to analysis, any fat contained in the samples was solubilised by immersion in 
petroleum ether for 20 minutes and removed by pouring off the solvent. Muscle 
samples were then dissected free of visible blood and connective tissue and 
powdered in a mortar and pestle. Aliquots of muscle powder were weighed for 
subsequent analysis of ATP, PCr, Cr (- 6.0 - 7.0 mg muscle powder) and 
glycogen (- 2.01 - 3.0 mg muscle powder) concentrations. 
Muscle samples for measurement of metabolite concentrations were first extracted 
with 80 µL. mg"1 d. m. (minimum 500 µL) 0.5 M perchloric acid (PCA) for 10 
minutes with intermittent mixing and storage in ice. The extract was then 
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centrifuged (14000 rpm, 1 min) and 400 µL of the supernatant transferred to an 
eppendorph tube and neutralised with 100 µL 2.2 M KHCO3. The resultant 
supernatant was immediately frozen in liquid N2 and stored at -80°C, prior to 
analysis. The extraction dilution factor (F) was then calculated for each sample as 
follows: 
F=VPCAx(Vs+VKHcoj 
VsxWtM 
where: VPCA = Volume of PCA added (µL) 
Vs = Volume of PCA supernatant (µL) 
Vxi-ico, = Volume of KHCO3 added to the PCA extract (µL) 
WtM = Weight of muscle powder (mg) 
Muscle ATP and PCr concentrations were determined spectrophotometrically in 
NADPH-linked reactions (Harris et al, 1974), as outlined below: 
Glucose-6-phosphate + NADp+ o-6'PDH P-gluconolactone + NADPH + H+ 
ATP + Glucose f ADP + G-6-P + H+ 
PCr + ADP + H+ CPKf Cr + ATP 
Briefly, the absorbances at 340 nm of microcuvettes containing all components of 
the reaction mixture (including sample or water as a blank), other than hexokinase 
(HK) and creatine phosphokinase (CPK) were measured (Al). Absorbances were 
also measured following the addition of HK (A2) and CPK (A3) to the reaction 
mixture. Following addition of each enzyme, cuvettes were incubated at room 
temperature with constant agitation on a rotating plate until the reaction had 
reached a plateau. Changes in absorbance measurements of samples were used to 
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calculate ATP and PCr concentrations of the samples using the following 
calculations: 
[ATP] (mmol. kg-1 d. m. ) = V2 (A2 -1312) - V1 (Al - 1311) "F 
6.22 " SV 
[PCr] (mmol. kg"' d. m. ) = V3 (A3 -B13) - V2 (A2 - B12) "F 
6.22"SV 
where: V1= initial reaction volume (µL) 
V2 =V1+ volume of HK added (µL) 
V3 = V2 + volume of CPK added (µL) 
Al (or Bll) = Initial absorbance of reagent + sample (or blank) 
A2 (or B12)= Absorbance following addition of HK to sample (or blank) 
cuvette 
A3 (or B13) = Absorbance following addition of CPK to sample (or blank) 
cuvette 
F= Extraction factor 
6.22 = millimolar absorption coefficient of NADPH @ 340 nm 
SV = Sample volume 
By a similar method, muscle Cr concentration was determined 
spectrophotometrically in NADH-linked reactions (Harris et al, 1974), as outlined 
below: 
Pyruvate + NADH + H+ LDH 10, Lactate + NAD+ 
ADP + phosphoenolpyruvate +H+ P_ K fPyruvate + ATP 
Cr + ATP CPK PCr + ADP+ H+ 
The absorbances at 340 nm of microcuvettes containing all components of the 
reaction mixture (including sampletblank), other than CPK were measured (Al). 
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Following addition of CPK, and incubation until the reaction had reached a 
plateau, absorbances of cuvettes were measured (A2). Changes in absorbance 
measurements of samples were used to calculate Cr concentrations of the samples 
using the following calculation: 
[Cr] (mmol. kg"1 d. m. ) = V2 (B12 - A2) - VI 1(B 1- Al) "F 
6.22 " SV 
Muscle glycogen concentration was determined by an assay that first involved 
hydrolysis of glycogen by heating at 80°C for 20 min in 120 µL 0.1 mol. L"' 
NaOH, followed by neutralisation with 480 µL of buffered HC1 (3: 1 ratio 0.2 
mol. L"1 citric acid/0.2 mol. L-1 Na2HPO4 buffer : 0.1 mol. L" HC1). The mixture 
was then incubated at room temperature for 1h in the presence of 10 µL 
amyloglucosidase and the supernatant stored at -20°C for subsequent analysis of 
glucose concentration. The extraction dilution factor (Pa) of the sample was then 
calculated by the following equation: 
FG=VEXT+Wt 1 
WtM 
where: VEXT = sum of all extraction reagent volumes 
The concentration of glucosyl units in the glycogen digests was determined 
spectrophotometrically in NADH-linked reactions (Harris et al, 1974), as outlined 
below: 
ATP + Glucose HK º ADP + G-6-P + H+ 
Glucose-6-phosphate + NA+ o-6-'' P-gluconolactone + NADH + H+ 
The absorbances at 366 nm of microcuvettes containing all components of the 
reaction mixture (including sample/blank), other than HK were measured (Al / 
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Bll). Following addition of HK, and incubation until the reaction had reached a 
plateau, absorbances of cuvettes were measured (A2 / B12). Changes in 
absorbance measurements of samples were used to calculate glucosyl 
concentrations of the samples using the following calculation: 
Glucose (mmol. kg"l d. m. ) = {{ "V2)A 1"Vl) 2"V2)--(1B 1"V1)} " Fo 
SV " 3.34 
where: 3.34 = millimolar absorption coefficient of NADH @ 366 nm 
A small number of muscle samples obtained in Chapter 5 were not of sufficient 
size (i. e. <4 mg dry weight) to separate for analysis of metabolite and glycogen 
concentration. In the case of these samples, the muscle powder was first extracted 
using 0.5M PCA, using the same method for metabolite extraction. Following 
metabolite extraction and removal of supernatant for metabolite analysis, the 
remaining pellet and a separate aliquot of PCA extract were hydrolysed in 100 
. tL. mg' d. m. 1M HCl for 2h and the resulting supernatants were stored at -80°C 
prior to analysis. Glucose concentration of the supernatant of these samples was 
determined fluorimetrically (, 340 nm, Xfl 460 nm) in NADPH-linked reactions 
(Lowry & Passoneau, 1973), as outlined below: 
ATP + Glucose ' ADP + G-6-P + H+ 
Glucose-6-phosphate + NADP+ G-6-PD f -gluconolactone + NADPH + H+ 
The glucose concentration of non HCl hydrolysed PCA extract was subtracted 
from that of the HCl hydrolysed PCA extract, giving the concentration of soluble 
glycogen in the sample. This value was then added to the insoluble glycogen 
concentration determined for the HCl hydrolysed muscle sample to give total 
glycogen concentration of the sample (Jansson, 1981). 
To ensure reliability of the assay procedures performed on different occasions, 
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standard solutions of ATP, PCr, Cr and glucose were also assayed at the same 
time as muscle extract samples. Very good repeatability was found between 
measurements of standard solutions for all assays performed on different 
occasions. Laboratory method sheets for muscle extraction and all analytical 
assays outlined above can be seen in Appendix B. 
2.10 Correction procedures for muscle metabolite and substrate concentrations 
Muscle PCr, Cr and glycogen concentrations were corrected to account for 
variations in non-muscle constituents (e. g. blood, connective tissue) of each 
sample. An accepted method of correcting for these constituents is to adjust 
values based on the concentration of ATP measured in each sample (Harris et al, 
1992), as muscle ATP concentration is considered to not vary with time for any 
given individual, but will change with exercise. Any non-muscle component of a 
sample is likely to decrease the ATP concentration measured in that sample. 
Thus, in a range of muscle samples taken at rest from any given individual, a low 
ATP concentration of a sample compared with other samples will be indicative of 
the presence of non-muscle constituents. To correct concentrations to account for 
contamination, the mean of the two highest ATP concentrations was taken to be 
representative of the actual concentration for that individual. The resulting value 
was then divided by the ATP concentration of each sample to produce a 
`correction factor' for each sample. The correction factor was then multiplied 
with the PCr, Cr and glycogen concentrations to give 'ATP-corrected' 
concentrations. In Chapter 6, muscle samples were obtained at rest, during 
exercise and immediately following exhaustive exercise. To remove any 
influence of exercise upon the relative concentration of ATP between resting and 
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exercised samples, the correction factor was determined for samples obtained 
within each time point. That is, samples obtained at rest were corrected based 
upon the mean of the highest 2 ATP concentrations of all of a subject's resting 
samples, and not of samples from rested and exercised muscle. Correction was 
similar for samples obtained during exercise and immediately following 
exhaustion. 
2.11 Statistical analysis 
The data presented as area under curve (AUC) in Chapter 4 were calculated from 
the glucose and insulin concentrations of each subject over the measurement 
period. A curve of best fit was constructed for each series of subject data using a 
Least Squares method. A third-order polynomial equation was used to predict the 
curve of best fit, and the area under the curve was found by calculating a definite 
integral from a lower to an upper value for each consecutive data point and 
totalling all area values in the measurement period. All AUC analysis was 
performed using graph analysis software (Kaleidagraph V 3.0.2, Synergy 
Software, Reading, USA). 
In Chapters 3,4, and 5, results are presented as mean values with standard errors 
of the mean (S. E. M. ). In Chapter 6, results are presented as mean values with 
standard deviations from the mean (SD) to allow clear interpretation of the 
clinical data presented therein. In Chapters 3,4,5 and 6, comparison of data 
across experimental groups was assessed for statistical significance using analysis 
of variance (ANOVA; 2-way ANOVA for treatment and time effects, 1-way 
ANOVA for treatment or time effects). Significant differences revealed by 
ANOVA were scrutinised further using, where appropriate, Fisher's Protected 
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Least Significant Difference t-test and Student's unpaired t-test. Comparison of 
data within an experimental group was analysed for statistical significance using 
Student's paired t-test. Where correlations between variables are reported, a 
Pearson's correlation coefficient was determined and the statistical significance of 
the relationship determined by linear regression. These statistical tests were 
conducted using commercially available statistical analysis software (SuperAnova 
V 1.11, Abacus Concepts Inc., Berkeley, CA, USA; Excel V 5.0, Microsoft 
Corporation, Redmond, WA, USA). 
2.12 Coefficient of variance for analytical measurements 
The coefficients of variance (CV %) for measurements of metabolite and substrate 
concentrations of blood and muscle samples are presented in Table 2.1. The 
CV % was determined by repeated measurements (n = 10) of the same sample and 
was calculated as follows: 
CV %= standard deviation of repeated measurement " 100 
mean of repeated measurement 
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Table 2.1 Coefficient of variance for analytical measurements 
Measurement n CV % 
Blood 
Glucose (Hemocue AB) 10 2.1 
Glucose (YSI 2300) 10 1.1 
Lactate 10 0.9 
Muscle 
ATP 10 0.6 
Cr 10 1.7 
PCr 10 0.9 
Glycogen 10 1.1 
(spectrophotometric method) 
Blood flow 7 13.7 
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Chapter 3 
EFFECTS OF EXHAUSTIVE EXERCISE AND 
CREATINE AND CARBOHYDRATE 
SUPPLEMENTATION UPON SKELETAL 
MUSCLE ACCUMULATION OF CREATINE 
AND GLYCOGEN 
3.1 INTRODUCTION 
In their paper describing the effects of Cr supplementation upon muscle Cr 
accumulation, Harns et al (1992) reported that performance of exercise during a 
period of Cr supplementation increased the magnitude of accumulation. 
Submaximal exercise performed by 5 subjects immediately prior to Cr ingestion 
on each day of supplementation resulted in 9% greater TCr concentration in 
exercised muscle than in non-exercised muscle. It was postulated that this effect 
may have been brought about by an exercise-induced increase in limb blood flow 
to the exercised muscle and thereby Cr delivery, or by a change in the kinetics of 
muscle Cr transport (Harris et al, 1992). It should be noted, however, that the 
differences observed between limbs were relatively small and highly variable 
between individuals. Furthermore, the greatest exercise induced increase in 
muscle Cr accumulation was observed in two vegetarian subjects. Preliminary 
evidence indicates that the magnitude of muscle Cr retention during Cr 
supplementation is, at least initially, markedly greater in vegetarians compared 
with non-vegetarians (Green et al, 1997). It would appear, therefore, that the 
small number of subjects, the variation in the supplementation protocol and the 
inclusion of vegetarians in the study of Harris et al (1992) has not provided clear 
insight into the effect of exercise on muscle Cr accumulation. Subsequent 
investigation of the effect of 1h submaximal exercise performed during a period 
of Cr + CHO supplementation showed no improvement in whole body Cr 
retention (Green et al, 1996c). However, the authors proposed that any 
stimulatory effect of exercise might have been overshadowed by the magnitude of 
the response to ingesting Cr with CHO. Creatine supplementation for 10 days, 
combined with exercise training, has been reported to produce improvements in 
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high intensity running performance in rats (Brannon et al, 1997). Although no 
difference in muscle Cr concentration was observed between training + Cr- 
supplemented and non-training + Cr-supplemented rats, it was suggested that the 
improvements in performance in the former group were attributable to changes in 
muscle Cr + PCr stores and an increase in muscle citrate synthase activity. 
During the initial 10-day Cr loading period of this study, exercise was restricted to 
submaximal treadmill running for only 7 min. d'', for familiarisation purposes. 
This relatively short exercise duration may not have been sufficient to study a true 
influence of exercise upon Cr accumulation. Presently there is inconclusive. 
evidence of any effect of exercise on muscle Cr accumulation. It is pertinent, 
therefore, to examine more closely the influence of exercise upon muscle Cr 
accumulation in humans. 
Whole-body Cr retention (Green et al, 1996c) and muscle TCr concentration 
(Green et al, 1996a) increases when large amounts of simple CHO are ingested in 
conjunction with Cr. An observation of the former study was that consumption of 
CHO with Cr resulted in a greater increase in body mass than when individuals 
consumed Cr alone. Further investigation of this supplementation regimen (Green 
et al, 1996b, Green, 1996) also revealed a tendency for greater glycogen 
accumulation in muscle when Cr + CHO was ingested, compared with Cr or CHO 
only. Furthermore, a significant correlation between the extent of muscle 
glycogen and TCr accumulation following Cr + CHO supplementation was 
observed (r = 0.75, n=8, p<0.05). This correlation was not evident when Cr or 
CHO alone were ingested. This finding is of interest, particularly as pre-exercise 
availability of muscle glycogen is a principal determinant of endurance exercise 
performance (Bergstrom et al, 1967). 
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The classically accepted method of increasing muscle glycogen stores is by 
`glycogen loading', which involves depletion of muscle glycogen, usually by 
exercise, followed by consumption of a high CHO diet for several days (e. g. 
Bergström & Hultman, 1966; Sherman & Costill, 1984). Methods such as these 
can increase muscle glycogen concentrations to between 150% and 200% of 
normal resting levels. This response has been attributed to an increase in 
glycogen synthase activity in the post-exercise period and an exercise-induced 
increase in insulin sensitivity of the glycogen depleted muscle (Bergstrom & 
Hultman, 1966). Based on the proposed relationships between exercise and Cr 
accumulation (Harris et al, 1992), between muscle Cr and glycogen accumulation 
during Cr + CHO supplementation (Green et al, 1996b) and between glycogen- 
depleting exercise and subsequent glycogen resynthesis (Bergstrom & Hultman, 
1966), it is of interest whether glycogen-depleting exercise could influence 
subsequent muscle Cr accumulation and whether the glycogen supercompensation 
response could be augmented by Cr ingestion. 
Aims 
The principal aims of this study were to examine a number of factors that have 
been proposed to increase muscle Cr accumulation in humans. Firstly, to 
determine whether exercise enhanced muscle Cr accumulation, a 1-legged cycling 
model of exercise was used to allow comparison of Cr accumulation between 
exercised and non-exercised muscle. In an attempt to stimulate insulin-mediated 
Cr transport, CHO was administered with Cr, which provided further opportunity 
to examine the relationship between muscle Cr and glycogen accumulation 
observed during Cr + CHO supplementation. 
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3.2 METHODS 
Fourteen healthy males (Means (t S. E. M. ); age 23 (1) yr., BMI 22 (0.5) kg. m'2) 
participated in the study. All subjects were moderately active and none were 
highly trained. Subjects reported to the laboratory on the morning of the study 
following an overnight fast, having abstained from alcohol consumption and 
strenuous exercise for 48 h. 
Protocol and treatment groups 
An outline of the experimental protocol is shown in Fig. 3.1. Subjects, in pairs, 
performed one-legged cycling exercise on a cycle ergometer, one subject on either 
side of the ergometer, supporting themselves with their contralateral leg 
(Bergstrom & Hultman, 1966). A cycling cadence of 70 rpm was maintained and 
subjects worked against a load predetermined to raise heart rate to between 160 
and 170 bpm. Consumption of water was allowed ad libitum throughout the 
exercise. Subjects continued cycling until near fatigue, when they were allowed 
to rest for a maximum of 5 min. This was followed by short periods of cycling 
and rest until the required cadence could not be maintained for longer than 2 min, 
or until a subject chose not to continue. If one subject exercised longer than his 
partner did, an investigator continued cycling in the partner's position. Upon 
exhaustion, subjects rested supine on a recovery bed and a muscle biopsy sample 
(Post-ex) was obtained from the vastus lateralis of the exhausted (EX) and non- 
exhausted (NEX) limbs, using the needle biopsy technique (Bergström, 1962). 
Further muscle samples were also obtained from each of the subjects' limbs six 
hours post-exhaustion (6 h) and 5 days later (5 day). Following the first muscle 
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Figure 3.1 Outline of an experimental protocol to determine the effect of 
ingesting Cr with CHO on subsequent muscle TCr and glycogen accumulation 
following exhaustive exercise. 
Day 1: Glyvogen. depletlnp exerdse 
Begin supplementation 
1-logged Blood 
"x"rclsa sampling 
148t10min 1 
Id - .4. No. 
4 11 1J 
Time 234E6 Day 
0 hr hr hr hr hr 6 
Muscle biopsy 44S 
Cr + CHO or CHO drink 44 
Food ingestion 4 
ay 2- day 5: Condnu.. uppi. m. nWion 
High CHO ä. t 
No exercise 
Day 6: Return for res$lng biopsies. 
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biopsy, a cannula was inserted into an antecubital vein of the subject's arm and 8 
ml blood samples were obtained at 20 min intervals for a period of 100 min. The 
cannula was kept patent during the sampling period using an isotonic saline drip. 
Following exercise, subjects were randomly allocated into two dietary treatment 
groups: 
CHO group consisted of 7 subjects (age 24 (2) yr., BMI 21.3 (0.3) kg. m'2). 
During the initial 6 hours of recovery from exercise each subject ingested a warm 
sugar-free drink, followed immediately by 500 ml of a drink containing 
approximately 93 g CHO (LucozadeTM) on 3 separate occasions, as described 
below. 
Cr + CHO group consisted of 7 subjects (age 23 (2) yr., BMI 22.5 (0.8) kg. m 
2). 
During the initial 6 hours of recovery from exercise each subject consumed 5g 
creatine monohydrate powder (Experimental and Applied Sciences, Golden, 
Colorado, USA) dissolved in a warm sugar-free drink, followed immediately by 
500 ml LucozadeTM on 3 separate occasions, as described below. 
The first supplement was ingested immediately following collection of a post- 
exercise blood sample (0 min), which occurred within 30 min of the end of the 
exercise and Post-ex biopsy sample. In the 6 hour period of recovery from 
exercise, prior to further muscle sampling, subjects ingested two additional doses 
of their respective supplements at 2h intervals (i. e. 3h and 5h after the initial 
supplement). In addition to this, all subjects consumed a small meal, containing 
approximately 70 g CHO per meal, 1h prior to supplement dose 2 and 3 (i. e. 2h 
and 4h after the initial supplement). 
Subjects repeated ingestion of the supplements four times each day (see Chapter 
2), for a further four days. In addition to the supplements, all subjects were 
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provided with high CHO foodstuffs (i. e. potatoes, rice and cereal) and dietary 
advice to maintain a diet of high CHO content (CHO contributing > 80% daily 
energy intake). During this period all subjects followed their normal daily 
activities, but did not perform any strenuous exercise. 
Muscle sample treatment and analysis. 
Muscle biopsy samples obtained were treated and analysed for Cr, PCr and 
glycogen concentrations, as described in Chapter 2. 
Blood sample treatment and analysis. 
It has previously been observed that exhaustive exercise, such as that employed 
during `glycogen loading', can result in a diminished insulin response to ingested 
glucose (Bloom et al, 1976; Galbo, 1985; Ivy et al, 1985). In order to ascertain 
whether this occurred in the present investigation, the blood sampling protocol 
outlined above was repeated during a separate visit to assess subjects' non- 
exercised responses to the supplements ingested. Analysis of blood samples for 
glucose and insulin concentrations was performed as described in Chapter 2. 
3.3 RESULTS 
Subjects reported compliance with all aspects of the protocol and did not report 
any ill effects. There was no significant body mass change of the CHO group 
following 5 days of supplementation, however, body mass of the Cr + CHO group 
increased significantly (pre-supplementation 72.8 (4.6) kg, post-supplementation 
73.8 (4.6) kg; P<0.05). 
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Muscle metabolite and substrate changes. 
No change in muscle ATP concentration was observed in limbs of either group 
throughout the study (Table 3.1). 
No significant changes in muscle TCr concentration were observed in the EX and 
NEX limbs of either group 6h following one legged exercise (Fig. 3.2) or in the 
limbs of the CHO group after 5 days (Fig. 3.2a). There was a significant increase 
in muscle TCr concentration in the EX (23% increase; P<0.001) and NEX (14% 
increase; P<0.05) limbs of the Cr + CHO group following 5 days of 
supplementation, with the EX limb having a 68% greater accumulation 
(P < 0.01; Fig. 3.2b). 
In accordance with the changes in muscle TCr concentration, no changes in PCr 
or Cr concentration were observed in limbs of the CHO group at any time. A 
significant increase in PCr concentration was observed in the NEX limb of the 
Cr + CHO group following 5 days of supplementation (Table 3.1) and there was 
also a significant increase in Cr concentration in the EX limb of this group 
(all P<0.05). 
The exercise protocol almost completely depleted glycogen in the EX limbs of the 
CHO group and Cr + CHO group (to 7% and 5% of the concentration measured in 
the NEX limb post-exercise, respectively; P<0.001; Fig. 3.3). Muscle glycogen 
concentration of the NEX limb after the exercise period was used as a measure of 
the initial glycogen concentration of the EX limb, as it has been previously shown 
that this one-legged cycling protocol does not affect muscle glycogen 
concentration in the supporting leg (Casey et al, 1995). 
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Figure 3.2 Muscle total creatine (TCr): 
a) from the exhausted (EX) and non-exhausted (NEX) limbs of the CHO group 
post one-legged exercise and 6h and 5 days after CHO supplementation; 
b) from the EX and NEX limbs of the Cr + CHO group post one-legged exercise 
and 6h and 5 days after Cr + CHO supplementation. 
Values represent means ± S. E. M. 
*P<0.05 and *** P<0.001, significant differences from post-ex concentration; 
§§ P<0.01, significant difference between EX and NEX limbs after 5 days of 
supplementation. 
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Post-ex 6 hr 5 day 
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Six hours following ingestion of the first supplement, glycogen had been restored 
in the EX limb to 68% and 72% of non-exhausted concentration in the CHO and 
Cr + CHO groups, respectively, but there was no difference between groups (Fig. 
3.3). Following 5 days of supplementation, glycogen had increased dramatically 
from the post-exercise concentration measured in the EX limb of the CHO and Cr 
+ CHO groups (both P<0.001; Fig. 3.3). Furthermore, the magnitude of this 
increase was 23% greater in the Cr + CHO group (P = 0.06), such that a 
significant difference in glycogen concentration between groups was very close to 
being achieved (P = 0.06). 
The glycogen concentration of the NEX limbs of both groups was unchanged 6h 
following ingestion, but was increased following 5 days of supplementation (CHO 
group, P<0.01; Cr + CHO group, P<0.05). However, no difference in NEX 
glycogen concentration was observed between groups (Fig. 3.3). 
Blood glucose & insulin changes. 
There was no significant difference between groups in either blood glucose (Table 
3.2) or serum insulin responses (Fig. 3.4) at any point during the initial 100 min 
post supplement ingestion. Comparison of these responses with the 
corresponding measurements made under non-exercised conditions showed that 
serum insulin concentrations of both groups in the exercised state were 
significantly lower during the first 40 min following ingestion of their 
supplements (Fig. 3.4). 
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Figure 3.3 Muscle glycogen concentrations in the EX and NEX limbs post one-, 
legged exercise and 6h and 5 days after carbohydrate (CHO group) or creatine 
and carbohydrate (Cr + CHO group) supplementation. 
Values represent means f S. E. M. 
*P<0.05, ** P<0.01 and *** P<0.001, significant differences from post-ex 
concentration of the same leg. 
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Figure 3.4 Serum insulin concentrations: 
a) of CHO group subjects at rest and after exhaustive exercise in response to 
ingestion of 500 ml CHO solution (- 90 g CHO). *P<0.05, significantly 
different from post-exercise concentration. 
b) of Cr + CHO group subjects at rest and after exhaustive exercise in response to 
ingestion of 5g creatine monohydrate and 500 ml CHO solution. 
Values represent means ± S. E. M. 
*P<0.05 and ** P<0.01, significant differences from post-exercise 
concentration. 
3.4 DISCUSSION 
A major finding of the present study was the difference in TCr concentration 
between the EX and NEX limbs of the Cr + CHO group after 5 days of 
supplementation. This demonstrates that a single bout of exhaustive exercise 
prior to Cr supplementation can markedly augment skeletal muscle Cr 
accumulation and that this response is restricted to the exercised muscle, which 
may be of practical importance. The present observation supports the indication 
of Harris et al (1992) that exercise can augment muscle Cr accumulation. In their 
investigation, the authors proposed that exercise increased muscle Cr uptake by 
increasing blood flow to the exercised muscle during the post-exercise period, or 
by increasing the kinetics of muscle Cr transport. The authors implied that 
increasing blood flow to the exercised muscle would maximise the exposure of 
that muscle to Cr concentrations above the Michaelis constant (KM) for its 
transport. Although muscle blood flow was not measured in the present 
investigation, these results suggest that an increased blood flow following 
exercise was unlikely to have been responsible for the greater Cr content of the 
EX limb in the present study. This contention is supported firstly by the lack of 
any difference in TCr concentration between limbs after 6 hours of 
supplementation, when differences in limb blood flow would be expected to be at 
their greatest. Secondly, evidence demonstrating that the KM of muscle Cr 
transport is substantially lower (20 - 110 pmol. L"1 ; Loike et al, 1986; Nash et al, 
1994; Odoom et al, 1996) than the value of 500 pmol. L"1 proposed by Fitch & 
Shields (1966), and cited by Harris et al (1992), makes it unlikely that Cr 
availability will limit transport using conventional regimens of Cr 
supplementation. 
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Creatine transport into muscle cells is dependent upon the presence of 
extracellular Na+ (Daly & Seifter, 1980). A specific Cr transporter has been 
identified and cloned (Guimbal & Kilimann, 1993; Mayser et al, 1992; Nash et al, 
1994), which is highly expressed in skeletal muscle. After 5 days of Cr + CHO 
supplementation, there was an 11 % difference in the TCr concentration between 
the EX and NEX limbs in the current study, which is in agreement with a 9% 
difference between limbs previously observed (Harris et al,. 1992). Given that 
both limbs were exposed to the same plasma Cr concentration over the 5 days of 
supplementation, it is feasible that exercise may have enhanced Cr accumulation 
by increasing the maximal rate (V, ) of Cr transport in the exercised limb. 
Indeed, exercise has been demonstrated to enhance the transport of other amino 
acids (Biolo et al, 1995), which has been suggested to be only partly dependent 
upon increased muscle blood flow (Tipton & Wolfe, 1998). An exercise induced 
augmentation of muscle Cr transport may have occurred by a number of as yet 
unknown mechanisms. For example, Odoom et al (1996) have suggested that an 
increase in the V. of Cr transport may occur as a result of an allosteric effect on 
the transporter itself, by recruitment or synthesis of new transporters, or by 
producing changes in the forces driving Cr transport. In support of the latter 
suggestion, it has been proposed that the majority of Cr transport is achieved by a 
Na+ - Cr co-transport system (Loike et al, 1986; Odoom et al, 1996), which makes 
use of the sarcolemmal Na / K+ pumps. It has been suggested that sarcolemmal 
Na+/ KK pump total activity can be increased through either an increase in intrinsic 
pump activity, or by a net gain in the number of pumps (Odoom et al, 1996). 
Exercise training has been demonstrated to produce increases in the number of 
muscle Na+/ K+ pumps, which attenuates the loss of KK from muscle during 
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subsequent exercise (McKenna et al, 1996,1997). In humans, Green and 
colleagues (1993) have shown that exercise training of sufficient duration and 
intensity (2 h. d. -1,65% VO2tax, 6 d) can upregulate Naa/ K+ pump concentration 
within the first week of training. Additionally, it has been demonstrated in rats 
that a single acute bout of running exercise can increase muscle concentration of 
some Na/ K+ pump subunits in the sarcolemma and also elevate mRNA levels for 
additional Na+/ K+ pump subunits (Tsakiridis et al, 1996). It is therefore feasible 
that in the present study the single bout of exhaustive exercise produced an 
upregulation of net muscle Na+/ K+ pump activity in the EX limb which facilitated 
muscle Cr transport. In support of this conclusion is the finding that 
pharmacological activation and inhibition of Na+/ K+ pump activity in mouse 
myoblast cells was paralleled by up- and down-regulation of cellular Cr 
accumulation in vivo (Odoom et al, 1996). 
The Na+/ K+ ATPase pump activity in skeletal muscle is also influenced by insulin 
(Hundal et al, 1992; Marette et al, 1993). The abundance of some pump subunits 
in the muscle membrane has been shown to increase with acute exposure to 
insulin, most likely by recruitment from intracellular compartments. It is likely 
that this change contributes to the enhancement of muscle Cr accumulation that is 
observed when CHO is ingested with Cr (Green et al, 1996a). It remains to be 
seen whether any interaction exists between exercise- and insulin- induced 
increases in total pump activity. 
Total creatine accumulation in the EX muscle in the present study 
(28.6 ± 4.8 mmol. kg" d. m. ), was no greater when compared with the magnitude 
of accumulation previously observed in non-exercised subjects ingesting Cr + 
CHO (33 ± 3.4 mmol. kg" d. m.; Green et al, 1996a). Furthermore, the magnitude 
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of TCr accumulation in the NEX muscle of the Cr + CHO group (17.0 f 4.7 
mmol. kg"' d. m. ), although significantly elevated above the initial concentration, 
was comparable with that achieved previously in non-exercised individuals 
supplemented with Cr only (20.7 ± 2.4 mmol. kg't d. m.; Green et al, 1996a). 
Given the diminished insulin response to oral CHO observed following exhaustive 
exercise in the present study, these findings also indirectly support a role for 
insulin in promoting Cr transport. Specifically, the exercise-induced blunting of 
CHO-mediated insulin release observed in the present study (Fig. 3.4) would be 
expected to negatively affect insulin-mediated stimulation of muscle Cr transport, 
particularly since recent work has demonstrated that high physiological 
concentrations of insulin are required to stimulate muscle Cr accumulation in 
humans (Steenge et al, 1998). This phenomenon is of practical importance in 
terms of optimising muscle TCr accumulation during supplementation i. e. 
individuals wishing to maximise muscle Cr transport by consuming CHO might 
refrain from performing exhaustive or prolonged exercise during the 
supplementation period. 
The present study found that combining Cr and CHO ingestion with prior 
glycogen-depleting exercise augmented glycogen resynthesis during recovery and, 
similar to muscle Cr accumulation, this response was restricted to the exercised 
muscle. This is the first documentation of this response in humans. Furthermore, 
the increase in glycogen concentration was of a magnitude that one would 
consider sufficient to produce a significant improvement in endurance exercise 
performance. Green et al (1996c) reported a significantly greater peak insulin 
concentration following the ingestion of Cr + CHO, compared with the ingestion 
of CHO alone and also showed a significant relationship between muscle Cr and 
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glycogen accumulation (r = 0.75, n=8, P<0.05) following 5 days of 
supplementation in non-exercised individuals. In the present study there was no 
significant difference in the glucose stimulated insulin response between groups 
following exercise. However, the extent of glycogen depletion produced by the 
present study would be expected to stimulate insulin-independent glycogen 
resynthesis for a major part of the initial recovery period (Price et al, 1994). 
Therefore the effect of diminished circulating insulin concentration observed 
following exercise might have, at least in terms of glycogen synthesis, been 
negligible during the early stage of resynthesis. However, the clear lack of an 
effect of Cr + CHO on glycogen accumulation in the NEX limb after 6h and 5 
days of recovery in the present study goes against an increase in insulin 
availability being responsible for the augmentation of glycogen resynthesis. 
Presumably one could have expected to see an increase in glycogen concentration 
in both limbs following Cr + CHO ingestion, albeit to a lesser extent in the NEX 
limb, had this mechanism been in operation. This is supported further by the lack 
of any difference in insulin responses between groups at rest following ingestion 
of their respective supplements (Fig. 3.4). 
It has recently been reported that muscle glycogen synthesis is modulated by 
muscle cell volume changes (Low et al, 1996a). Osmotically-induced swelling of 
primary rat myotubes increased glycogen synthesis independently of changes in 
glucose uptake. Creatine supplementation in man has been shown to increase 
body mass (e. g. Greenhaff et al, 1994), in particular fat-free mass (Dentowski et 
al, 1997; Kreider et al, 1998), and has also been shown to increase body water 
content over the supplementation period (Dentowski et al, 1997). It has been 
suggested that Cr accumulation results in water retention by the muscle (Hultman 
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et al, 1996), which would be expected to cause muscle swelling. Indeed, it has 
recently been reported that 3 days of Cr ingestion (-. 21 g. d"1) significantly 
increased total body water and intracellular volume by 2% and 3.1 %, respectively, 
as measured by multifrequency bioimpedence analysis (Zeigenfuss et al, 1998). 
Whilst this method of measurement is not the most sensitive for measuring fluid 
changes (c. f magnetic resonance spectroscopy), these results suggest that Cr 
supplementation can increase muscle volume. If this is the case, it is possible that 
the greater accumulation of Cr in the EX limb of the Cr + CHO group produced a 
greater muscle cell volume change than in the corresponding limb of the CHO 
group, thereby contributing to the higher glycogen concentration in the Cr + CHO 
group following 5 days of supplementation. Such a response would also, at least 
partly, explain the lack of an effect of Cr + CHO on glycogen synthesis in the 
NEX limb, where Cr accumulation was markedly lower than previously observed 
following Cr + CHO ingestion (Green et al, 1996a). 
In conclusion, this study demonstrated that exhaustive exercise could enhance 
creatine accumulation in exercised muscle through an as yet undetermined 
mechanism. This effect was restricted to the exercised muscle itself and did not 
appear to be due to an increase in muscle blood flow. Exhaustive exercise 
diminished glucose-stimulated insulin release, however, thereby attenuating any 
enhancement of Cr accumulation due to CHO ingestion. Finally, Cr + CHO 
supplementation following glycogen-depleting exercise augmented glycogen 
resynthesis in the exercised muscle which might be considered sufficient to 
significantly improve endurance exercise performance. 
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Chapter 4 
EFFECTS OF ARGININE INGESTION UPON 
THE FATE OF INGESTED GLUCOSE IN 
RESTED AND EXERCISED HUMANS 
4.1 INTRODUCTION 
Ingestion of Cr with a drink containing a large amount of CHO has been shown to 
result in an enhanced insulin release compared with ingestion of CHO only 
(Green, 1996). Whilst a similar response was not observed in Chapter 3, in 
subjects at rest or following glycogen-depleting exercise, glycogen concentration 
was markedly greater in supercompensated muscle after 5 days of Cr + CHO 
supplementation than in comparative muscle supplemented with CHO only. 
When CHO is consumed after exercise, the rate of glycogen resynthesis is directly 
related to the insulin response to the ingested supplement (Zawadzki et al, 1992). 
Insulin promotes glucose transport into cells for glycogen synthesis, possibly by 
increasing GLUT4 protein content in the muscle membrane (Klip & Marette, 
1992; Rodnick et al, 1992). Secondly, insulin activates glycogen synthase (Ivy & 
Holloszy, 1981), presumably via an intracellular signal for the enzyme's 
dephosphorylation (Connett & Sahlin, 1996). It follows that any mechanism that 
can enhance insulin release when a CHO beverage is ingested after exercise might 
improve glycogen resynthesis. The amino acid, arginine, is another guanidine- 
based compound which, when administered intravenously to humans, has been 
shown to stimulate insulin release (Floyd et al, 1966) and augment glucose- 
stimulated insulin release (Efendic et al, 1974). It can also induce peripheral 
vasodilation (Giugliano et al, 1997), thereby increasing muscle blood flow. As a 
consequence of these latter two effects, arginine (specifically L-arginine) 
significantly increases insulin-mediated glucose uptake (Paolisso et al, 1997). 
Dietary supplementation with relatively large amounts (-25 g) of arginine, in 
humans, has been found to result in higher plasma insulin concentrations after a 
meal than in subjects following a normal diet (Beaumier et al, 1995). 
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Different types of exercise have different effects upon muscle glycogen storage. 
Prolonged exercise that depletes muscle glycogen concentration results in a high 
rate of subsequent glycogen storage if adequate CHO is supplied (Bergstrom & 
Hultman, 1966). Exercise that has a significant eccentric component, however, 
can result in impairment of glycogen resynthesis (Costill et al, 1990; Pascoe & 
Gladden, 1996). There is considerable interest in the optimisation of muscle 
glucose uptake during exercise recovery, as evidenced by the many different 
CHO-containing beverages marketed for post-exercise `energy replenishment'. 
Prolonged consumption (7 d) of a high-arginine diet, however, was shown to 
cause excessive loss of sodium in the urine, and an associated loss of free water. 
This water loss consequently led to a weight loss in subjects (Beaumier et al, 
1995). High doses of arginine are also unpalatable (personal observation) and 
might also cause gastrointestinal discomfort in some individuals (Gater et al, 
1992). These side-effects of high-dose arginine consumption would negatively 
affect individuals who ingested them in a beverage designed for post-exercise 
repletion of CHO stores. Based upon the observations that Cr + CHO 
supplementation increased muscle glycogen storage (Chapter 3) it is of interest to 
study whether a palatable quantity of arginine could also influence the fate of 
ingested glucose, in rested individuals and following different forms of exercise. 
Aim 
The aim of the present study was to examine the effects of ingesting a palatable 
dose of arginine upon the fate of glucose ingested at the same time. These effects 
were investigated in rested subjects and following two different types of exercise. 
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4.2 METHODS 
Six healthy males participated in the study (mean (± S. E. M. ), age 25 (2) years; 
BMI 25.9 (1.8) kg. m 2). All subjects reported that they were moderately active, 
but were not involved in any exercise training. 
Experimental protocol 
On six separate occasions each subject reported to the laboratory following an 
overnight fast. The meal prior to each visit was identical for each subject. Upon 
arrival, subjects lay supine for 30 min whilst resting measurements of heart rate 
(HR), blood pressure (BP) and forearm blood flow (BF) were recorded and an 
arterialised venous blood sample was collected (see Chapter 2) for glucose and 
insulin determination. Immediately following this baseline measurement period, 
subjects were required to perform one of three `activities' in a randomised 
manner: 
a) 45 min laying semi-upright on an experimental bed (Rest). 
b) 1h of repeated bouts of squatting exercise, carrying a backpack 
containing weight equivalent to 25% of their body weight (Resistance). 
Each squat required the subject to bend his leg at the knee and lower the 
weight until the axis of the hips was parallel with the axis of the knees, 
followed by a return to the standing position. Subjects performed 20 
repetitions of the squatting exercise in a 1-min period followed by 3 min of 
rest in a standing position, whereupon they repeated the squatting exercise. 
All subjects completed 15 bouts of this work/rest cycle in the 1h period. 
Heart rate was monitored throughout the exercise period using a telemetric 
heart rate monitor (Polar PE3000, Polar, Kempele, Finland). 
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c) 1 hr cycling exercise (Cycling). Each subject cycled at a cadence 
of 70 rpm against a workload predetermined to elicit an oxygen 
consumption approximately 70% of his maximum aerobic capacity. During 
exercise, subjects ingested 200 ml of water every 15 min to maintain 
euhydration. Heart rate was monitored by a 3-lead ECG throughout the 
exercise period. 
Each activity was aimed at modifying glucose disposal differently; resting 
responses were considered as a control treatment, cycling exercise was anticipated 
to increase muscle glucose storage and resistance exercise was expected to result 
in a relative decrease in the amount of glucose stored. Visits were separated by at 
least 1 week. 
Following each activity, subjects rested supine for 30 min whilst measurements of 
HR, BP and BF were recorded, and samples of blood and expired air were 
collected. Subjects then ingested 250 ml of a sugar-free fruit drink containing, in 
a randomised manner, either 10 g glycine (placebo) or 10 g L-arginine. This was 
immediately followed by ingestion of 378 ml of a CHO solution containing 70 g 
simple sugars (LucozadeTM). At the time of the investigation, subjects and 
investigators were unaware of the identity of the amino acid drink. During the 
subsequent 3h post-ingestion period, blood samples were collected every 20 min, 
expired air samples were collected during the last 15 min of each 30 min period 
and HR, BP and BF were recorded during the last 8 min of each 30 min period. 
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4.3 RESULTS 
Blood glucose 
Blood glucose concentration decreased significantly following resistance exercise 
prior to arginine ingestion (Fig. 4.1b; P<0.05), and following cycling exercise 
(Fig. 4.1c; P<0.001) prior to both treatments. Following CHO ingestion, blood 
glucose concentration increased significantly in rested subjects and following 
resistance and cycling exercise (all P<0.001). Glucose concentration peaked 40 
min after CHO ingestion following all activities (Table 4.1) and gradually 
declined toward resting concentration. Glucose concentration was no longer 
significantly different from resting concentration 140 min, 160 min and 140 min 
following CHO ingestion in subjects when rested, following resistance exercise or 
cycling exercise, respectively. This response following arginine ingestion was no 
different from when placebo was ingested (Fig. 4.1a, b, c). The area under blood 
glucose concentration / time curve (Glucose AUC), following any activity, was no 
different following arginine ingestion than when placebo was ingested (Table 
4.1). 
Serum insulin 
One subject involved in the investigation demonstrated a hyperinsulinaemic 
response to the ingested CHO on all occasions. The pattern of insulin response to 
ingested CHO was similar to the other subjects, however, insulin concentration 
was 3 times greater than the mean of the rest of the group. To avoid 
misinterpretation of the results, data for that subject's insulin response were not 
included in the analysis or reports of the group's response to the treatments. ' 
1 Refer to note 4.1 at end of Chapter. 
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Figure 4.1 Whole blood glucose concentration prior to activity and during a3h 
period following ingestion of 70 g CHO and either 10 g placebo (filled symbols) 
or arginine (open symbols) in subjects (n = 6): 
a) without prior exercise (Rest) 
b) following resistance exercise (Resistance) 
c) following cycling exercise (Cycling) 
Values represent mean ± S. E. M. 
Arrows indicate time of drink ingestion. 
*P<0.05, significant difference from pre-activity concentration, prior to arginine 
ingestion. *** P<0.001 significant difference from pre-activity concentration, 
prior to both treatments. tri P<0.001, significant increase from post-activity, 
pre-ingestion concentration, both treatments. 
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Table 4.1 Blood glucose and insulin responses (area under curve, 
AUC) and peak glucose and insulin concentrations during 3h of 
exercise recovery following CHO and either placebo (Pla) or arginine 
(Arg) ingestion. 
Values are mean (± S. E. M. ), n=6(. n= 5). 
Rest Resistance Cycling 
Pla Arg Pla Arg Pla Arg 
Glucose AUC 1037 1100 999 1028 968 1031 
(mmol/L/3h) (35) (23) (44) (28) (34) (31) 
Insulin AUC* 5608 5464 4881 5028 4459 4274 
(mIU/L/3h) (565) (886) (410) (598) (359) (251) 
Peak glucose 7.5 8.48 6.9 7.1 6.62 7.4 
(mmol/L) (0.5) (0.3) (0.3) (0.2) (0.4) (0.6) 
Peak insulin* 53 58 49 59 42 43 
(mITJ/L) (9) (17) (5) (13) (4) (13) 
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Serum insulin significantly increased in response to CHO ingestion after all 
activities (all P<0.001; Fig. 4.2), peaked after 40 min and had returned to resting 
concentrations by the end of the measurement period (P > 0.05 at 180 min, all 
conditions). No difference in peak insulin concentration was observed between 
activities, nor were there any differences in peak insulin concentration within any 
activity when arginine was ingested. No significant difference was observed, 
between insulin concentrations following arginine or placebo ingestion, at any 
time point during the measurement period. The area under the insulin 
concentration / time curve (Insulin AUC), over the post-ingestion period 
following each activity was no different following arginine ingestion than when 
placebo was ingested (Table 4.1) 
Carbohydrate oxidation 
Total CHO oxidation over the 3h post-ingestion period (Fig. 4.3) was 
significantly lower following resistance (P < 0.01) and cycling exercise 
(P < 0.001), compared with CHO oxidation at rest. Within any activity, there was 
no significant difference in CHO oxidation when arginine was consumed, 
compared with placebo ingestion, although a consistent tendency for less CHO 
oxidation was apparent (Fig. 4.3). 
Forearm blood flow 
Forearm blood flow did not change from resting, pre-ingestion levels following 
ingestion of CHO and either supplement when subjects were rested or after they 
had performed resistance exercise (Fig. 4.4a, b). Forearm blood flow increased 
significantly above pre-exercise levels after cycling (P < 0.01). The rate of 
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Figure 4.2 Serum insulin concentration prior to activity and during a3h period 
following ingestion of 70 g CHO and either 10 g placebo (filled symbols) Or 
arginine (open symbols) in subjects (n = 5): 
a) without prior exercise (Rest) 
b) following resistance exercise (Resistance) 
c) following cycling exercise (Cycling) 
Values represent mean ± S. E. M. 
Arrows indicate time of drink ingestion. 
ttt P<0.001, significant increase from post-activity, pre-ingestion concentratian, 
both treatments. 
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Figure 4.3 Total CHO oxidation during a3h period following ingestion of 70 g 
CHO and either 10 g placebo (solid bars) or arginine (hatched bars) in subjects (n 
= 6) without prior exercise (Rest), following resistance exercise (Resistance), and 
following cycling exercise (Cycling). 
Values represent mean ± S. E. M. 
** P<0.01, *** P<0.001, significantly different from rested values, both 
treatments 
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Figure 4.4 Forearm blood flow prior to activity and during a3h period following 
ingestion of 70 g CHO and either 10 g placebo (filled symbols) or arginine (open 
symbols) in subjects (n = 6): 
a) without prior exercise (Rest) 
b) following resistance exercise (Resistance) 
c) following cycling exercise (Cycling) 
Values represent mean ± S. E. M. 
Arrows indicate time of drink ingestion. 
** P<0.01 significant difference from pre-activity measurement, both treatments. 
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decline in forearm blood flow following exercise was no different following 
arginine ingestion than when placebo was ingested (Fig. 4.4c). 
Blood pressure and heart rate 
Mean arterial pressure decreased significantly following resistance (P < 0.01) and 
cycling (P < 0.05) exercise, but remained constant during the remainder of the 3h 
measurement period (Fig. 4.5). Mean arterial pressure was no different following 
arginine ingestion compared with after placebo ingestion after any activity. No 
effect of arginine treatment upon HR was observed after any activity. 
Palatability and tolerance of amino acid drinks 
All subjects reported that one drink (subsequently known to contain arginine) had 
an unpleasant flavour, some reported it leaving a `plastic' aftertaste. One subject 
reported gastrointestinal discomfort and diarrhoea during the day following two of 
the three occasions that arginine was ingested. No subjects reported any problems 
associated with ingestion of the placebo drink. 
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Figure 4.5 Systolic (square symbol), diastolic (circular symbol) and mean arterial 
(no symbol) blood pressures prior to activity and during a3h period following 
ingestion of 70 g CHO and either 10 g placebo (filled symbols) or arginine (open 
symbols) in subjects (n = 6): 
a) without prior exercise (Rest) 
b) following resistance exercise (Resistance) 
c) following cycling exercise (Cycling) 
Values represent mean values for treatments. Standard error bars are not shown 
for purpose of clarity. 
Arrows indicate time of drink ingestion. 
*P<0.05, ** P<0.01, significant differences from pre-activity measurements, 
prior to both treatments. 
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4.4 DISCUSSION 
The aim of this investigation was to determine whether an amount of arginine, 
when administered orally, could influence the fate of glucose ingested at the same 
time. Previous investigations have demonstrated that intravenous administration 
of arginine augments glucose-stimulated insulin release (Efendic et al, 1974) and 
insulin-mediated whole body glucose disposal (Paolisso et al, 1997). Normal 
daily uptake of arginine from the diet is approximately 5 g. d"1 (Visek, 1986). 
Consumption of a meal containing approximately 25 g arginine causes higher 
plasma insulin concentrations than a meal containing a normal arginine intake 
(Beaumier et al, 1995). However, such a high amount of arginine can be 
unpalatable (personal observation) and might cause gastrointestinal distress (Gater 
et al, 1992). Therefore, an amount of arginine lower than this, but above the 
normal daily intake was used in the current investigation. The results of the 
investigation suggest that, at the dosage administered, oral arginine ingestion does 
not influence CHO disposal, either when given to rested subjects or after different 
types of exercise. Glucose concentrations following CHO ingestion with arginine 
were no different from placebo conditions, after different activities. These results 
are reflected by the observation that serum insulin responses (peak insulin and 
insulin AUC) to CHO ingestion were no different from placebo conditions when 
arginine was consumed. This suggests that plasma arginine concentration did not 
reach a sufficiently high level to exert any influence upon insulin-stimulated 
glucose disposal. 
Recent preliminary evidence (Gannon et al, 1998) has reported glucose and 
insulin responses of healthy subjects receiving arginine (1 mmol. kg"1 lean body 
mass), glucose (25 g) or arginine + glucose. The amount of arginine administered 
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was approximately the same as the 10 g doses used in the current investigation. 
Blood samples collected over 2h post-ingestion revealed that arginine alone 
stimulated a modest rise in glucose concentration, but did not stimulate insulin 
release. When arginine was provided with glucose it decreased peak glucose 
concentration, compared with glucose ingestion alone, but prolonged the rise in 
blood glucose over the post-ingestion period. From their evidence the authors 
proposed that arginine delayed glucose absorption and/or affected endogenous 
glucose production or clearance from the blood. Whilst the current investigation 
has no comparative data for glucose only ingestion, it might be suggested that no 
impairment of glucose absorption was apparent. Comparison with the response to 
the ingestion of glycine (which is not known to have any effect upon glucose or 
insulin metabolism) with glucose, peak glucose concentration after arginine 
ingestion was not significantly different following any activity. However, it 
cannot be discounted that both arginine and glycine might have similar effects 
upon CHO absorption. 
Arginine is also known to stimulate glucagon release (Barbul, 1986), which in 
turn stimulates glycogenolysis in the liver (Ganong, 1979). It is possible that the 
stimulation of glucagon release by arginine elevated endogenous glucose 
production, contributing to the slight increase in peak glucose concentration seen 
in subjects when rested and following cycling exercise. The glucagon response to 
arginine may only have been small in the present study, however, as it is 
diminished relative . to 
increases in circulating glucose concentration (Palmer et al, 
1975). 
The information provided by total CHO oxidation gives an indication of the fate 
of the ingested CHO, which can be utilised for energy immediately or stored in 
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muscle or liver as glycogen (Richter, 1996). Following exercise, glucose storage 
is greater in muscle than in the liver (Maehlum et al, 1978). The degree of CHO 
oxidation is less when the drive for CHO storage is high. This is demonstrated in 
the present study by the lesser CHO oxidation following both forms of exercise, 
compared with that in rested subjects (Fig. 4.3). There was no significant 
difference in CHO oxidation between treatments after any activity, although a 
consistent tendency for less CHO oxidation (and presumably greater CHO 
storage) following arginine treatment was apparent. The amount of CHO storage 
suggested by this small difference is unlikely, however, to represent any 
significant improvement in post-exercise substrate replenishment. 
The results show that there was no effect of the arginine treatment upon forearm 
blood flow in rested subjects or after resistance exercise. Blood flow appeared to 
be higher when arginine was consumed following cycling exercise (Fig 4.4c). 
This apparent effect was, however, most likely as a consequence of the post- 
exercise blood flow being slightly higher prior to CHO ingestion. Examination of 
the decrease in blood flow from pre-ingestion levels through to the end of the 
measurement period revealed no effect of arginine ingestion upon blood flow, 
compared with the response to placebo. The vasodilatory effect of arginine is 
partly mediated by endogenous insulin release (Giugliano et al, 1997), which in 
the present study was no different between arginine and placebo treatments. 
Nitric oxide is also involved in vasodilation, but despite arginine being the unique 
precursor to NO, no evidence exists that arginine availability is limiting to NO 
production, or that increasing its availability produces a consequent increase in 
NO formation (Kurz & Harrison, 1997). Therefore it can be suggested that the 
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lack of an effect of arginine ingestion upon forearm blood flow was most 
probably because of the lack of any stimulatory effect on insulin release. 
The majority of investigations that have administered arginine intravenously to 
humans have used doses that produce plasma arginine concentrations in the 
millimolar range (Palmer et al, 1975; Roti et al, 1986; Giugliano et al, 1997). 
Plasma arginine concentration following ingestion of food containing 
approximately 25 g arginine elevated plasma arginine concentration by less than 
400 . tmol. L"1 to a concentration of approximately 600 µmol. L" (Beaumier et al, 
1995). It has recently been demonstrated that only 70% of an oral dose of 
arginine is available for use by the body (Bode-B6ger et al, 1998). These authors 
also demonstrated that a6g oral dose of arginine was insufficient to influence BP 
or peripheral blood flow. It is feasible, therefore, to suggest that the dosage of 
arginine given in the present study did not raise plasma arginine concentration 
sufficiently to produce a glycogenic effect. It would be of interest to determine 
the minimum amount of ingested arginine necessary to produce these desired 
effects. The amount of arginine ingested in the present study was near the limit of 
palatability and one subject experienced gastrointestinal intolerance during two of 
the days that arginine was ingested. These findings, coupled with the loss of 
water and sodium in the urine following prolonged arginine feeding previously 
observed (Beaumier et al, 1995) all suggest that including high amounts of 
arginine in a CHO beverage would not be a practical method of improving post- 
exercise CHO replenishment. 
In summary, a 10 g oral dose of arginine was found to not have any effect upon 
blood glucose disposal of human subjects following oral CHO ingestion, either 
when rested, or following different types of exercise known to differentially affect 
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glucose disposal. These results suggest that addition of arginine to a CHO 
beverage would not provide any additional benefit to post-exercise CHO 
replenishment. 
Note 4.1 The author accepts that if an individual's data for a particular 
measurement is to be removed from those of an experimental group, then no data 
from that individual should be reported. It would be considered more appropriate 
to either remove that subject's data from the investigation, or to increase the size 
of the experimental group sufficiently to dilute any effect of large variations 
between subjects. 
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Chapter 5 
EFFECTS OF CREATINE AND 
CARBOHYDRATE SUPPLEMENTATION 
UPON MUSCLE GLYCOGEN AND 
CREATINE ACCUMULATION AND 
SUBSEQUENT ENDURANCE EXERCISE 
PERFORMANCE 
5.1 INTRODUCTION 
Studies investigating the effect of Cr supplementation on muscle TCr 
accumulation have noted a wide variability in accumulation between subjects 
(Harris et al, 1992; Greenhaff et al, 1994; Casey et al, 1996). Generally, 
accumulation was greatest in individuals with low initial TCr concentrations. 
This variability was reduced when large amounts of CHO were ingested during Cr 
supplementation, due to improvements in Cr accumulation of all individuals 
(Green et al, 1996a). Supplementation with Cr + CHO also produced a tendency 
for greater muscle glycogen storage than was achievable by supplementation with 
CHO alone, although this tendency was not significant (Green et al, 1996b; 
Green, 1996). Chapter 3 demonstrated similar results in previously exercised 
muscle of subjects following 5d ingestion of Cr + CHO. Further analysis of the 
changes arising from Cr + CHO supplementation in non-exercised subjects (Green 
et al, 1996b) revealed a significant positive correlation between the changes in 
muscle concentration of TCr and glycogen (r = 0.75, n=8, p<0.05), which was 
not evident when Cr or CHO alone were ingested. These findings are of interest 
as elevation of muscle glycogen concentration could have important implications 
for treatment of disease states such as diabetes mellitus, and pre-exercise 
availability of muscle glycogen is a principal determinant of endurance exercise 
performance (Bergstrom et al, 1967). 
It is accepted that muscle CHO stores are influenced by dietary CHO intake, 
however increasing dietary CHO intake from around 55% of energy intake to 80- 
90% will only increase muscle glycogen concentration by approximately 50 
mmol. kg 1 d. m. (Maughan et al, 1997). It can be calculated that this increase in 
muscle glycogen would be sufficient to fuel exercise at 70% VO2max for 
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approximately 15 minutes (Sahlin, 1986). In the investigation by Green (1996) 
the magnitude of the difference in glycogen concentration between individuals 
receiving Cr + CHO and CHO only was approximately 75 mmol. kg"1 d. m. This 
difference in concentration could be sufficient to extend exercise at 70% VO2max 
by approximately 20 min above that achieved by CHO supplementation only 
(based upon Sahlin, 1986). By the same calculation, the difference between 
glycogen accumulation by exercised muscle of the Cr + CHO and CHO only 
groups in Chapter 3 could supply energy for an additional 40 min of exercise. 
Therefore it would appear that combination of Cr and CHO ingestion could not 
only be of benefit to individuals performing high-intensity exercise, but also be 
used by individuals to enhance endurance performance. 
Aims 
The aims of the present investigation were to examine whether muscle glycogen 
concentration could be increased by ingesting Cr with CHO, and if so, whether 
endurance exercise performance could be improved through this supplementation 
regimen. 
5.2 METHODS 
Thirteen healthy male subjects (Means (± S. E. M. ); age 30 (2) yr; BMI 24.8 (0.7) 
kg. m 2) participated in this study. All subjects regularly performed strenuous 
exercise for 1h or more on at least 3 occasions per week. Mean VO2peak of the 
subjects was 51.6 (1.4) ml. kg'l. min 1 (range 45 - 59 ml. kg''. min"1). 
109 
Experimental design 
After initial health screening and exercise testing (see Chapter 2), suitable subjects 
reported to the laboratory on 4 separate occasions and performed cycling exercise 
to the point of exhaustion. Details of experimental conditions and protocols are 
outlined below. 
Visit 1: Familiarisation with exhaustive exercise 
To familiarise subjects with the exercise protocol, all subjects visited the 
laboratory in the morning, following an overnight fast, and performed cycling 
exercise to exhaustion, as outlined below. This visit was included to allow 
subjects to familiarise themselves with the experience of exercising at relatively 
high workloads to the point of exhaustion. It was anticipated that the 
familiarisation session would make subjects more likely to stop exercise during 
subsequent test visits due to substrate depletion rather than for any other reason. 
Visit 2: Exhaustive exercise following a normal diet (EXI) 
At least one week following the familiarisation visit, subjects reported to the 
laboratory in the morning, following an overnight fast, for the first test visit 
(EX 1). During the 3 days prior to EX 1, each subject consumed his normal diet, 
which was recorded in a food diary. During this 3-day period, subjects refrained 
from strenuous exercise and consumption of alcohol. Subjects' nude weights 
were recorded upon arrival at the laboratory for the EX! visit. Subjects then 
rested supine in preparation for the experimental protocol outlined below. 
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Visit 3: Exhaustive exercise following CHO supplementation (EX2) 
Two weeks following the EX1 visit, subjects reported to the laboratory in the 
morning, following an overnight fast, for the second test visit (EX2). For 5 days 
prior to the EX2 visit, subjects had consumed four 500 ml servings of a CHO 
drink (LucozadeTM) per day (see Chapter 2). During the 5-day CHO 
supplementation period subjects consumed their normal diets, repeating their 
dietary intake, as previously recorded, over the 3 days prior to the EX2 visit. 
Subjects did not perform any strenuous exercise during the CHO supplementation 
period. Subjects' nude weights were recorded on the day prior to ingestion of the 
first CHO supplement and upon arrival at the laboratory for the EX2 visit. 
Subjects then rested supine in preparation for the experimental protocol outlined 
below. 
Visit 4: Exhaustive exercise following Cr only or Cr + CHO supplementation 
(EX3) 
Two weeks following the EX2 visit, subjects reported to the laboratory in the 
morning, following an overnight fast, for the third test visit (EX3). For this visit, 
subjects were randomly allocated into 2 supplementation groups. One group 
ingested 5g Cr. H20 (Cr only group, n= 6) and the other group ingested 5g 
Cr. H20 and 500 ml of a CHO drink (Cr + CHO group, n= 7). For 5 days prior to 
the visit, subjects ingested their respective supplements four times per day (see 
Chapter 2). During the 5-day supplementation period subjects consumed their 
normal diet, repeating their dietary intake, as previously recorded, over the 3 days 
prior to the EX3 visit. Subjects did not perform any strenuous exercise during the 
supplementation period. Subjects' nude weights were recorded on the day prior to 
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ingestion of the first supplement and upon arrival at the laboratory on the morning 
of the EX3 visit. Subjects then rested supine in preparation for the experimental 
protocol outlined below. 
Experimental protocol 
Whilst the subject rested supine on a bed, his left arm was cannulated and a 
resting blood sample was obtained (see Chapter 2). The subject's leg was then 
prepared for muscle biopsy sampling. Three incisions (two in the case of EX 1) 
were made through the skin of the central area of the ventral side of the thigh. 
Each incision was approximately 5 mm long and spaced approximately 3 cm apart 
from each other (Harris et al, 1974). A resting muscle sample was obtained 
(Rest), using the percutaneous needle biopsy technique (see Chapter 2), by 
insertion through the uppermost of the incisions, whereupon it was immediately 
frozen in liquid nitrogen. A sterile dressing was applied over the incisions, which 
was held in place using an adhesive elasticated bandage. Following 15 min 
recovery from the muscle sampling procedure, the subject performed cycling 
exercise to exhaustion. 
Subjects performed 3 min of warm-up exercise on an electrically braked 
ergometer (Excalibur Sport, Lode N. V. Instrumenten, Groningen, The 
Netherlands) at a constant cadence of 70 rpm against a workload of 100 W. The 
electrical resistance of the cycle was then adjusted to produce a workload 
designed to elicit an oxygen consumption of 70% VO2peak. Every 15 min during 
exercise, expired air samples were collected for measurement of V02 and RER 
(see Chapter 2), and heart rate was recorded. During the three test visits (EX 1, 
EX2, EX3), a blood sample was also obtained every 15 min. To maintain 
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euhydration subjects ingested 200 ml water at ambient temperature every 15 min 
throughout the exercise period. Subjects were verbally encouraged to continue 
cycling for as long as possible to the point of volitional exhaustion, or until they 
could no longer maintain the required cadence. 
Immediately at the point of exhaustion of visit EX1, the subject was supported in 
the saddle by an investigator and a muscle sample was obtained from the leg 
through the previously-prepared incision. The muscle sample obtained at that 
time was termed `Time of exhaustion visit 1 following normal dietary conditions' 
(TEX 1 Nou, ). During visits EX2 and EX3, each subject stopped at the same time 
as his exhaustion time during visit EX1, and another muscle sample was 
immediately taken. Muscle samples obtained at these times are termed `Time of 
exhaustion visit 1 following CHO (TEX1CHO), Cr (TEX1cr) or Cr + CHO 
(TEX1cr. +cxo), depending upon the dietary condition preceding the exercise visit. 
Following the removal of a TEX1 muscle sample, a new sterile dressing was 
applied to the biopsy area and the subject continued cycling to the point of 
exhaustion. Muscle samples obtained at exhaustion during test visits EX2 and 
EX3 are termed TEX2 and TEX3cr (or TEX3cr+cHO), respectively. All muscle 
samples were frozen in liquid nitrogen immediately following removal from the 
leg (time from stopping exercise to freezing was 12 (2) s). An additional blood 
sample was obtained five minutes after the time of exhaustion, whilst the subject 
recovered on a bed. 
Analyses of muscle samples for ATP, PCr, Cr and glycogen concentration, and 
blood samples for glucose (all subjects) and lactate (8 subjects only) concentration 
were performed as outlined in Chapter 2. 
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5.3 RESULTS 
Body mass 
A significant increase in body mass occurred following CHO supplementation 
(1.0 (0.3) kg, n= 13, P<0.01) and Cr + CHO supplementation (1.7 (0.3) kg, 
n=7, P<0.001). No significant change in body mass was seen following Cr 
supplementation (-0.2 (0.3) kg, n=6, P>0.05). 
Muscle glycogen concentration and utilisation during exercise 
Resting glycogen concentrations were not significantly elevated above those of 
the normal dietary condition following CHO supplementation, Cr 
supplementation or Cr + CHO supplementation (Fig. 5.1). Muscle glycogen 
concentrations at TEXicHo and TEXlc1 were not significantly different from 
glycogen concentration at TEXlNOI (Fig. 5.2). Muscle glycogen concentration 
at TEXlcr+CHO (214 (69) mmol. kg'' d. m., n= 5) was significantly greater than at 
TEXlNo,,,, al (100 (20) mmol. kg-1 d. m., n= 13; P<0.05; Fig. 5.2). Muscle 
glycogen concentration was reduced to 21%, 13% and 16% of the resting pre- 
exercise concentration by exercise, during EX I, EX2 and EX3 visits, respectively. 
Glycogen concentrations at TEX2, TEX3cr and TEX3c, T+cHO were not different 
from those at TEX1No,,, uI (Fig. 5.2). 
There was a trend for greater glycogen utilisation, from the time of exercise 
commencing to TEX1, after CHO or Cr + CHO supplementation, although 
utilisation did not differ significantly from that of the whole exercise period after 
normal dietary conditions (Table 5.1). 
114 
Figure 5.1 Resting muscle glycogen concentrations after normal dietary 
conditions and following CHO, Cr or Cr + CHO supplementation. 
Values are mean (± S. E. M. ) 
Numbers in parentheses refer to the number of samples contributing to each mean 
value. 
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Figure 5.2 Muscle glycogen concentrations at rest, and during and immediately 
following exhaustive exercise, after normal dietary conditions and following 
CHO, Cr or Cr + CHO supplementation. 
Values are mean (± S. E. M. ) 
Numbers in parentheses refer to the number of samples contributing to each mean 
value. 
*P<0.05, significant difference from TEX1Ni. 
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Table 5.1 Glycogen utilisation (mmol. kg-1 d. m. ) during exercise to TEX1 of 
groups following normal, CHO, Cr or Cr + CHO supplemented 
diets. 
Values represent mean (f S. E. M. ) 
Dietary condition 
Normal CHO Cr Cr + CHO 
n=13 n=9 n=3 n=5 
Glycogen 376 412 374 455 
utilisation (28) (27) (93) (52) 
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Exercise time to exhaustion 
On one occasion, an EX2 exercise test was stopped at TEX 1 due to a subject 
experiencing pain in the muscle sampling area. For this reason that subject's data 
was not included for analysis of exercise time to exhaustion. 
Mean exercise times to exhaustion are shown in Fig. 5.3. No significant 
difference in exercise time to exhaustion was observed between dietary 
conditions, although there was a tendency for longer exercise duration following 
Cr + CHO supplementation. 
Muscle metabolite concentrations 
Mean resting TCr concentration of subjects was similar to that previously 
observed (Harris et al, 1992). Resting muscle TCr concentrations increased 
significantly following Cr supplementation (13.8 (5) mmol. kg"' d. m., P<0.01; 
Fig. 5.4) and following Cr + CHO supplementation (25.2 (7.0) mmol. kg 1 d. m., P 
< 0.001; Fig. 5.4). Muscle TCr concentrations of Cr and Cr + CHO groups were 
not significantly different following supplementation (P = 0.19). 
Resting muscle PCr concentration increased significantly from pre-supplemented 
conditions following Cr + CHO supplementation (6.7 (2.7) mmol. kg'1 d. m., P< 
0.05, Table 5.2), but not following Cr supplementation. No difference in resting 
PCr concentration was observed between the Cr -supplemented and Cr + CHO - 
supplemented groups. Muscle PCr concentrations at TEX 1 cT, TEX 1 cr+cxo, 
TEX3c or TEX3c, +cHO were not significantly different from those at TEX1No I 
(43.4 (3.3) mmol. kg"1 d. m. ). 
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Figure 5.3 Exercise times to exhaustion after normal dietary conditions and 
following CHO, Cr or Cr + CHO supplementation. 
Values are mean (± S. E. M. ) 
Numbers in parentheses refer to the number of samples contributing to each mean 
value. 
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Figure 5.4 Resting muscle total creative concentrations after normal dietary 
conditions and following CHO, Cr or Cr + CHO supplementation. 
Values are mean (± S. E. M. ) 
Numbers in parentheses refer to the number of samples contributing to each mean 
value. 
** P<0.01, *** P<0.001, significant difference from Normal concentration. 
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Table 5.2 Resting muscle ATP, PCr and Cr concentrations (mmol. kg"' d. m. ) 
following normal, CHO, Cr or Cr + CHO dietary conditions. 
Values represent mean (f S. E. M. ) 
P<0.05, `* P<0.01, *** P<0.001, significant difference from 
Normal concentrations. 
Dietary condition 
Normal 
n=13 
CHO 
n=13 
Cr 
n=6 
Cr + CHO 
n=7 
PCr 80.0 (1.7) 77.1 (1.8) 81.8 (2.5) 88.9 (3.5)* 
Cr 45.5 (2.5) 43.3 (1.9) 57.2 (2.2)4 62.1 (3.5)`*" 
ATP 24.4 (0.6) 24.2 (0.9) 24.0 (1.4) 22.6 (1.8) 
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Resting muscle Cr concentration increased significantly from pre-supplemented 
conditions following Cr supplementation (9.4 (3.4) mmol. kg"' d. m., P<0.01) and 
following Cr + CHO supplementation (18.5 (4.9) mmol. kg"1 d. m., P<0.001; 
Table 5.2). Resting Cr concentration was no different between Cr and Cr + CHO 
groups following supplementation. 
Resting muscle ATP concentrations of both groups were similar on all occasions 
and did not change following dietary intervention (Table 5.2). ATP concentration 
immediately following exhaustion was not significantly different from that at rest 
during any experimental visit. 
Blood glucose and lactate during exercise 
Concentrations of blood glucose and lactate were compared within and between 
treatments for exercise time points up to 60 min. After this time point the number 
of samples contributing to each group's mean concentration decreased due to 
some subjects fatiguing earlier than others. 
Blood glucose concentration did not change significantly from resting 
concentrations during the first 60 min of exercise following any dietary condition. 
No significant differences in blood glucose concentrations were observed at any 
time point (Rest - 60 min) between dietary conditions (Table 5.3). Blood glucose 
concentrations 5 min post-exhaustion were not significantly different from normal 
conditions, following any dietary condition (Normal, 4.71 (0.26); CHO, 5.04 
(0.45); Cr, 4.72 (0.2); Cr + CHO, 4.93 (0.28) mmol. L''; P>0.05). 
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Table 5.3 Whole blood glucose concentrations (mmol. L') of experimental 
groups at rest and during the first 60 min of exercise, following 
normal, CHO, Cr or Cr + CHO dietary supplementation. 
Values represent mean (± S. E. M. ) 
Dietary 
Condition Rest 
Time 
15 
of 
30 
measurement 
45 
(min) 
60 
Normal (n = 13) 4.73 4.24 4.34 4.33 4.30 
(0.17) (0.10) (0.15) (0.16) (0.2) 
CHO (n = 13) 4.59 4.39 4.69 4.51 4.34 
(0.10) (0.10) (0.17) (0.11) (0.07) 
Cr only (n = 6) 4.54 4.41 4.57 4.71 4.72 
(0.28) (0.15) (0.21) (0.31) (0.3) 
Cr + (n = 7) 4.45 4.33 4.5 4.54 4.24 
CHO (0.11) (0.14) (0.29) (0.37) (0.1) 
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Blood lactate was increased above resting concentrations during exercise 
following all dietary conditions (all P<0.05). Blood lactate concentrations 
during the first 45 min of exercise were significantly higher than normal 
conditions following CHO supplementation (P < 0.05; Table 5.4), but not 
following Cr or Cr + CHO supplementation. Blood lactate concentrations 5 min 
post-exhaustion were not significantly different from normal conditions, 
following any dietary condition (Normal, 2.58 (0.31); CHO, 3.90 (0.74); Cr, 3.10 
(0.47); Cr + CHO, 2.79 (0.23) mmol. L"1; P>0.05). 
V02 and RER during exercise 
The workloads used in the exercise protocols produced V02 measurements of 
approximately 73% VO2peak. A tendency for RER values greater than those 
following normal dietary conditions was observed during exercise following CHO 
and Cr + CHO supplementation, although no significant difference was observed 
at any time point (Fig. 5.5). 
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Table 5.4 Whole blood lactate concentrations (mmol. L"1) of experimental 
groups at rest and during the first 60 min of exercise, following 
normal, CHO, Cr or Cr + CHO dietary supplementation.. 
Values represent mean (± S. E. M. ) 
*P<0.05, significant difference from corresponding time point 
under normal dietary conditions. 
Dietary 
Condition Rest 
Time 
15 
of 
30 
measurement 
45 
Normal (n = 8) 0.68 2.79 2.72 2.56 
(0.09) (0.28) (0.31) (0.25) 
CHO (n = 8) 0.90 3.94' 4.16* 3.80' 
(0.08) (0.33) (0.44) (0.37) 
Cr only (n = 3) 0.66 3.27 3.31 3.16 
(0.12) (0.73) (0.58) (0.53) 
Cr + (n = 5) 0.78 3.46 3.54 3.51 
CHO (0.14) (0.34) (0.51) (0.53) 
(min) 
60 
2.70 
(0.26) 
3.55 
(0.46) 
3.15 
(0.56) 
3.65 
(0.47) 
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Figure 5.5 Respiratory exchange ratio measurements taken during the first 60 min 
of exhaustive exercise after normal dietary conditions and following CHO, Cr or 
Cr + CHO supplementation. 
Values are mean (± S. E. M. ) 
Numbers in parentheses refer to the number of samples contributing to each mean 
value. 
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5.4 DISCUSSION 
The primary aim of this study was to investigate the effect of Cr + CHO 
supplementation upon muscle glycogen accumulation. Previous investigation of 
non-exercised subjects (Green et al, 1996a) and results in Chapter 3 had shown 
that there was a strong tendency for greater muscle glycogen storage with Cr + 
CHO supplementation than with CHO supplementation alone. In the present 
study, however, although muscle glycogen concentration tended to be higher than 
normal after CHO and Cr + CHO supplementation, these differences were not 
significant. Furthermore, there was no difference in post-supplementation muscle 
glycogen concentration between CHO alone and Cr + CHO treatments. The 
observation that glycogen concentration at TEX1cI. +CH0 was two-fold greater than 
at TEX1No,,, I suggests, however, that Cr + CHO supplementation can be of 
benefit to endurance exercise performance. Indeed, there was a tendency for 
improved exercise duration in those subjects following Cr + CHO 
supplementation (26 (20) min longer than normal), compared with their exercise 
times after CHO supplementation (15 (8) min longer than normal). Examination 
of the glycogen concentrations of those subjects only, after each dietary condition, 
suggests that there was a tendency for greater glycogen storage following Cr + 
CHO supplementation. Carbohydrate supplementation increased glycogen 
concentration by only 61 (26) mmol. kg"1 d. m. (P > 0.05), whereas after Cr + CHO 
supplementation, glycogen concentration was 172 (56) mmol. kg" d. m. higher 
than under normal dietary conditions (P < 0.05). Glycogen concentrations of 
those subjects after CHO and Cr + CHO supplementation were not significantly 
different, however. 
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The lack of any difference in glycogen accumulation between CHO and Cr + 
CHO treatments of the whole experimental population is similar to results seen in 
Chapter 3. In that investigation, there was no difference in resting glycogen 
concentration of non-exercised muscle, of groups ingesting Cr + CHO or CHO 
alone for 5 days. However, in previously exercised muscle, glycogen 
concentration was greater following Cr + CHO supplementation than after 
supplementation with CHO alone. This suggests, therefore, that to achieve the 
maximum effect of Cr + CHO supplementation upon muscle glycogen 
accumulation, glycogen-depleting exercise must be performed prior to Cr + CHO 
supplementation. 
Performance of prolonged exercise was not significantly improved above normal 
conditions by any of the dietary conditions employed in the present study, 
although there was a tendency for increased exercise duration following Cr + 
CHO supplementation. It is possible that this was due to there being no 
significant effect of these treatments upon muscle glycogen concentration. One 
might have expected, however, that the significantly greater glycogen 
concentration at TEX1cr+cHO would have improved exercise performance above 
normal conditions. Scrutiny of individuals' results reveal that one subject in this 
group stopped exercise 60 min prior to his TEX1Non. 1 time following Cr + CHO 
supplementation, despite a glycogen concentration near 200 mmol. kg"' d. m. It is 
likely that this was for a reason other than substrate depletion, particularly as the 
remainder of the subjects in that group had exhaustion glycogen concentrations S 
71 mmol. kg"1 d. m. under the same conditions. Removal of this subject's exercise 
time reveals that exercise duration following Cr + CHO supplementation was 
extended by 40 (15) min above normal conditions. This highlights a potential 
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problem associated with using small numbers of subjects in experimental groups, 
especially when a large variation in concentration exists between subjects. If one 
measurement for a particular subject is substantially higher or lower than the 
remainder of the groups' measurements, the mean result will be skewed toward 
that particular direction. When experimental populations are small, such 
measurements can potentially overshadow results that may otherwise be 
considered significant, and ultimately lead to misinterpretation of the data. In the 
present study, comparison of TEX1 measurements following Cr or Cr + CHO 
supplementation could be particularly affected by this. This is because the sample 
size was reduced furthermore by some subjects stopping exercise before TEXT 
during EX2 and EX3 visits. 
An elevation of resting glycogen concentration prior to exercise would be 
expected to result in greater rates of glycogen utilisation during exercise (Golinick 
et at, 1972; Sherman et al, 1981; Hargreaves et al, 1995). In the present study, 
glycogen utilisation appeared to parallel the tendency for higher glycogen 
concentration after CHO and Cr + CHO supplementation, although utilisation did 
not differ significantly from normal dietary conditions. This may have resulted in 
there being no observable improvement in exercise performance, despite a relative 
increase in glycogen concentration following CHO and Cr + CHO 
supplementation. 
Other factors may have contributed to the apparent lack of effect of Cr + CHO 
supplementation upon muscle glycogen accumulation and subsequent exercise 
performance. It was suggested in Chapter 3 that Cr accumulation by muscle may 
indirectly increase muscle glycogen concentration by increasing cell volume. The 
relatively smaller Cr accumulation of the Cr + CHO group in the present study, 
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compared with that previously observed (Green et al, 1996b; Green, 1996) might 
be expected to not influence cell volume to as great an extent. This may possibly 
account for the relatively small increase in glycogen accumulation of the Cr + 
CHO group seen in the present study. It is of interest that subjects showing the 
smallest increases in TCr concentration (11.3 - 13.1 mmol. kg'' d. m. ) following Cr 
+ CHO supplementation also displayed the smallest increases in glycogen 
concentration (42 - 91 mmol. kg"1 d. m. ). However, no significant correlation was 
observed between these changes in the whole group. This does not support the 
previously observed relationship between TCr and glycogen accumulation 
following Cr + CHO supplementation (Green et al, 1996b). It is possible that 
other factors known to influence glycogen synthesis may have affected glycogen 
accumulation in the present study. The greatest individual increase in glycogen 
concentration after Cr + CHO supplementation was observed in a subject with the 
highest VO2peak. Endurance trained individuals have enhanced sensitivity to 
insulin, which is thought to be mediated by a greater concentration of glucose 
transport protein in their muscle (Andersen et al, 1993). The enhanced capacity 
for muscle glucose transport of these individuals may influence glycogen 
accumulation to a greater extent than a change in cell volume. This is supported 
by the observation that a significant correlation existed between VO2peak and 
glycogen accumulation following Cr + CHO supplementation (r = 0.87, n=7, P< 
0.05). 
It is possible that the exercise to exhaustion protocol employed in the present 
study was not reproducible enough to provide a reliable measurement of exercise 
performance (Krebs & Powers, 1989). A similar exercise protocol, in which well 
trained subjects cycled continuously at 75% of their maximal power output until 
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exhaustion, was demonstrated to have a coefficient of variance of almost 27% 
(Jeukendrup et al, 1996). Two different time-trial cycling tests using 10 subjects 
per test were more reproducible over 5 separate visits (coefficient of variation 
both - 3.5%). The reproducibility of these tests in groups of untrained subjects is 
currently unknown, and may be no more reliable than the test used in the present 
study. Nevertheless, it may be prudent to consider using such tests in future 
investigations that measure endurance performance. 
The protocol used in this study also allowed investigation of the effects of Cr + 
CHO supplementation upon muscle Cr accumulation. Although Cr 
supplementation significantly increased muscle TCr concentration of both groups 
in the present study, unlike a previous investigation (Green et al, 1996a), there 
was no greater increase when CHO was ingested during Cr supplementation. 
Furthermore, comparison of the present results with those using an identical 
supplementation protocol (Green et al, 1996a) suggest that Cr accumulation was 
blunted in both groups supplemented with Cr. Although not the central issue of 
this study, these results are interesting, particularly as the study aimed to 
investigate a possible relationship between muscle Cr and glycogen accumulation. 
Examination of individuals' results showed that 2 subjects in the Cr group 
appeared to be `non-responders' (Greenhaff et al, 1994; Casey et al, 1996), 
demonstrating increases in TCr concentration of less than 10 mmol. kg"1 d. m. 
Removal of those subjects' contributions to the group's mean revealed Cr 
accumulation values similar to previous investigations (21.1 (3.0) mmol. kg"' 
d. m. ). Previously, CHO ingestion during Cr supplementation had been shown to 
substantially increase muscle TCr concentration of many subjects and appeared to 
abolish the phenomenon of the `non-responder' (Green et al, 1996a). However, in 
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the present study, although a tendency for increased Cr accumulation existed, 
subjects ingesting Cr + CHO did not have significantly greater TCr concentration 
than those supplemented with Cr alone. Again, examination of individuals' 
results showed that 3 subjects demonstrated only modest increases in TCr 
concentration (11.3 - 13.1 mmol. kg"1 d. m. ). Removal of these subjects' values 
caused the group mean to resemble that observed in a previous investigation (34.8 
(7.6) mmol. kg" d. m.; similar to Green et al, 1996a). As mentioned previously, it 
is possible that the population sizes of the Cr (n = 6) and Cr + CHO (n = 7) groups 
were not large enough to show significant differences in concentrations, 
particularly when a large variability in measurements between individuals existed. 
It is suggested that increasing the size of the experimental groups in the present 
investigation would allow clearer interpretation of results. Nevertheless, the 
observation that some subjects showed only modest increases in TCr 
concentration suggests that ingestion of CHO during Cr supplementation may not 
augment Cr accumulation in all individuals. The reasons for these results cannot 
presently be adequately explained. As with glycogen accumulation, changes in 
TCr concentration may possibly be' influenced by an individual's training status. 
Training can influence factors which may affect Cr accumulation, such as muscle 
fibre composition (Komi & Karlsson, 1978), muscle Na /K+ pump concentration 
(Klitgaard & Clausen, 1989; Green et al, 1993; McKenna et al, 1993; Madsen et 
al, 1994) and glucose-stimulated insulin release (Heath et al, 1983; King et al, 
1987; Rodnick et al, 1987; Engdahl et al, 1995; Hickner et al, 1997). The training 
status of the subjects used in the present study, as indicated by V02peak, covered 
a range from untrained (-45 mL 02. kg"'. min') up to moderately trained (50 - 59 
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mL 02. kg"'. min1). However, no correlation was observed between VO2peak and 
Cr accumulation. 
In conclusion, Cr ingestion did not significantly improve glycogen accumulation 
during a period of CHO supplementation, and did not improve subsequent 
performance of prolonged exercise. Furthermore, Cr + CHO supplementation did 
not produce any significant improvement in muscle Cr accumulation above that 
achieved by Cr supplementation alone. It is suggested that low population sizes 
and large variations of the experimental groups used may have confounded the 
significance of the results of the present study. Further investigation is required of 
the effects of Cr + CHO supplementation upon muscle glycogen and TCr 
accumulation and subsequent exercise performance. 
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Chapter 6 
EFFECTS OF CREATINE 
SUPPLEMENTATION UPON INDICES OF 
HAEMATOLOGICAL, HEPATOLOGICAL, 
MUSCLE AND RENAL FUNCTION 
6.1 INTRODUCTION 
Much of the research concerning Cr supplementation has demonstrated 
improvements in exercise performance, particularly upon repeated bouts of short- 
lasting maximal exercise. Other effects of Cr supplementation include an increase 
in body mass (Balsom et al, 1993a; Greenhaff et al, 1994; Stroud et al, 1994), 
which has been attributed to increased fat-free mass (Earnest et al, 1995). It has 
been proposed that this increase is due to enhanced water retention by the body 
(Hultman et al, 1996), possibly resulting from changes in muscle osmolarity as Cr 
is accumulated. A consequence of increased water uptake by muscles is a 
tendency for swelling, or increased definition of muscles, a phenomena which has 
not passed unnoticed by bodybuilders. As a result of research findings being cited 
in popular fitness and sporting media, Cr has become a very popular dietary 
supplement used by amateur and professional athletes. 
Recently, however, anecdotal opinions have been expressed about the potential 
effects of ingesting Cr on aspects of health, such as muscle cramping, muscle- 
tendon injury and renal dysfunction (Anon, 1998a, b; Josefson, 1998). These 
concerns have prompted comments from officials of sporting and health bodies 
that there is insufficient information concerning the safety of Cr ingestion over a 
prolonged period. Opinions such as these, however, have not been substantiated 
with scientific evidence, other than two recent case reports of renal dysfunction 
accompanying oral creatine supplementation (Pritchard & Kaira, 1998; Koshy et 
al, 1999), albeit one in a patient with pre-existing kidney disease (Pritchard & 
Kalra, 1998). Despite its apparent widespread use amongst athletes (Harris & 
Arthur, 1998), there is little published evidence of the effects of Cr 
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supplementation on indices of health, such as haematological, hepatic, and renal 
function or muscle damage. 
A problem with interpreting anecdotal 'side-effects' of Cr supplementation is the 
variation in dosage that individuals supplement with. In the majority of controlled 
studies, the dosing regimen established by Harris and colleagues (1992) of 20 g Cr 
on a daily basis for 5d has been used to load muscles with Cr. The elevated 
muscle TCr concentrations achieved by this regimen can be maintained by 
continuing Cr ingestion at a "maintenance dose" of approximately 2g every day 
(Hultman et al, 1996), which represents the rate of daily Cr degradation to 
creatinine (Walker, 1979). However, some individuals may consume much higher 
doses during a loading phase and subsequent maintenance (Anon, 1998a). 
Aim 
The aim of the present study was to obtain information relating to indices of 
haematological, hepatic and renal function and muscle damage in young healthy 
adult subjects, before and after a regimen of "Cr loading", and also after Cr 
loading followed by an 8-week "maintenance dose". 
6.2 METHODS 
Subjects and experimental groups 
Forty-eight healthy subjects volunteered to take part in the present series of 
experiments. None reported any history of kidney or liver related illness. All 
subjects were moderately active, but none were highly trained. The subjects were 
divided randomly into 7 experimental groups to examine two different aspects of 
Cr supplementation. 
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Effects of a Cr loading regimen 
Group `CrLOAD' consisted of 7 male subjects (mean (± SD) age 23 (4) years; BMI 
22.4 (2.1) kg. m"Z) who ingested 5g of Cr dissolved in a warm drink followed by 
500 ml of a CHO -containing solution 4 times daily for 5 d. This regimen was 
used because it has previously been shown to augment muscle Cr accumulation by 
60% compared with accumulation when Cr alone was ingested (Green et al, 
1996a). Blood samples for analysis were obtained before supplement ingestion on 
the first day and on the day after the ingestion regimen had been completed. 
Group 'PLOAD' (a placebo group) consisted of 7 male subjects (age 24 (5) years; 
BMI 21.3 (0.9) kg. m 2) who ingested 500 ml of a CHO containing solution 4 
times daily for 5 d. Blood samples for analysis were obtained as for CrLOAD 
group. 
Group `CrWA ' consisted of 6 male subjects (age 24 (3) years; BMI 25.6 (6.3) 
kg. m 2) who ingested 5g of Cr plus 1g glucose dissolved in a warm drink 4 times 
daily for 5 d. Blood samples for analysis were obtained prior to the start of 
supplementation and six weeks after the ingestion regimen had been completed. 
Group `PLOAD+6' (a placebo group) consisted of 6 subjects (age 22 (2) years; BMI 
21.7 (2.0) kg. m 2; 3 males), who ingested 6g of glucose dissolved in a warm drink 
4 times daily for 5 d. Blood samples for analysis were obtained as for CrLOAD+6 
group. 
Effects of Cr loading and an 8-week maintenance regimen 
Group 'CrMAINT' consisted of 7 female subjects' (age 26 (8) years; BMI 23.3 (1.9) 
kg. m 2) who ingested a loading dose of 5g Cr dissolved in a warm drink 4 times 
daily for 5 d, and who then maintained an intake of 3g Cr in a warm drink, once 
1 Refer to Note 6.1 at end of Chapter 
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daily for 8 weeks. Blood samples for analysis were obtained before supplement 
ingestion on the first day of the loading dose and on the day after the maintenance 
regimen had been completed. 
Group 'CrMAINT+EX' consisted of 9 female subjects (age 27 (6) years; BMI 23.4 
(3.2) kg. m 2) who ingested a loading dose of 5g Cr dissolved in a warm drink 4 
times daily for 5 d, and who then maintained an intake of 3g Cr in a warm drink, 
once daily for 8 weeks. During the 8 week maintenance period subjects engaged 
in a resistance training program, involving 3 one-hour supervised sessions on 
resistance equipment each week. This exercise program was used to create 
similar conditions to those of individuals who ingest Cr during periods of training 
to improve athletic performance. Blood samples for analysis were obtained as for 
the CrMA! NT group. 
Group `PMAINT+EX' (a placebo group) consisted of 6 female subjects (age 28 (5) 
years; BMI 24.5 (3.6) kg. m 2) who ingested a "loading dose" of 5g of a glucose 
polymer (dextrose) in a warm drink 4 times daily for 5 d, and who then 
maintained an intake of 3g of dextrose in a warm drink, once daily for 8 weeks. 
During the 8 week supplementation period subjects engaged in a resistance 
training program identical to subjects in the CrMA +Ex group. Blood samples for 
analysis were obtained as for the CrmAiNT group. 
Supplement formulations 
Subjects in the CrLoAn+6, PWAI+s, CrMAINT, CrMA! NT+EX and PMAINT+EX groups Were 
provided with supplements in a double-blind manner. During the 5d "loading 
dose" period, subjects in all groups ingested their supplements as described in 
Chapter 2. During the 8-week "maintenance dose" subjects ingested their daily 
supplement dose at the same time each day. 
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Blood sampling protocol 
Subjects reported to the laboratory on the morning of the experiments following 
an overnight fast, having abstained from alcohol consumption and strenuous 
exercise during the previous 48 h. Height and body mass in light clothing were 
recorded. Blood samples were obtained and treated as described in Chapter 2. 
Samples were subsequently analysed for indices of renal function (serum sodium, 
potassium, urea and creatinine concentrations), hepatic function (serum gamma 
glutamyl transferase, alkaline phosphatase, alanine aminotransferase activity, and 
albumin and total bilirubin concentrations) and indices of haematological function 
(haemoglobin concentration was measured and white blood cells and platelets 
counted). Additionally, an index of muscle damage (serum creatine kinase 
activity) was measured in the groups assessed six weeks following acute 
supplementation and following the more chronic maintenance regimen. 
6.3 RESULTS 
All subjects reported adherence to the experimental protocol and complete 
ingestion of the supplements. None of the subjects reported any adverse effects as 
a result of ingesting the supplements. 
Effects of a Cr loading dose regimen 
Group mean data of the indices measured were within the normal range prior to, 
the day following and 6 weeks following the loading regimen (Table 6.1). On the 
day following Cr loading there was no significant difference in any of the indices 
measured prior to Cr loading, however, moderate decreases were observed in 
serum urea and bilirubin concentrations of the PLOAD group. Although there were 
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no differences in absolute concentrations, there was a significant between-group 
difference in the change in serum creatinine concentration over time (CrLOAD, 24 
(10) µmol/L; PLOnn, -3 (2) µmol/L; P<0.05). This difference was not evident six 
weeks following the completion of the loading dose (CrLOAn+6,2 (2) µmo1. L''; 
PLOAD+6,3 (2) µmo1. L-1; P>0.05). Serum sodium and urea concentrations had 
increased in the CrLOAD+6 group six weeks after completion of Cr loading (Table 
6.1). The change in serum urea concentration with time was significantly different 
in the CrLOAD+6 group compared with its placebo group (CrLOA , 1.2 (0.3) 
m mom-; PLOAD+6, -0.4 (0.2) mmol/L; P<0.00 1). A moderate decrease in serum 
albumin concentration was observed in the PL0AD+6 group. 
Effects of a Cr maintenance dose regimen 
Group mean data of the indices measured were within the normal range prior to 
the Cr loading regimen, and on the day after the maintenance dose was completed 
(Table 6.2). Moderate increases in serum potassium, creatinine and albumin 
concentrations were observed in both groups receiving Cr. Additionally there was 
a small decrease in alanine aminotransferase activity in the CrMAINT group and an 
increase in alkaline phosphatase activity in the CrMAINT+EX group. There was a 
significant decrease in serum urea concentration in the PMAINT+EX group. The 
changes in serum creatinine concentration over time in the groups receiving Cr 
were significantly different from the placebo group, (CrMAINT, 26 (6) µmol/L; 
CrMAINT+EX, 17 (4) µmol/L; PMAINT+EX, -6 (3) µmoVL; 
P<0.001, P<0.01, 
respectively). 
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Table 6.1 
tMeasurement units for indices of renal, hepatological, muscle and haematological 
function; sodium (mmol/L), potassium (mmol/L), urea (mmol/L), creatinine 
(pmoWL), gamma glutamyl transferase (Gamma GT; UL), alkaline phosphatase 
(alk. phos; U/L), alanine aminotransferase (ALT; U/L), albumin (g/L), total 
bilirubin (µmoUL), creatine kinase (CK; U/L), haemoglobin (Hb; g/100ml), white 
blood cells (WBC; x 109/L), platelets (x 1091L). 
*P <0.05, ** P<0.01, and "` P<0.001 indicate significant differences between 
pre- and post- supplementation values, within each group. 
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Table 6.2 
tMeasurement units for indices of renal, hepatological, muscle and haematological 
function; sodium (mmol/L), potassium (mmol/L), urea (mmol/L), creatinine 
(gmol/L), gamma glutamyl transferase (Gamma GT; U/L), alkaline phosphatase 
(alk. phos; U/L), alanine aminotransferase (ALT; UL), albumin (g/L), total 
bilirubin (gmol/L), creatine kinase (CK; U/L), haemoglobin (Hb; g/10(ml), white 
blood cells (WBC; x 109/L), platelets (x 109/L). 
;`P<0.01, and "` P<0.001 indicate significant differences between pre- and 
post- supplementation values, within each group. 
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6.4 DISCUSSION 
This study has reported the effects of short-term (20 g. d"' for 5 d) and chronic (3 
g. d"1 for 56 d) Cr supplementation on a range of indices of haematological, 
hepatic, renal and muscle function in young healthy adults. Data from blood 
samples taken prior to supplementation, on the day following and six weeks after 
an established Cr loading dose regimen (Hultman et al, 1996), and following a 
subsequent 8-week maintenance dose of 3 g. d"1 have been examined in the present 
study. Mean concentrations of all indices were within the normal range (Medicine 
Publishing Foundation, 1983) at all times. Information examining some of these 
indices in older adults (-51 years) during 8 week Cr supplementation has been 
published in abstract form (Almada et al, 1996; Earnest et al, 1996), whilst more 
recent work has reported some clinical chemistry indices in male athletes 
ingesting Cr for 28 d (Kreider et al, 1998) and renal responses in healthy males 
after short-term supplementation (Poortmans et al, 1997). In none of these reports 
were adverse responses reported. 
Creatinine has been established as the sole end product of Cr degradation, being 
formed non-enzymatically in an irreversible reaction (Fitch & Sinton, 1964; Fitch 
et al, 1968). As skeletal muscle is the major store of the body Cr pool (Walker, 
1979), it is therefore the main site of creatinine production. In normal healthy 
individuals plasma creatinine concentration is dependent upon total muscle mass 
(Heymsfield et al, 1983), thus daily renal creatinine excretion is relatively 
constant in a given individual, but can vary between individuals (Fitch, 1977). In 
the present study, serum creatinine concentration on the day following Cr loading 
was within the normal range and was not significantly greater than pre- 
supplementation concentration. These results compare well with those of 
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Poortmans and colleagues (1997), who found no difference in subjects' plasma 
creatinine concentrations between Cr supplemented (20 g. d"l, 5 d) and placebo 
conditions. The relatively greater change in serum creatinine concentration over 
time compared with that of the placebo group in the present study merely reflects 
the contribution of the increased muscle Cr concentration to the rate of muscle Cr 
degradation to creatinine. This has been reported previously, together with a 
parallel increase in urinary creatinine excretion (Hultman et al, 1996). This 
change in creatinine production, coupled with the fact that creatinine 
concentration remained within the normal range, suggests that kidney function 
was unaffected by Cr loading. Six weeks after discontinuation of Cr loading there 
was no indication of an elevated serum creatinine concentration. Muscle TCr will 
have returned close to pre-supplementation levels by this time (Hultman et al, 
1996), as will have renal creatinine excretion. Maintaining elevated muscle Cr 
concentration by ingesting 3 g. d"1 Cr after Cr loading increased serum creatinine 
above . pre-supplementation concentrations. However, these concentrations were 
again within the normal range and again, were likely due to the increase in muscle 
Cr concentration. Similar results have been observed following 28 d Cr 
supplementation (15 g. d"') and training in young athletes (Kreider et al, 1998), 
however, serum creatinine concentration did not change in older adults following 
8 week Cr supplementation (20 g. &, 5d followed by 10g. d"1 for 51 d; Earnest et 
al, 1996). 
No difference in serum urea concentration was observed on the day following Cr 
supplementation. This is in contrast to studies in rats, which showed elevated 
plasma urea concentrations on the day following a7d period of Cr administration 
(ÖSpik et al, 1996). The authors attributed this result to an increased availability 
143 
of arginine for urea synthesis, resulting from a decrease in its use in endogenous 
Cr biosynthesis. The increase in serum urea concentration six weeks following 
the Cr loading regimen is likely to be of little clinical significance. The serum 
concentration of urea represents primarily a balance between urea formation from 
protein catabolism and its excretion in urine. As urea is formed almost solely in 
the liver from the catabolism of amino acids it is unlikely that any changes in 
serum urea at this time would be seen as a direct result of Cr supplementation. 
The breakdown pathway for Cr is via transformation to creatinine and is not a 
reversal of its synthesis from its amino acid precursors. This contention is 
supported by the lack of any difference in serum urea concentration on the day 
following a Cr loading regimen. It has been proposed that Cr supplementation 
may promote lean tissue synthesis, at least during an exercise training period 
(Vandenberghe et al, 1997; Kreider et al, 1998). If this was the case in the present 
study, it is possible that the elevated urea concentration resulted from an increased 
lean tissue mass following Cr supplementation contributing to a greater degree of 
net protein catabolism during the six week post-supplementation period. This 
explanation seems unlikely in this case, however, given that Cr was ingested for 
only 5d without any concurrent training, and is refuted further by the finding that 
serum urea was unchanged after more chronic supplementation with training 
(CrMAINT+EX group)* 
Serum sodium concentration was increased six weeks after Cr loading. However, 
the absence of any similar change on the day after completing supplementation 
suggests that this was unlikely to be due to supplementation, and the magnitude of 
the change would be expected to be of little clinical significance. Similarly the 
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increase in serum potassium concentration following chronic Cr supplementation 
was small and again unlikely to be of clinical significance. 
All hepatic function indices were within the normal limits before and after Cr 
loading. The changes observed in serum alkaline phosphatase (CrMAINT+EX) and 
alanine aminotransferase (ALT) activity (CrMAINT), and albumin (PLOAD+6, 
CrMAINT+EX, CrMAINT) and bilirubin (PLOAD) concentrations with time were all 
marginal and occurred in both directions. Elevated ALT activity is a commonly 
used indicator of liver cell damage, however, in the present study its activity 
decreased over time. A small increase in ALT has been observed following 28 d 
Cr supplementation (Kreider et al, 1998), however, no similar changes in hepatic 
function indices have been observed by other investigators (Almada et al, 1996; 
Earnest et al, 1996; Kreider et al, 1998; Poortmans et al, 1997). It is suggested 
that the changes in the present study are unlikely to be of clinical significance and 
probably unrelated to the experimental protocol. 
Haematological indices were unchanged by the supplementation protocols. 
Similar observations have been made by Kreider et al (1998). In an investigation 
of athletes ingesting Cr whilst engaged in body mass reduction for weight-classed 
competition, haemoglobin concentration was slightly increased post- 
supplementation (Öiipik et al, 1998). However, this small increase was likely to 
have been mediated by a 3.8% decrease in plasma volume observed at the same 
time, and not as a result of Cr supplementation. 
Serum CK activity, an accepted marker of muscle damage, was unchanged six 
weeks following acute Cr supplementation, nor was it changed following more 
chronic supplementation in the presence and absence of resistance training. This 
latter finding is of particular interest, as anecdotal comments have linked Cr 
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supplementation to the development of muscle cramps and muscle-tendon injury 
during or following exercise (Anon, 1998a; Anon 1998b; Josefson, 1998). In the 
present study there were no reports of muscle cramping or injury. An increase in 
CK activity has been observed in males, but not females, following 8 weeks Cr 
supplementation (Almada et al, 1996). 
In conclusion, results from this study provide evidence that there are no obvious 
adverse clinical effects of acute or more chronic Cr supplementation on indices of 
haematological, hepatic, muscle and renal function. Additionally, all subjects 
reported no adverse effects of Cr supplementation and no incidences of muscle 
injury occurred in individuals ingesting Cr during a resistance training program. 
It can therefore be suggested that there is no obvious health risk associated with 
Cr supplementation to healthy individuals when ingested in the recommended 
quantities that have been scientifically proven to have an ergogenic effect. 
Note 6.1 It is accepted that variations in hormone concentrations may influence 
the indices measured in the present investigation, particularly in females. In an 
attempt to control for such influences, blood samples obtained from each female 
subject pre- and post-supplementation were taken at approximately the same stage 
of her menstrual cycle. All females were pre-menopausal and were taking oral 
contraceptive medication at the time of the investigation. 
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Chapter 7 
GENERAL DISCUSSION 
The experiments described in this thesis were conducted to examine various 
effects upon human metabolism of oral supplementation with the guanidino 
compounds creatine and arginine. Creatine supplementation has received a lot of 
attention since it was first shown that muscle TCr concentration could be 
increased by oral Cr ingestion (Harris et al, 1992). The first demonstrations that 
Cr supplementation could improve exercise performance of repeated bouts of 
high-intensity exercise (Greenhaff et al, 1993; Balsom et al, 1993a) stimulated a 
great amount of subsequent investigation. This included studies of the effects of 
Cr ingestion upon performance of different activities and also of the mechanisms 
by which Cr supplementation produced these effects. It was noted in some 
investigations that some individuals demonstrated little or no change in muscle 
TCr concentration following Cr supplementation, and that a large variation in TCr 
accumulation existed between individuals. Methods proposed to improve muscle 
TCr accumulation included the performance of submaximal exercise (Harris et al, 
1992) and ingestion of CHO (Green et al, 1996a) during the period of Cr 
supplementation. 
Chapter 3 of this thesis examined the effects of combining exhaustive exercise 
with Cr + CHO supplementation upon subsequent accumulation of TCr and 
glycogen in skeletal muscle. Using a 1-legged model of exercise, it was 
demonstrated that exhaustive exercise performed prior to Cr + CHO 
supplementation resulted in greater Cr accumulation in exercised than in non- 
exercised muscle. No increase in TCr concentration of the exercised muscle was 
apparent after 6h of Cr supplementation immediately following exhaustive 
exercise, which suggested that an exercise-induced increase in blood flow to the 
muscle was not the cause of the increased accumulation. Therefore other factors, 
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probably localised to the exercised muscle itself, may be responsible for this 
effect. Further investigation is required, therefore, into mechanisms by which 
exercise augments Cr accumulation. The combined exercise / supplementation 
protocol used in the study did not result in muscle TCr concentrations above those 
achieved by Cr + CHO supplementation without exercise (Green et al, 1996a), 
however, and appeared to diminish Cr accumulation in non-exercised muscle. It 
was demonstrated that the exercise protocol resulted in diminished glucose- 
stimulated responses of subjects compared with their responses when in a rested 
state. This provides further support to the proposed importance of insulin in 
muscle Cr transport (Steenge et al, 1998). It is intriguing, however, that such a 
difference in Cr accumulation existed between limbs. Although the post-exercise 
blunting of the CHO-stimulated insulin response is likely to have affected Cr 
transport in the early period of supplementation, it is unlikely to have lasted 
beyond the first day of supplementation (LeBlanc et al, 1981). It is possible that 
by this time the process of Cr transporter down-regulation had begun, diminishing 
net Cr uptake despite a return to a normal insulin response to glucose. This 
proposal is given support by the observation that less Cr is retained by the body 
during days 2 and 3 of supplementation than during the first day of 
supplementation (Harris et al, 1992). 
Another interesting finding of Chapter 3 was that the glycogen supercompensation 
response, seen following glycogen-depleting exercise and a high CHO diet, was 
augmented when Cr was also ingested. This suggested that muscle Cr 
accumulation could influence muscle glycogen synthesis by some mechanism. 
One explanation proposed for this effect was that muscle cell volume increased 
due to Cr accumulation, which stimulated glycogen synthesis. This proposal has 
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been given support by findings, recently published, that acute Cr supplementation 
increases intracellular volume in man (Zeigenfuss et al, 1998). The augmentation 
of glucose-stimulated insulin release by ingestion of Cr with CHO (Green et al, 
1996c) could be another mechanism by which Cr ingestion might improve muscle 
glycogen storage. However, in Chapter 3 no difference in insulin response to 
CHO was observed between subjects receiving CHO or Cr + CHO under rested 
conditions or following exercise. Furthermore, there was no difference, between 
groups, in glycogen concentration of the non-exercised muscle. These results 
suggest that further investigation of the effects of Cr + CHO ingestion upon 
insulin release are warranted. 
The finding, in Chapter 3, that Cr + CHO supplementation resulted in greater 
glycogen storage in exercised muscle, led to the investigation undertaken in 
Chapter 4. In this experiment, the effects of another guanidino compound, 
arginine, upon physiological factors known to influence CHO storage were 
studied. It was proposed that oral ingestion of arginine might increase the muscle 
storage of an ingested quantity of CHO, by enhancing insulin release and 
increasing blood flow to muscles. This investigation (performed using subjects 
under rested conditions and following types of exercise known to differentially 
affect glucose storage) aimed to assess whether arginine ingestion could be a 
beneficial aid to post-exercise glycogen replenishment. There was no indication, 
however, that arginine ingestion improved the storage of ingested CHO following 
any type of activity. Although not measured in the study, it was likely that the 
quantity of arginine ingested was insufficient to increase plasma arginine 
concentrations to levels that would influence insulin release or stimulate 
peripheral vasodilatation. A question for future research would be to determine 
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the oral arginine dose necessary, to reproduce the effects observed when arginine 
is administered intravenously. However, from a practical point of view, it is 
unlikely that such information would be of use to individuals wishing to improve 
muscle CHO storage after exercise. Dietary intake of -30 g. d"' arginine leads to 
sodium and water loss in urine (Beaumier et al, 1995). Furthermore, the 
observation that some individuals experience gastrointestinal disturbances 
following ingestion of 6- 10 g doses of arginine (present investigation; Gater et 
al, 1992) suggests that higher oral doses of arginine may not be well tolerated. 
One way in which this problem may be overcome would be to combine the 
ingestion of two or more insulinotropic amino acids. 
Results of Chapter 3 supported a previous observation that a tendency existed for 
greater muscle glycogen accumulation when Cr was ingested with CHO (Green et 
al, 1996b; Green, 1996). The amounts of additional glycogen stored, compared 
with those stored following CHO supplementation, were proposed to be sufficient 
to prolong the duration of subsequent exhaustive submaximal exercise. In 
Chapter 5, the effects of CHO, Cr + CHO and Cr supplementation regimens upon 
muscle glycogen and Cr accumulation were examined, along with their effects 
upon subsequent endurance exercise performance. It was shown that Cr ingestion 
during CHO supplementation did not significantly improve muscle glycogen 
accumulation compared with CHO supplementation alone. As a consequence of 
this, performance of endurance exercise was not significantly improved, although 
a tendency for prolonged exercise duration was apparent following Cr + CHO 
supplementation. For practical reasons, the experimental group was split into 2 
sub-groups, which effectively decreased the statistical power of the tests used to 
analyse the data. It was suggested that the results were inconclusive due to low 
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sample numbers in each of the Cr treatment groups and that more conclusive 
information would be obtained if additional subjects were included in the 
investigation. 
Chapter 5 also showed that, although muscle Cr concentration tended to be higher 
following Cr + CHO supplementation, TCr concentrations were not significantly 
different from those of individuals supplemented with Cr alone. This may also 
have been due to the small numbers of subjects in the experimental groups and a 
wide individual variation in their TCr concentrations. Examination of the muscle 
TCr accumulation of subjects following Cr and Cr + CHO supplementation 
revealed that this was less than had been previously observed in subjects receiving 
identical supplements. This may partly have been due to some individuals 
demonstrating little or no change in muscle TCr concentration (non-responders). 
Indeed, some subjects receiving Cr alone and some in the Cr + CHO group could 
be considered as `non-responders'. Removal of these subjects' values from their 
respective group mean TCr concentrations suggested that the remainder of the 
subjects in each group had responses similar to those previously observed in 
subjects receiving the same treatments (e. g. Green et al, 1996a). It was suggested 
that further insight into the effects of Cr + CHO supplementation could be 
achieved, by increasing the number of subjects in each experimental group. 
Although the results of Chapter 5 suggested that Cr + CHO supplementation may 
not improve endurance performance, the results of Chapter 3 suggest that 
performing glycogen-depleting exercise prior to Cr + CHO supplementation may 
achieve this goal. The changes in muscle glycogen concentration produced by the 
protocol in Chapter 3 were far greater than by Cr + CHO supplementation in 
rested individuals. Therefore, the next direction of research in this area should 
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examine endurance performance of individuals before and after a supplementation 
protocol that involves glycogen-depleting exercise followed by Cr + CHO 
ingestion. Careful consideration should be made of the method for measuring 
endurance performance and of the training status of experimental subjects, to 
minimise within- and between- subject differences that may overshadow the 
statistical power of the results. 
Another direction for future research is to investigate the influence that an 
individual's training status has upon muscle Cr accumulation. To date, there has 
been no investigation that has compared muscle Cr accumulation of trained and 
untrained subjects. In a critical review of the ergogenic effects of Cr on exercise 
performance in competition-like tasks, it was proposed that highly trained athletes 
did not benefit from Cr supplementation as much as untrained subjects (Mujika & 
Padilla, 1997). The training status of an individual can be suggested to influence 
a number of factors that may affect Cr accumulation. 
An individual's training status is known to influence muscle Na fK pump 
concentration, a factor that provides a driving force for muscle Cr transport. 
Muscle total Na+/K+ pump activity has been proposed to influence Cr 
accumulation by its ability to generate a Na+ gradient across muscle cell 
membranes. An increase in net Na+/K+ pump activity (by increases in the total 
number of pumps or in pump activity, or both) would increase the drive for Na+- 
dependent Cr transport (Odoom et al, 1996). Exercise training results in increases 
in muscle total Na /K+ pump concentration (Klitgaard & Clausen, 1989; Green et 
al, 1993; McKenna et al, 1993; Madsen et al, 1994), with strength training having 
a greater effect than endurance training (Clausen, 1998). It can be proposed, 
therefore, that trained subjects might achieve a greater degree of Cr accumulation 
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than untrained individuals, due to a higher concentration of muscle Na+f+ 
pumps. Net activity of Nä /K+ pumps also depends upon the activity of the 
individual pumps themselves. Insulin has a potent stimulatory effect upon Na+/+ 
pump activity and is believed to act by increasing the affinity of the pumps for 
intracellular Na+, thereby promoting Naa transport from the cell (Clausen, 1998). 
An increase in serum insulin concentration, such as that following ingestion of 
CHO, would be expected to increase Na+/K+ pump activity. It is this phenomenon 
that has been suggested to account for the greater Cr accumulation seen with Cr + 
CHO supplementation (Greenhaff, 1997). Trained individuals exhibit a 
diminished insulin response to a given amount of CHO than untrained individuals 
(Heath et al, 1983; King et al, 1987; Rodnick et al, 1987; Engdahl et al, 1995; 
Hickner et al, 1997). It is known that high physiological concentrations of insulin 
are necessary to stimulate Cr transport into human muscle in vivo (Steenge et al, 
1998). Such high concentrations can usually be achieved by ingesting large 
amounts of CHO. As glucose-stimulated insulin release is diminished in trained 
subjects, it is possible that they may not benefit from CHO ingestion during Cr 
supplementation. Some of the diminished insulin response seen in trained 
subjects is attributable to the effect of the preceding bout of exercise. This was 
shown in trained individuals, who had an increase in glucose-stimulated insulin 
response above their normal response, after 10 days of detraining (Heath et al, 
1983). An interesting direction for future research would, therefore, be to 
examine Cr accumulation of trained individuals. Experimental interventions 
might include Cr supplementation following various periods of detraining, or 
comparison of muscle Cr accumulation in trained and untrained subjects under 
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conditions where circulating insulin concentrations are identical (e. g. by use of an 
insulin clamp technique and naso-gastric Cr feeding). 
The type of training that individuals are involved in may also influence their 
capacity for Cr accumulation. Although mainly genetically-determined, muscle 
fibre composition can be influenced, to a limited extent, according to the type of 
activity that an individual is regularly engaged in (Komi & Karlsson, 1978). PCr 
concentration varies between fibre types (Soderlund et al, 1992; Greenhaff et al, 
1994; Sahlin et al, 1997), with type II fibres having approximately 20% more PCr 
than type I fibres. Although not demonstrated, it is possible that this is achieved 
by type II fibres having a greater number of Cr transporters than type I fibres. It 
could be proposed, therefore, that individuals with a greater proportion of type II 
fibres (e. g. sprinters, weightlifters) would have greater muscle TCr concentrations 
following supplementation than individuals with a more even distribution of type 
I and II fibres. Examination of PCr distribution across fibre types before and after 
supplementation has shown, however, that type II fibres have the same change in 
PCr concentration as type I fibres (Casey et al, 1996b). Although no information 
is available for single fibre concentration of Cr, it is reasonable to assume that 
similar changes in muscle Cr concentration between fibre types occur with Cr 
supplementation. This would suggest that any differences in muscle fibre 
composition of subjects would be unlikely to influence the extent of muscle Cr 
accumulation. 
The rise in the popularity of Cr as a dietary supplement has ultimately led to an 
increase in the attention it has received from the public media. An unfortunate 
accompaniment to this publicity is the opportunity for anecdotal opinions to be 
expressed, which subsequently become regarded as factual information. In the 
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case of Cr supplementation, such anecdotal claims have implicated Cr 
supplementation with causing muscle injury, cramping, dehydration, and 
gastrointestinal disturbance and, in one extreme case, the deaths of three 
American college wrestlers. However, these claims have not been substantiated 
with any scientific evidence, indeed scrutiny of the circumstances associated with 
the wrestlers' deaths led the U. S. Department of Health and Human Services to 
conclude that Cr was not associated with the deaths (Centers for Disease Control 
and Prevention, 1998). " Two recent case reports remain the only scientific 
evidence linking Cr supplementation to impaired health (Pritchard & Kalra, 1998; 
Koshy et al, 1999). Both of these reports linked Cr supplementation to kidney 
dysfunction, although neither could definitively conclude that the supplementation 
caused the conditions. A small number of investigations have examined the 
effects of Cr supplementation on various aspects of health, such as kidney 
function (Earnest et al, 1996; Kreider et al, 1998; Poortmans et al, 1997), liver 
function (Almada et al, 1996; Earnest et al, 1996; Kreider et al, 1998; Poortmans 
et al, 1997) and muscle damage (Almada et al, 1996). Chapter 6 investigated the 
effects of Cr supplementation on markers of haematological, hepatological, 
muscle and renal function in healthy individuals. No obvious indication of 
impaired function was observed for any of the aspects measured. The majority of 
concerned comments expressed in the media from individuals or governing bodies 
have been related to the effects of Cr supplementation on the kidneys. It is likely 
that these concerns stem from the use of serum creatinine concentration as a 
marker of glomerular function in the kidney. Creatinine concentration above the 
normal range in the blood traditionally has indicated impairment of renal function, 
and a change in concentration over time is usually as a result of a change in 
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glomerular filtration rate (Marshall, 1993). Diagnosis of impaired renal function 
arising from serum creatinine measurement makes the assumption that creatinine 
production is constant in the body. This is not the case following Cr 
supplementation, however, as creatinine production rises with an increased 
muscle Cr store (Hultman et al, 1996). Furthermore, creatinine excretion in the 
urine rises during Cr supplementation and is maintained at elevated levels for a 
week or more following ingestion of the last supplement (Hultman et al, 1996). 
Under circumstances where renal dysfunction is indicated in an individual who 
has supplemented with Cr, it might be appropriate to assess the clearance rate 
from the circulation of intravenously infused inulin. Inulin clearance is accepted 
as being equal to the glomerular filtration rate, as it is completely filtered from the 
blood by the glomeruli and is not secreted, reabsorbed or metabolised by renal 
tubules (Marshall, 1993). It may be prudent to incorporate this method into any 
future laboratory-based investigations of the effects of Cr supplementation upon 
kidney function. 
The general findings from Chapter 6 suggest that there are no obvious adverse 
effects to an individual's health from short-term Cr supplementation (i. e. 20 g. d"1 
for 5 days) or prolonged Cr ingestion (e. g. 3 g. d-1 for 8 weeks). The effects of Cr 
supplementation for longer periods (> 8 weeks) upon health are currently 
unknown. It would be of value to obtain clinical information, similar to that 
measured in Chapter 6, from individuals ingesting Cr over longer periods such as 
during a season of athletic training. Information relating to the incidence of injury 
or other side effects attributed to Cr ingestion should also be recorded. This data, 
when compared with closely-matched control individuals undergoing identical 
training regimens, could allow assessment of whether Cr supplementation per se 
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contributes to these side effects, or whether they arise as a result of increased 
workloads attempted during training. At present there is no information 
concerning the effects of ingesting amounts of Cr higher than those proven to 
have an ergogenic effect. Anecdotal comments have claimed that some athletes 
use 10 - 30 times the recommended doses (Anon, 1998a). As there appears to be 
no additional benefit of ingesting very large amounts of Cr for long periods (the 
majority of the daily 20 g administered is excreted in urine after the initial days of 
supplementation, Harris et al, 1992), this practice should be discouraged. Perhaps 
some responsibility should fall upon researchers to promote sensible use of Cr, by 
reinforcing this message in scientific publications. 
In summary, the experiments reported in this thesis have demonstrated that Cr 
accumulation by muscle can be enhanced by prior exhaustive exercise (Chapter 
3), but that the stimulatory effect of CHO ingestion upon Cr accumulation is 
abolished under these conditions, possibly due to diminished glucose-stimulated 
insulin release following exercise. It was also shown that CHO ingestion during 
Cr supplementation might not augment Cr accumulation in all individuals 
(Chapter 5), suggesting that further research is required into this method of Cr 
supplementation. Ingestion of Cr + CHO enhanced glycogen storage in exercised 
muscle, to a greater extent than CHO ingestion alone (Chapter 3). 
Supplementation with Cr + CHO without prior exercise did not significantly 
improve glycogen accumulation, however, and did not significantly improve 
subsequent exercise performance. This suggests that it may be necessary to 
perform glycogen-depleting exercise prior to Cr + CHO supplementation to 
achieve glycogen concentrations that could improve endurance performance. 
Arginine, which is involved in Cr biosynthesis and has also been associated with 
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improvements in CHO disposal, was found to be ineffective in promoting CHO 
storage in rested or exercised subjects when given orally (Chapter 4). It is likely 
that this was due to an inability to achieve a plasma arginine concentration 
sufficient to stimulate mechanisms that would promote CHO storage. Finally, 
Chapter 6 showed that there was no obvious impairment to health of acute (5 d) or 
more chronic (8 week) periods of Cr supplementation at doses shown to 
significantly increase muscle TCr concentration. 
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APPENDICES 
Su jects' information sheets 
Effects of e haustive exercise and creatine and carbohydrate supplementation 
upon muscle creating and glycogen accumulation 
Mr Tristan M. Robinson, Dr Paul L. Greenhaf Dr Dean A. Sewell 
Department of Physiology and Pharmacology, University of Nottingham Medical 
School, Queen's Medical Centre, Nottingham. NG7 2UH. 
Subject information sheet 
Within the Department of Physiology and Pharmacology we are interested in the 
effect of muscle glycogen depletion upon subsequent glycogen resynthesis and 
creatine uptake into skeletal muscle. 
Creatine is important to energy transduction during normal muscle function. 
Almost all of the human pool of creatine is contained in skeletal muscle. Humans 
have the ability to synthesise creatine, but can also receive it in their diet from 
meat and fish. 
In this present study we will be asking volunteers to consume creatine and/or 
glucose following 1-legged exhaustive exercise on a bicycle ergometer. To 
measure muscle creatine and glycogen concentration, a small sample of muscle (a 
biopsy) will be taken from each leg following exercise, 6 hours following exercise 
and after 5 days of supplementation with creatine and/or glucose. The creatine 
dose to be administered will be 5g each time, this amount has not been shown to 
produce any adverse effects in human individuals. 
You are free to withdraw from this study at any stage, if you so wish. 
On the day prior to the visit, please refrain from: 
a) heavy exercise 
b) consumption of alcohol 
c) consumption of food from 9 p. m. onwards. You are allowed to drink water. 
On the day of the visit: 
Please report to room B8a, medical school building at 11 a. m. 
You will be required to lie on a bed, and rest for approximately two hours. A 
cannula will be inserted into a vein in your arm and a blood sample will be taken. 
You will then be given a warm fruit drink to consume, possibly containing 
creatine, followed by 500 ml of Lucozade. Blood samples will then be taken 
every 20 minutes for the following 100 minutes. After this you are free to leave. 
I 
High carbohydrate food list 
Please try to eat only foods listed below: 
Provided: 
Potatoes (boiled or baked) 
Rice 
Cereal (e, g, Kellogg's Cornflakes, Rice Crispies) 
Pasta (e. g. spaghetti) 
Other suggested items: 
Bread 
Jam, Honey, Golden syrup, Marmalade 
Baked beans 
Fruit, esp. Bananas, Apples 
Dolly mixtures, Liquorice allsorts, Bioled sweets, fruit gums etc. 
Ginger snap biscuits & Fig rolls 
Vegetables (except for nuts) 
Any soft drinks 
Chutney, pickles etc. 
Dried fruit (e. g. Figs) 
Low carbohydrate content, please eat as little as possible. 
Semi-skimmed milk (we'd prefer you to use skimmed milk) 
Margarine/butter 
Meat (including sausages, hamburgers etc. ) 
Chocolate & cakes 
Fish 
Cream 
Cheese 
U 
Effects of ar 'nip ingestion on blood response to an oral glucose load at rest and 
follpwin_g exercise 
Mr Tristan M. Robinson, Dr Paul L. Greenhaf Dr Dean A. Sewell 
Department of Physiology and Pharmacology, University of Nottingham Medical 
School, Queen's Medical Centre, Nottingham. NG7 2UH. 
Subject information sheet 
Within the Department of Physiology and Pharmacology we are interested in the 
supply of glucose to skeletal muscle for energy storage. Uptake of glucose by 
muscle is mediated by insulin which is secreted following ingestion of a meal. 
The naturally occuring amino acid, arginine, can be obtained from the diet and, 
although not an essential amino acid, is necessary for cell growth and normal 
tissue repair following injury. Additionally, arginine is known to stimulate insulin 
secretion. 
The aim of this study is to look at the effect of drinking an arginine solution on 
blood glucose and insulin concentration following oral glucose ingestion. In 
addition, we wish to investigate the effect of two different forms of exercise upon 
this response, as exercise is also known to influence insulin release and blood 
glucose disappearance. 
Following routine medical screening, some preliminary exercise tests will be used 
to determine the intensity of exercise at which you will perform during the study. 
There will then be six further visits to the laboratory over the following seven 
weeks, each separated by at least one week. At each visit, following a 48 hour 
period refraining from alcohol consumption and strenuous activity, and an 
overnight fast, you will be required to undertake one of the following three 
regimens; 
i) Consume a test drink and rest on a bed for 3 hours, 
ii) Exercise on a cycle ergometer for an hour at an intensity which will 
raise heart rate to approximately 170 bpm. You will then consume 
a test drink and rest on a bed for 3 hours, 
iii) Perform repeated bouts of `squat' weightlifting exercise, lifting a 
weight determined in the preliminary test. You will then consume a 
test drink and rest on a bed for 3 hours. 
Each activity will be performed twice, on separate occasions, during the study 
period. 
During each visit a small plastic needle (a cannula) will be inserted into a vein of 
your arm, this will be used to obtain small blood samples in the recovery period 
following consumption of the test drink. Measurements of expired gases, heart 
rate, blood pressure and blood flow will also be taken in this period. 
You are free to withdraw from this study at any time that you wish. 
An inconvenience allowance of £ 100 has been allocated for your compliance 
with and completion of this study. 
III 
UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL 
Healthy Volunteer's Information Sheet 
Dr Dean A. Sewell, Dr Paul L. Greenhaff, Mr Tristan M. Robinson*, 
Cardiovascular, Metabolism and Nutrition Section, School of Biomedical 
Sciences, University of Nottingham Medical School, Queen's Medical Centre, 
Nottingham, NG7 2UH. 
*Person to whom correspondence should be sent 
Subject Information Sheet 
Within the School of Biomedical Science we are interested in muscle 
function and fatigue during exercise. We are presently investigating the intake and 
metabolic consequences of the consumption of creatine, a compound involved in 
energy production in muscle. Creatine is synthesised in the body, but can also be 
obtained from the diet by eating meat. 
In this present study we will be asking volunteers to consume powdered 
creatine and glucose. We will measure the amount of creatine and other energy 
stores in muscle samples. 
After routine medical screening and the completion of a health 
questionnaire, we will ask you to perform a short exercise test to exhaustion on a 
cycle ergometer to measure maximal oxygen uptake (VO2). The test will last 
for approximately 12 minutes and involves breathing through a mouthpiece so 
that we can sample the air breathed out. A few days later you will return to repeat 
this test, to confirm your VO2, = value. After this visit you will be required to 
make 4 visits to the laboratory in the following six weeks. We ask that you do not 
exercise or drink any alcohol for 48hrs before each visit. 
On the next visit (the first test session), following an overnight fast (from 9 
p. m. the previous evening) you will be asked to cycle to exhaustion at an intensity 
of 70% VO21. It is expected that this will take approximately two hours. A small 
sample of muscle (a biopsy) will be taken from your leg prior to exercise and 
immediately following the end of exercise. Muscle samples are taken from a small 
incision -(approximately 4 mm) through the skin, local anaesthetic is injected into 
the area to prevent discomfort during the procedure. Some subjects report slight 
soreness but no complications are anticipated. During each test visit a small 
plastic needle (a cannula) will be inserted into a vein of your arm, this will be 
used to obtain small blood samples during the exercise. 
Following a week of normal diet and activity you will be given 
supplements of a glucose drink, to take over a period of 5 days, in addition to your 
usual diet. During this supplementation period we require you not to perform 
any exercise. The day following the last day of supplementation you are required 
to return to the laboratory to repeat the exercise/sampling test session, during 
N 
which an additional muscle sample will be taken (3 samples in total during this 
visit). 
A week following this exercise session you will be given supplements of either 
creatine (to be dissolved in a warm drink) and glucose drink, or creatine only, to 
take over a period of 5 days, in addition to your usual diet. Again, we require you 
not to perform any exercise during this 5-day period. On the day following this 
supplementation period you will be required to return to the laboratory to repeat 
the test session outlined above, including muscle sampling. 
An inconvenience allowance of £150 is available for completion of the study. 
You are free to withdraw from this study at any stage, if you so wish. 
V 
Guidelines for diet & activity during the study. 
On the day prior to any visit to the laboratory: 
" Do not consume any food or drink, other than water, after 9 p. m. 
" Do not drink any alcohol 
During the three days prior to the Familiarisation visit: 
" Follow your normal diet and record everything you eat in the food diary 
provided. You will be required to keep to this diet prior to future visits. 
" Do not engage in any strenuous activity (e. g. training, anything other than 
`normal daily activity') 
During the 5-day carbohydrate (CHO) supplementation period (prior to Test Session 
2): 
" You are asked to drink a 500 ml `serving' of Lucozade, at four equally- 
spaced times each day (e. g. 8 am, 12 pm., 4 pm., 8 pm. ) 
" Do not engage in any strenuous activity 
" Keep to your `normal diet', as recorded in your food diary, during the 3 
days prior to the next visit. 
EITHER 
OR 
During the 5-day creatine and carbohydrate (Cr + CHO) 
supplementation period (prior to test session 3): 
" You are asked to drink a warm-to-hot drink containing one vial 
of creatine powder, at four equally-spaced times each day, 
followed immediately by 500 ml of Lucozade (see note below 
concerning creatine drink preparation) 
" Do not engage in any strenuous activity 
" Keep to your `normal diet', as recorded in your food diary, 
during the 3 days prior to the next visit. 
During the 5-day creatine (Cr) supplementation period (prior to test 
session 3): 
" You are asked to drink a warm-to-hot drink containing one vial of 
creatine powder, at four equally-spaced times each day, (see note 
below concerning creatine drink preparation) 
" Do not engage in any strenuous activity 
" Keep to your `normal diet', as recorded in your food diary, during 
the 3 days prior to the next visit. 
NB. You may partake in physical activity/training in the period between a visit to 
the laboratory and the first day of any supplementation. 
Creative drink pr ra_ation 
You are provided with vials containing 5g creatine monohydrate. To prepare a 
drink, creatine must be dissolved in a warm-to-hot, but not boiling, drink. Ensure 
that all of the powder is dissolved in the drink (e. g. by stirring). We ask that you do 
not dissolve the creatine in coffee. 
Care of biopsied area 
You are advised to keep the area covered with the transparent sheet applied after the 
biopsies are obtained. This will prevent the area from becoming wet when washing, 
and also maintain sterility of the area. DO NOT TAKE ASPIRIN OR ANY 
ASPIRIN-CONTAINING PRODUCT in the days following biopsy sampling. 
vi 
Oxygen consumption 
The volume of oxygen inspired is calculated by multiplying the volume of air 
inspired per minute (VI; corrected to standard temperature and pressure for dry 
gas, STPD) with the proportion of inspired air that is made up of oxygen (F102). 
The volume of expired oxygen is calculated in a similar manner, with the expired 
volume of air (STPD corrected) and proportion of air that is oxygen given the 
terms VE and FEO2, respectively. 
Therefore V02 can now be expressed as: 
V02=(V1"FI02) - E"FEO2) 
Carbon dioxide production 
VCO2 = (VE " FECO2) - (VI " FIC02) 
where FECO2 and F1C02 are the proportions of carbon dioxide in expired and 
inspired air, respectively. 
Calculation of substrate oxidation from RER 
Protein oxidation (VO2P) can be estimated by the equation 
V02P = V029 0.125 
Where 0.125 is the proportional contribution of protein to the total V02 under 
thermoneutral conditions at rest. 
Given V02P, we can calculate the non-protein component of V02 (VO2NP): 
VO2NP = V02 - VO2P 
VII 
By similar methods we can calculate VCO2P and VCO2NP: 
VCO2P = V02p " 0.81 
VCO2NP = VCO2 - VCO2 9 
where 0.81 is the RER value for protein oxidation. 
Consequently, the non-protein component of RER (RERNp) can be calculated: 
RERNP = V[ZNP 
VO2NP 
The percentage contribution of CHO and fat to RERNP can be calculated: 
%CHONP _ $$&P - 0.707 . 100 
1-0.707 
%FAT = (100 - %CHONp) 
where 0.707 is the RER value for fat oxidation and 1 is the RER value for CHO 
oxidation. 
From the resultant values, the rate of oxidation of CHO (CHOox) or fat (FATox) 
can be calculated: 
VO2CHO = Y-Q. Ql. QNP! VQNP 
100 
CHOox = YQ2cxo (g. mii-1) 
0.788 
VO2FAT = Y"NP " VO2Np 
100 
FATox = YQ2FAT (g. miri 1) 
2.019 
where 0.788 is the amount of oxygen consumed per gram of CHO oxidised (mean 
of glycogen and glucose oxidation) and 2.019 is the amount of oxygen consumed 
per gram of fat oxidised. From these oxidation rates, the total amount of substrate 
utilised over any given period can be calculated. 
vin 
Analytical Assay Procedures 
Method for ATP and PCr determination 
The 3 reactions involved 
1 Glu 6-P + NADP ----G6PDH---> P-gluconolactone +NADPH 
2 ATP + Glu -----HK-------> ADP + Glu 6-P 
3 PCr + ADP ----CPK------> Cr + ATP 
No Reagents Final conc. conc. mass/vol vol/375gl 
------ 
(mM) stock (mM) 
------------------------------------------------------------- ----------------------- --------- 
D1 TEA 100 1000 18.6mg/100m1 37.5 
pH 7.5-7.6 
Mg(Ac)2.4H20 10 100 2.14mg/100ml 
EDTA. Na. 2H20 1 10 0.372mg/100ml 
(+4"C) 
F1 DTT 1 50 7.8mg/ml 7.5 
(+4°C) 
F2 NADP. Na2.4H20 1 25 21.48mg/ml 15 
(+4°C) 
F3 ADP. Na. 2H20 0.04 10 5.01mg/ml 1.5 
(-20°C) 
F4 glucose 5 20 22.5mg/ml 15 
** G-6-PDH Dilute 1p in 2p H2O 1.1 mg/ml 1.125 
------ 
H2O 
----------------------------------------------- -------------- ----------------------- 
297.4 
--------- 
HK Dilute lp in lp H2O 2.0mg/ml 3µl 
CPK Dilute in NaCO3BSA 15mg/ml 3µl 
Ix 
Note: 
G-6-PDH order Boehringer (cat. no. 127035) 1.1mg/ml 
Dilute 1 part in 2 with water. 
HK order Boehringer ammonium sulfate suspension (cat no. 127175) 
2mg/ml. Dilute 1 part in 1. 
CPK order Sigma lyophilised enzyme (cat no. C-3755). 
Dissolve 15mg/ml in 0.5% NaHCOI + 0.05% BSA (DZ). 
--------------------------------------------------------------------------------------------------- 
" Always remember that reagents and samples are to be kept on ice when ever 
possible, but also allowed to come to room temperature. 
" Before starting remove reagents fl, f2, f3 & f4 from fridge/freezer for weighing, 
keeping in the bag with dessicant for 15 min. 
" Prepare reagents f1-f4 and enzymes, calculating the exact proportions required 
for the number of samples and blanks that are being done. 
" Take an aliquot of D1 sufficient for the number of samples to be done, and if not 
doing reaction 1 ensure G-6-PDH is added to the mixture. 
" Mix together all reagents thoroughly in proportions described above. 
" Never do more than 20 samples in one run, placing a blank sample every 6-10 
samples. 
" To the cuvettes 50µ1 of sample is added and 450pl of mixed reagents is added 
" The absorbance is then measured and at 20 s intervals, aliquots of 3g l of the first 
enzyme are added. 
" Twenty minutes from the addition of the first enzyme absorbance. is measured 
again, and at 20 s intervals the next enzyme is added 
" after 45min total the final absorbance measurement is made at 20 s 
intervals. 
X 
Glycogen method 
1. G5 0.1 M NaOH stored at 4°C 
2. G6 0.1M HCl stored at 4°C 
3. G7 0.2 M citric acid, 0.2M Na2HPO4, pH =5, stored at 4°C 
4. AGS Amyloglucosidase (Boehringer, from Aspergilus niger) 200mg/ml, made 
on the day. 
G7 must then be mixed with the G6 at a ratio of 3: 1. 
# NOTE this ratio may need to be slightly adjusted if G5 (which is added to the 
sample) prior to the addition of G6/G7 mix, is not sufficient to neutralise all 
G6/G7 mix. Therefore, before mixing the G7 and G6 the proportion of G5 
required to fully neutralise G6 needs to be checked. Ideally it would be close to a 
1: 1 ratio, but this is not always the case. Do this by adding equal proportions of 
G5 and G6 and check the pH is neutral, and if this is not the case repeat it again 
with increasing proportions of G5 or G6 (as appropriate). Remember this will 
affect the relative proportions of G6/G7, i. e. if more G5 is required to neutralise 
G6, then less G6 is added to the G6/G7 mix proportionally. 
# Remember to have heating block turned on and set to 80°C also before 
commencing. 
Method 
Bring freeze-dried weighed samples to room temperature in dessicant, and store 
on ice. 
To each vial add the appropriate amount of NaOH according to the table below 
(limit samples done at any one time to no more than ten). After adding NaOH to 
each sample, vortex vigorously until all the sample is dissolved and the solution 
has a distinct green tinge. Place samples into heating block set at 80°C to allow 
full solubilisation and reaction with the NAOH for 10 minutes. 
Powder 
(mg) 
0.1 M NaOH 
(111) 
Buffer G6+G7 
(111) 
AGS 
(µ1) 
0.0-1.0 75 300 15 
1.0-2.0 100 400 15 
2.01-3.0 120 480 15 
3.01-4.0 160 640 20 
4.01-5.0 200 800 25 
5.01-6.0 240 960 30 
After 10 minutes remove samples and neutralise by the addition of G6/G7 mix to 
each vial, followed by the addition of AGS. 
xi 
Samples must then be left at room temperature with caps off, for 1 hour. 
The samples must then be spun for one minute at 14,000rpm and the supernatant 
taken. 
Extraction factor calculation 
Ex. Factor = (111) G5 + (111) G6/G7 +(111) AGS 
(mg) of weighed sample 
Glucose assay 
G6PDH 
Glu-6-P + NAD P-gluconolactone + NADH 
HK 
Glu + ATP Glu-6-P + ADP 
RV =450 SV= 40 
Reagents 
Reagents 
Mass/volume 
Final conc. 
(mM) 
Vol 450 
(gl) 
*20 
(Al) 
conc. of 
stock (mM) 
G1 Triethanolamine 100 120 2400 375 
7.00g/ 100ml 
KOH 40 150 
0.8g/100ml 
Mg(AC)2.4H20 30 112.5 
2.4g/100ml 
EDTA. Na. 2H20 1 3.75 
0.14g/100ml 
Adjust to pH 8.2 
With KOH 
H1 ATP 0.75 5 150 45 
27.72mg/ml 
H4 DTT 1 5 150 60 
9.36mg/ml 
F8 NAD 1 10 300 30 
19.92 
H2O 225 4500 
XIII 
G6PDH order Sigma G-5885 (sulphate free! ) dilute vial in 200µ1 H2O only 
lasts a matter of a week once dissolved 
Hexokinase order Sigma H-4502 (sulphate free! ) 200 units dilute 200µl H2O 
Enzymes should be mixed in a 1: 1 ratio sufficient for 3 t1 to be added per cuvette. 
Set spectrophotometer to 366nm. Read each samples abs then add 3µl of enzyme 
mix every sample, and let them incubate for no more than 10 minutes and read the 
abs again. 
XIII 
The 3 reactions involved: 
1 Pyruvate + NADH ----LDH---> Lactate +NAD 
2 ADP + PEP ----- PK------- > ATP + Pyruvate 
3 Cr + ATP ---- CPK------ > PCr + ADP 
Metho 
1) Make up the following reagent mixture with these amounts per cuvette: 
Reagent 
Mass/volume 
Glycine buffer 
KCI 15g/100m1 
ATP Na2.5H20 
PEP 
NADH 
LDH 
PK 
H2O 
Vortex and keep on ice. 
Volume per cuvette (µl) 
150 
7.5 
30 
22.5 
7.5 
0.75 
0.75 
232.5 
--------------------------------------------------------------------------------------------------- 
2) Prepare the enzyme: 
CPK Dilute in 0.5% NaCO3/ 0.05% BSA 15mg/ml 6µ1 per 
cuvette 
Vortex and keep on ice. 
--------------------------------------------------------------------------------------------------- 
3) Set spectrophotometer to read at 340 nm for 1200 s using "METABOLI" 
program. 
--------------------------------------------------------------------------------------------------- 
4) Pipette 450gl of the reagent mix into each cuvette. 
--------------------------------------------------------------------------------------------------- 
5) Defrost the samples quickly in hot water and vortex. 
--------------------------------------------------------------------------------------------------- 
6) Pipette 30µl of water / sample into each cuvette. Mix and start reading. 
--------------------------------------------------------------------------------------------------- 
7) After 4 min add 6µl of CPK to each cuvette. Agitate to mix. Continue reading 
for 20 min where a plateau marks the end point of the reaction. 
XIV 
Note: 
CPK order Sigma lyophilised enzyme (cat no. C-3755). 
Dissolve 15mg/ml in 0.5% NaHCOO + 0.05% BSA (D5). 
--------------------------------------------------------------------------------------------------- 
" Always remember that reagents and samples are to be kept on ice when ever 
possible, but also allowed to come to room temperature. 
" Before starting remove reagents from fridge/freezer for weighing, keeping in the 
bag with dessicant for 15 min. 
" Prepare all reagents and enzymes, calculating the exact proportions required for 
the number of samples and blanks that are being done. 
" Mix together all reagents thoroughly in proportions described above. 
" Never do more than 20 samples in one run, placing a blank sample every 6-10 
samples. 
" To the cuvettes 3Oµ1 of sample is added and 450µ1 of mixed reagents is added 
" The absorbance is then measured and at 20 s intervals, aliquots of 6µd of the first 
enzyme are added. 
" Thirty min from the addition of CPK absorbance. is measured again. 
xv 
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